UBC Theses and Dissertations

UBC Theses Logo

UBC Theses and Dissertations

Development of a lymphatic stress test Lane, Kirstin Nicole 2007-12-31

You don't seem to have a PDF reader installed, try download the pdf

Item Metadata

Download

Media
[if-you-see-this-DO-NOT-CLICK]
ubc_2007-267462.pdf [ 8.26MB ]
[if-you-see-this-DO-NOT-CLICK]
Metadata
JSON: 1.0077005.json
JSON-LD: 1.0077005+ld.json
RDF/XML (Pretty): 1.0077005.xml
RDF/JSON: 1.0077005+rdf.json
Turtle: 1.0077005+rdf-turtle.txt
N-Triples: 1.0077005+rdf-ntriples.txt
Original Record: 1.0077005 +original-record.json
Full Text
1.0077005.txt
Citation
1.0077005.ris

Full Text

D E V E L O P M E N T OF A L Y M P H A T I C STRESS TEST  by  Kirstin Nicole Lane  B.Sc. (Honours), The University o f Victoria,  1997  M . S c , The University of Victoria, 2000  A THESIS S U B M I T T E D IN P A R T I A L F U L F I L M E N T OF T H E R E Q U I R E M E N T S FOR T H E D E G R E E OF  D O C T O R OF PHILOSOPHY  in  T H E F A C U L T Y OF G R A D U A T E STUDIES  (Human Kinetics)  T H E U N I V E R S I T Y OF BRITISH C O L U M B I A  April 2007  © Kirstin Nicole Lane, 2007  ABSTRACT There is a need for a test that will provide information on the lymphatic system of the upper extremity in women with breast cancer related lymphedema ( B C R L ) and this forms the basis of this research project. In order to determine an appropriate upper body exercise protocol that could be combined with lymphoscintigraphy to describe lymphatic function in women treated for breast cancer, a series of studies were completed in healthy, college-aged females. Collectively, these studies demonstrated the following: 1) arm cranking was superior to intermittent hand grip exercise in enhancing depot clearance rate (CR), 2) moderate intensity arm cranking exercise was superior to low intensity arm cranking exercise in enhancing C R and uptake of radiopharmaceuticals at the axillary lymph nodes (AX), 3) C R and A X were symmetrical between arms, 4 ) a lower coefficient of variation was demonstrated with moderate intensity exercise compared to low intensity exercise, and 5) high intra-subject reliability in arm cranking C R . Thus, an intermittent, moderate intensity arm cranking protocol was selected to evaluate lymphatic function in women treated for breast cancer with B C R L ( B C R L ) , breast cancer survivors (no B C R L ) , and age-matched controls. Main findings of the final project were: 1) contralateral arm lymphatic function was similar between groups at rest or during exercise; 2) A X and uptake of radiopharmaceuticals in the forearm ( F O R E ) in the ipsilateral arm relative to the contralateral arm was compromised in B C R L only; and 3) the addition of exercise increased ipsilateral C R and A X in breast cancer survivors and increased ipsilateral C R and F O R E in B C R L subjects (an increase in F O R E is not expected with exercise). T h e s e results indicate that despite the small sample size, lymphatic function (with the exception of C R ) is impaired in B C R L at rest and during exercise compared to breast cancer survivors and controls but not different between breast cancer survivors and controls. Clinical applications of this study are that while breast cancer survivors have similar lymphatic function as controls, there is a highly variable response suggesting that s o m e breast cancer survivors may be at risk for developing B C R L .  ii  TABLE OF CONTENTS  ABSTRACT  ii  TABLE OF CONTENTS  iii  LIST O F T A B L E S  v  LIST O F F I G U R E S  vii  LIST O F A B B R E V I A T I O N S  ix  ACKNOWLEDGEMENTS  x  CO-AUTHORSHIP STATEMENT  CHAPTER ONE  xi  Literature R e v i e w a n d Introduction to T h e s i s  1.1  LITERATURE R E V I E W  1.2  STATEMENT OF THE R E S E A R C H PROBLEM  1 1 26  1.3  P U R P O S E A N D H Y P O T H E S E S O F T H E THESIS  26  1.4  REFERENCES  28  CHAPTER TWO  L y m p h o s c i n t i g r a p h y to E v a l u a t e the E f f e c t s o f U p p e r B o d y D y n a m i c Exercise and Handgrip Exercise on Radiopharmaceutical Clearance f r o m H a n d s of Healthy F e m a l e s  38 38  2.1  INTRODUCTION  2.2  MATERIALS AND METHODS  39  2.3  RESULTS  43  2.4  DISCUSSION  43  2.5  REFERENCES  50  CHAPTER THREE  L y m p h o s c i n t i g r a p h y to E v a l u a t e the Effect of H i g h V e r s u s L o w Intensity U p p e r B o d y D y n a m i c E x e r c i s e o n L y m p h a t i c F u n c t i o n in Healthy Females  54  3.1  INTRODUCTION  54  3.2  MATERIALS AND METHODS  55  3.3  RESULTS  3.4 3.5  DISCUSSION REFERENCES  57 ••• 61 64  CHAPTER FOUR  S y m m e t r y in L y m p h a t i c F u n c t i o n b e t w e e n the Right a n d Left U p p e r Extremities d u r i n g Intermittent A r m C r a n k E x e r c i s e in H e a l t h y Subjects 66  4.1  INTRODUCTION  66  4.2  MATERIALS AND METHODS  67  4.3  RESULTS..  68  4.4  DISCUSSION  72  4.5  REFERENCES  74  C H A P T E R FIVE  U p p e r Extremity L y m p h a t i c F u n c t i o n at R e s t a n d d u r i n g E x e r c i s e in B r e a s t C a n c e r S u r v i v o r s with a n d without L y m p h e d e m a 75  5.1  INTRODUCTION  5.2  MATERIALS AND METHODS  75 77  5.3  RESULTS  83  5.4  DISCUSSION  102  5.5  REFERENCES  119  C H A P T E R SIX 6.1  C H A P T E R EIGHT  General Summary and C o n c l u s i o n s  124  REFERENCES  129  Appendices  132  A P P E N D I X A . INDIVIDUAL D A T A F R O M C H A P T E R Two  132  A P P E N D I X B. I N D I V I D U A L D A T A F R O M C H A P T E R T H R E E  133  APPENDIX C  INDIVIDUAL D A T A F R O M C H A P T E R F O U R  134  A P P E N D I X D . INDIVIDUAL D A T A F R O M C H A P T E R F I V E  136  A P P E N D I X E. C O P Y O F U B C  148  ETHICS CERTIFICATE O F A P P R O V A L  iv  LIST O F T A B L E S  T a b l e 2.1  Comparison of methods used in present study and those of Havas et al  T a b l e 5.1  Sample characteristics of subjects with breast cancer related lymphedema, breast cancer, and controls 79  T a b l e 5.2  Details of patients treated for breast cancer with and without breast cancer related lymphedema  T a b l e A-1  47  80  Individual descriptive data  132  T a b l e A - 2 Individual clearance rate data  132  T a b l e B-1  Individual descriptive data  133  T a b l e B-2  Individual data for clearance rate, axillary uptake, and heart rate during the high and low intensity arm cranking conditions 133  T a b l e C-1  Individual descriptive data  T a b l e C-2  Individual clearance rate and axillary uptake data for the right and left upper  134  extremities  135  T a b l e D-1  Individual clearance rate data for breast cancer related lymphedema subjects... 136  T a b l e D-2  Individual clearance rate data for breast cancer subjects  136  T a b l e D-3  Individual clearance rate data for control subjects  137  T a b l e D-4  Individual axillary uptake data for breast cancer related lymphedema subjects.... 137  T a b l e D-5  Individual axillary uptake data for breast cancer subjects  138  T a b l e D-6  Individual axillary uptake data for control subjects  138  T a b l e D-7  Individual forearm uptake data for breast cancer related lymphedema subjects... 139  T a b l e D-8  Individual forearm uptake data for breast cancer subjects  139  T a b l e D-9  Individual forearm uptake data for control subjects  140  T a b l e D-10  Individual time of first appearance data for breast cancer related lymphedema subjects  Table  140  D-111ndividual time of first appearance data for breast cancer subjects  T a b l e D-12  Individual time of first appearance data for control subjects  v  141 141  T a b l e D - 1 3 C o m p a r i s o n of scoring system for evaluating breast cancer related lymphedema developed by S z u b a et al. and modified by Lane et al 142 T a b l e D-14Application of the modified scoring system for evaluating breast c a n c e r related lymphedema applied to subjects with breast cancer related lymphedema, breast cancer, and controls at rest and during exercise 143  vi  LIST O F F I G U R E S  Figure 2.1 Graphical representation of the arm cranking and intermittent handgrip protocols.. 42 F i g u r e 2.2  The effects of arm cranking and intermittent handgrip on clearance rate from the hands of healthy females 44  Figure 2.3 Individual depot activity-time curves for arm cranking with the counts averaged for the right and left hand at each time point, intermittent handgrip exercise, and a control arm from the hands of healthy females 45 F i g u r e 3.1  F i g u r e 3.2  The effects of high versus low intensity arm cranking on clearance rate from the hands of healthy females  58  The effects of high versus low intensity arm cranking on radiopharmaceutical uptake at the axilla 65 min post-injection relative to the initial dose in healthy females 59  Figure 3.3 Individual depot activity-time curves for high intensity and low intensity arm cranking with the counts averaged for the right and left hand at each time point 60 F i g u r e 4.1  F i g u r e 4.2  Correlation in depot clearance rate between right and left upper extremities in healthy subjects  69  Correlation in tracer uptake between right and left axillary lymph nodes 65 minutes post-injection relative to initial dose in healthy subjects 70  Figure 4.3 Reliability of depot clearance rate during moderate intensity arm cranking exercise performed on two separate days 71 Figure 5.1 Lymphatic function as represented by depot clearance rate, uptake in the axillary lymph nodes at 65 min post-injection, and uptake in the forearm at 65 post-injection at rest and during exercise in the normal of women treated for breast cancer with lymphedema, women treated for breast cancer with no lymphedema, and agematched controls 85 F i g u r e 5.2  Plot of fractional removal rates of Tc-antimony colloid from the subcutaneous depot of the affected arm and unaffected arm of women treated for breast cancer with lymphedema, women treated for breast cancer with no lymphedema, and agematched controls at rest and during exercise 89  F i g u r e 5.3  Ratio of ipsilateral to contralateral arm depot clearance rate in women treated for breast cancer with lymphedema, women treated for breast cancer, and agematched controls at rest and during exercise 90  99m  Figure 5.4 Clearance rate during exercise for all pairs of contralateral and ipsilateral arms of women treated for breast cancer with lymphedema and women treated for breast cancer 91 F i g u r e 5.5  Scattergram of clearance rate plotted against arm circumference for ipsilateral relative to contralateral arms in patients with BCRL during exercise.  vii  92  Figure 5.6 Ratio of ipsilateral to contralateral arm radiopharmaceuticals uptake in the axilla 65 minutes post-injection in women treated for breast cancer with lymphedema, women treated for breast cancer with no lymphedema, and age-matched controls at rest and during exercise 94 Figure 5.7 Radiopharmaceutical uptake in the axilla 65 min post-injection during exercise for all pairs of contralateral and ipsilateral arms of women treated for breast cancer with lymphedema and women treated for breast cancer 95 Figure 5.8 Scattergram of radiopharmaceuticals uptake in the axilla 65 min post-injection plotted against arm circumference with circumferences expressed relative to contralateral arm in patients with breast cancer related lymphedema during exercise Figure  96  5.9 Ratio of ipsilateral to contralateral arm radiopharmaceuticals uptake in the forearm 65 min post-injection in women treated for breast cancer with lymphedema, women treated for breast cancer, and age-matched controls at rest and during exercise... 97  Figure 5.10 Time of first radiopharmaceutical appearance at rest and during exercise in the normal, or contralateral arm, and the affected, or ipsilateral arm, of women treated for breast cancer with lymphedema, women treated for breast cancer with no lymphedema, and age-matched controls 99 Figure 5.11 Individual lymphoscintigrams taken at 65 min post-injection from two subjects with breast cancer related lymphedema (BCRL, Subject #2 and #9) and Subject #9's identical twin (control subject) 111 F i g u r e D-1  Figure  Scattergram of contralateral clearance rate plotted against contralateral axillary uptake at rest and during exercise in all subjects 145  D-2 Scattergram of axillary lymph nodes dissected plotted against clearance rate and axillary uptake during exercise in women treated for breast cancer 146  F i g u r e D-3  Scattergram of clearance rate and axillary uptake during exercise in women treated for breast cancer plotted against number of axillary lymph nodes dissected and stratified by whether radiation therapy was performed 147  viii  LIST OF ABBREVIATIONS  AC APP AX  arm cranking . time of first radiopharmaceutical appearance at the axillary lymph nodes uptake of radiopharmaceuticals at axillary lymph nodes 65 minutes post-injection relative to the initial dose  BC  women treated for breast cancer without lymphedema  BCRL  breast cancer related lymphedema  CONT  control subjects  CR  clearance rate  FORE  uptake of radiopharmaceuticals in the forearm 65 minutes post-injection relative to the initial dose  HG  handgrip exercise  HI  high intensity protocol  HlgG  Human Immunoglobulin G  LO  low intensity protocol  99m  -Tc  Technetium-99m  VEGF  vascular endothelial growth factor  W  Watts  ix  ACKNOWLEDGEMENTS  First and foremost, I would like to thank my supervisor, Dr. Don M c K e n z i e , for your mentorship and guidance over the past 5V2 years. There were a few bumps along the way and I cannot thank you enough for your support.  I would also like to thank my committee members, Dr. Bill S h e e l , Dr. Karen G e l m o n , and Dr. Dan Worsley, for their guidance throughout my doctoral degree. S p e c i a l thanks to Dr. Worsley (nuclear medicine physician) and Kevin Hammerstrom (nuclear medicine technologist) for teaching me about lymphoscintigraphy and answering my naive questions. Kevin w a s there for every lymphoscintigraphy test from pilot work through to the final study and b e c a m e a friend in the process.  I a m grateful for the participation of all the subjects in e a c h of the studies. E a c h subject had to endure an injection of radiopharmaceuticals to four different sites in the hand on two or more testing days - and the injections stung. Without your participation, this research would not have been possible and I thank you for giving up your time and putting up with those injections!  T h a n k s to Diana for all of your help through this process. To my fellow lab mates, B e n , Lianne, Alastair, and Mike - the best days over the past five years was when s o m e o n e else w a s up at the lab b e c a u s e the conversations were always good. Special thanks to B e n , Sunita, and Lianne for being fantastic friends and always being there to either help with testing or go out for coffee ;).  Finally, I would like to thank my husband and my parents. T o Andrew...during my busiest days over the past year, you would bring dinners and desserts up to me at my office so I could work late. A n d , thankfully, you are still making dinner for me today! Y o u are always there to give me the 'just give'R' s p e e c h when I need it and you keep me smiling. To my parents...every day I wake up and think how lucky I am to be the daughter of Bill and S u s a n Lane. Thank you for all the opportunities you have given me growing up and being the best parents possible!  x  CO-AUTHORSHIP STATEMENT  Published Papers  L a n e , K., Worsley, D., & M c K e n z i e , D. Exercise and the lymphatic system: Implications for breast cancer survivors. Sports Medicine, 2005; 35 (6): 461-471. (Presented •  in Chapter One)  The thesis author was responsible for developing the research question, performing the literature review, and writing and preparing the manuscript for publication. Dr. Worsley provided expertise on the section related to lymphoscintigraphy. Dr. M c K e n z i e assisted in developing the research question and editing the manuscript.  L a n e , K., Worsley, D., & M c K e n z i e , D. Lymphoscintigraphy to evaluate the effects of upper body dynamic exercise and handgrip exercise on radiopharmaceutical clearance from hands of healthy females. Lymphatic Research (Presented •  and Biology, 2005;3(1 ):16-24.  in Chapter Two)  T h e thesis author was responsible for developing the research question, completing data collection, performing data analysis/interpretation, and writing and preparing the manuscript for publication. Dr. Worsley assisted with the methods associated with lymphoscintigraphy and editing of the manuscript. He also made arrangements to allow the study to be conducted in the Department of Nuclear Medicine at V a n c o u v e r G e n e r a l Hospital. Dr. M c K e n z i e assisted in developing the research question and editing the manuscript.  L a n e , K., Dolan, D., Worsley, D., & M c K e n z i e , D. Lymphoscintigraphy to evaluate the effect of high versus low intensity upper body dynamic exercise on lymphatic function in healthy females. Lymphatic Research (Presented •  and Biology. 2006; 4(3): 159-65.  in Chapter Three) -  The thesis author w a s responsible for developing the research, completing data collection, performing data analysis/interpretation, and writing and preparing the manuscript for publication. Miss Dolan assisted with data collection and editing the  xi  manuscript. Dr. Worsley assisted with the methods associated with lymphoscintigraphy and editing of the manuscript. He also made arrangements to allow the study to be conducted in the Department of Nuclear Medicine at V a n c o u v e r General Hospital. Dr. M c K e n z i e assisted in developing the research question and editing the manuscript.  xii  CHAPTER ONE  Literature R e v i e w a n d Introduction to T h e s i s  1.1  LITERATURE REVIEW*  1.1.1  Introduction  The lymphatic system, a s it relates to exercise, is not a physiological system that receives a great deal of attention in the sports medicine literature. It is not often heard that patients are limited by their lymphatic system when performing a job task, recreational activity, or sport. However, breast cancer survivors were once cautioned by healthcare professionals to avoid participating in vigorous, upper-body exercise for fear of causing lymphedema (1). Breast cancer related lymphedema ( B C R L ) is a chronic swelling that can occur in the ipsilateral hand or arm of breast cancer survivors but has also been reported in the chest wall and breast. A s defined by O l s z e w s k i (2), lymphedema is an accumulation of water, proteins, migrating immune cells, erythrocytes, biochemical products of immigrating immune cells and resident cells, and debris of apoptotic cells within the expanded intracellular s p a c e and lymphatics. It is essentially an incurable condition, although treatments exist to contain swelling. Current research has not supported the notion that there is a relationship between vigorous, upper-body exercise and the occurrence of B C R L (3-8). In fact, there is the possibility that exercise may be useful in the prevention and treatment of B C R L , but further investigation is required to s e e what physiological c h a n g e s may be taking place at the tissue level in the affected arm in response to short- and long-term exercise.  This review summarises the current research on the lymphatic system related to exercise and critically evaluates the implications for exercise performance by survivors of breast cancer. A brief synopsis of the relevant anatomy and physiology of the lymphatic system applicable to the topic of exercise and breast cancer is also included. Aukland and R e e d (9) and Schmid-Shonbein (10) provide thorough reviews of the anatomy and physiology of the lymphatic system.  Parts of this Chapter have been previously published: Lane, K., Worsley, D., & McKenzie, D. Exercise and the lymphatic system: Implications for breast cancer survivors. Sports Medicine, 2005; 35 (6): 461-471  A  1  1.1.2  A n a t o m y a n d P h y s i o l o g y of the L y m p h a t i c S y s t e m  T h e lymphatic system is a one-way transport system c o m p o s e d of lymphatic v e s s e l s and lymphoid organs. The lymphatic vessels carry interstitial fluid, plasma proteins, lymphocytes, cytokines, macrophages, and other cellular debris that have leaked into the interstitial s p a c e back to the cardiovascular system. The lymphoid organs including the bone marrow, thymus, lymph nodes, spleen, and tonsils each function to produce, maintain and distribute lymphocytes. There are also specialized lymphatic capillaries, called lacteals, in the villi of the intestinal mucosa to assist in fat absorption. Thus, essential functions of the lymphatic system include assisting in the regulation of tissue volume and pressure, aiding immune system function, and contributing to fat absorption in the intestine (11). For the purposes of this article, only the structures involved in lymph transport will be d i s c u s s e d .  Two continuous segments of vessels make up the lymphatic system: (i) the initial lymphatics, also known as lymphatic capillaries; and (ii) the contractile lymphatics. Lymphatic v e s s e l s vary between individuals in their exact location and length and this variation may account for why only some breast cancer survivors develop B C R L . The initial lymphatics, which are blind-ending vessels that originate in tissue parenchyma, are found in close proximity to vascular arterioles (12). T h e y have a single layer of endothelial cells with overlapping regions that form one-way valves (9). T h e s e one-way endothelial valves, also referred to a s primary valves (12), allow interstitial fluid to enter into lymphatic capillaries but prevent lymph from escaping. Evidence for the endothelial valves w a s provided by Trzewik and colleagues (13) who injected fluorescent microspheres into the cremaster muscle interstitium of rats. Through a variety of experiments, the researchers demonstrated that the microspheres could pass into the lymphatic lumen but could not be forced out. Other anatomical features of the initial lymphatics include anchoring filaments that attach the vessels to collagen fibres in the extracellular matrix, an absence of smooth muscle cells, and intralymphatic (or secondary) valves that may or may not be present (10).  Lymph formation occurs when interstitial substances (i.e., interstitial fluid, proteins, cytokines, lymphocytes, and colloids) enter lymphatic capillaries through the primary valves. O n c e lymph enters the initial lymphatics, it then travels to the larger, contractile lymphatics that unlike the lymphatic capillaries, are usually present outside of organ parenchyma and  2  have smooth muscle that undergoes spontaneous, peristaltic contractions. Contraction of the smooth muscle lining lymphatic vessels is initiated by pacemaker cells (14) but c a n also respond to sympathetic activation (9, 15). Contractile lymphatics also have intra-lymphatic valves that prevent the backflow of lymph and ensure lymph moves in the proximal direction (12). It is possible that failure of the intra-lymphatic valves may contribute to the development of B C R L .  Lymph traveling through contractile lymphatic is filtered by clusters of lymph nodes found throughout the body. Lymph nodes relevant to B C R L are found in the axilla and have been classified a s levels l-lll (16). If any of the lymph nodes throughout the body detect a foreign substance, then specialized lymphoid cells (T-lymphocytes, B-lymphocytes, and macrophages) function to destroy the foreign cells, and if necessary, activate an immune response (17). D a m a g e to lymph nodes and the lymphatic vessels serving the lymph nodes, which can occur a s part of breast cancer treatment (i.e. lymph node excision and/or irradiation), contribute to the development of B C R L .  Lymph re-enters the cardiovascular system by way of the central thoracic ducts that drain into the subclavian veins. There is also the possibility that lymph can enter the venous system by way of lymphaticovenous communications (16). T h e s e communications are thought to exist in normal, healthy individuals but may not be functional unless there is chronic obstruction of lymphatic vessels or nodes (18). If the lymphatic system were under chronic stress due to obstruction, then the opening of lymphaticovenous communications would allow lymph to bypass the obstructed area. This was demonstrated in early research by Threefoot et al. (19) who used a dog model with the major lymphatic channels obstructed for >5 days to demonstrate the presence of lymphaticovenous communications. The presence and functioning of lymphaticovenous communications may play a role in the development of B C R L .  Mechanisms  of Lymph Formation  and  Transport  Starling's equation describes the forces affecting fluid flux between the microcirculation and the interstitium: J v = K M  [(PMV-PINT) - o (3t -jt| )] - where J MV  F C  NT  M  V  represents the net  microvascular filtration, K c is the microvascular filtration coefficient, a is the osmotic F  pressure of all plasma proteins, P v a n d PINT are the hydrostatic pressures of the M  microvasculature and interstitium, respectively, and n and m  3  n  m  are osmotic pressure of the  microvasculature and interstitium, respectively (20). Thus, net microvascular filtration reflects a balance between filtration and absorption. At rest, in individuals without lymphatic dysfunction; the balance lies in favour of absorption, and the accumulation of fluid and substances in the interstitial space is opposed by the osmotic pressure gradient and lymph formation.  M u c h of what is known about the mechanisms of lymph formation and transport in humans has been derived from animal research. However, caution should be taken when interpreting animal research since variations in the length of lymphatic v e s s e l s , tissue volumes, gravitational forces, and hydrostatic pressures between animals and humans have the potential to affect lymph contractility and flow (14, 21).  Unlike the cardiovascular system, the lymphatic system lacks an organ to act as a pump and move lymph from the initial lymphatics to the contractile lymphatics and finally to the cardiovascular system. Pressures within initial lymphatics are near zero and significantly higher in the great veins of the neck/thorax (22); thus, the lymphatic system also has to overcome this pressure gradient. In order to transport lymph from the interstitial s p a c e to the venous system, the lymphatic system relies on both intrinsic and extrinsic forces. Extrinsic mechanisms include active and passive limb movements, pressure c h a n g e s associated with respiration, and the pulse of nearby arteries. Intrinsic m e c h a n i s m s , on the other hand, involve spontaneous, intermittent contraction of the smooth muscle in the contractile lymphatic vessels. Autoregulation of these spontaneous contractions by nerves and circulating vasocactive substances modulates the frequency and force of contractions (9, 10, 15, 22).  Both lymph formation and lymph propulsion within the initial lymphatics are dependent on extrinsic driving forces since the initial lymphatic vessels do not have smooth muscle media. M a z z o n i et al. (23) investigated lymph formation in the spinotrapezius muscle of rats fixed in situ in the stretched and contracted states. Stretched skeletal muscle pulled on connective tissue joined to lymphatic vessels and opened the initial lymphatics permitting interstitial fluid to enter. Contracted skeletal muscle, on the other hand, increased muscle fibre c r o s s sectional area, which compressed both adjoining connective tissue and the lymphatics resulting in lymph being driven in the proximal direction to collecting vessels. Although the work of M a z z o n i and colleagues is specific to subfascial lymph formation, skeletal muscle  4  contractions also influence epifascial lymph formation. Similar to the pressure changes associated with respiration and vasomotion of nearby arterioles, skeletal muscle contractions c a u s e fluctuations in tissue pressure that in turn influences interstitial fluid pressure (22, 24). A s interstitial fluid pressure rises, the anchoring filaments exert radial tension on the lymphatic capillary, thereby increasing the volume of the lumen and pulling open the endothelial microvalves allowing interstitial fluid and molecules to enter (25).  Lymph propulsion from the initial lymphatics to contractile lymphatics relies on oscillations in tissue pressure from extrinsic forces to expand and compress the initial lymphatics. Also, the presence of both endothelial microvalves and intralymphatic valves ensures that lymph moves proximally to the larger contractile vessels and does not leak out of the initial lymphatic vessel (12). The compression of an initial lymphatic vessel due to a skeletal muscle contraction, for example, forces open the intralymphatic valve and closes the endothelial microvalves resulting in lymph movement in the proximal direction toward the contractile lymphatics.  O n c e lymph reaches the contractile lymphatics, then intrinsic forces are believed to be the main factor responsible for lymph flow at rest in humans (15). For example, O l s z e w s k i and Engeset (21) measured lymph pressure, pulse frequency and lymph flow in the legs of healthy males. Pulse frequency increased during free lymph flow conditions when subjects changed from the recumbent to upright position. This increase w a s thought to be a result of a n increase in pressure exerted on the foot tissues, which would c o m p r e s s the initial lymphatics and force lymph to the larger contractile vessels. A s lymph accumulates in the contractile lymphatics, the vessel wall is stretched thereby triggering a reflexive contraction of the smooth muscle endothelium.  Subjects in this study (21) also contracted the foot while in both the recumbent and upright positions. There was no measurable change in flow between pulse waves during foot movement indicating that intrinsic mechanisms were the main factor responsible for propelling lymph through the lymphatic system. Also, neither a significant change in intralymphatic pressures during obstructed flow and free-flow conditions, nor a change in pulse amplitude was recorded. Pulse frequency and mean lymph flow, on the other hand, were observed to significantly rise. The increase in mean lymph flow during foot contractions in both the recumbent and upright positions suggests that the increase in lymph  5  formation occurred due to an increase in capillary filtration and oscillations in tissue pressure as a result of muscle contractions. The increase in lymph formation coupled with repeated foot contractions would also contribute to the higher pulse frequency as described earlier in this section. The frequency and force of the spontaneous, intermittent contractions of the smooth muscle in the contractile lymphatic vessels is modulated by neural factors and circulating vasoactive substances (15, 22, 26). For example, epinephrine (adrenaline) and norepinephrine (noradrenaline) infusion has been shown to increase the frequency and force of lymphatic pumping in sheep (27, 28). Epinephrine may cause an increase in lymph flow by either acting directly on the lymphatic vessels, reflexively triggering the autonomic nervous system, or increasing blood flow to the region drained by the lymphatic vessels (27). However, not all vascular beds undergo vasodilation in response to sympathetic activation. While capillary filtration can be reduced in some areas, such as the gastrointestinal tract as a result of sympathetic activation, it can be concomitantly increased in other areas, such as active skeletal muscle.  1.1.3  M e a s u r e m e n t of L y m p h a t i c F u n c t i o n  The most direct method of measuring lymph flow is direct lymphography which involves infusing oily contrast into cannulated lymphatic collectors in distal limbs (22). This method has been used in animals (29-32), and to a lesser extent in humans (21, 33, 34), to investigate the effects of exercise on lymph flow. However, this procedure in humans is less practical as it is invasive; rather, lymphoscintigraphy is performed to give a semi-quantitative measure of lymph flow. Lymphoscintigraphy typically involves administration of a radiopharmaceutical to a lymphatic drainage source and imaging the limb using a gamma (y) camera at various time points over one to five hours post-injection. The resulting images can be used to determine objective measures of lymphatic function such as the clearance of radiopharmaceutical from the site of injection (clearance rate, or CR), time taken for the tracer to reach the axillary lymph nodes, and percentage of tracer in the axillary lymph nodes or regions of the upper extremity at a fixed time point post-injection (35-37). The radiopharmaceutical is generally a technetium labeled macromolecule that is of sufficient size (i.e. between 4 and 100nm) to enter the lymphatic capillaries and not blood capillaries (36, 37). Several studies have used massage at the injection site or light exercise such as  6  fist clenches or squeezing a rubber ball with the intent of enhancing radiopharmaceutical clearance (37-42).  Despite lymphoscintigraphy being a standard nuclear medicine technique used to investigate lymphatic obstructions, differences in protocols exist which makes the direct comparison of findings difficult and complicates the understanding of the pathophysiology of B C R L . For example, there are differences in particulate administered (i.e., colloid,  9 9 m  T c - H l g G , or  99m  99m  Tc-antimony  T c - h u m a n serum albumin (HSA), etc.) which can affect the speed  of uptake by lymphatic vessels and also retention within lymph nodes. preferred for evaluating lymphatic vessels, whereas colloids such as  9 9 m  99m  T c - H S A is  T c - a n t i m o n y colloid  are better at a s s e s s i n g lymph nodes due to their longer retention time (36). Other differences in lymphoscintigraphy protocols include intradermal, subcutaneous, or subfascial injections; injections administered in the w e b s p a c e , forearm, or upper arm; various outcome variables such as depot clearance rate, uptake at the axillary lymph nodes relative to the amount initially injected, systemic blood accumulation rate, and/or lymphatic vessel morphology; and exercise such a s fist clenching or arm cranking sometimes being included as part of the lymphoscintigraphy protocol to stimulate lymph flow between imaging s c a n s .  In a n attempt to determine a n optimal lymphoscintigraphic method to image upper extremity lymphatic vessels, O ' M a h o n e y et al. (43) compared intradermal and subcutaneous injections of  99m  T c - n a n o c o l l o i d and  9 9 m  T c - H l g G in healthy subjects. W h e n only the injection  route w a s compared (intradermal vs. subcutaneous), clearance rate was significantly faster and image quality superior after intradermal injections compared to subcutaneous injections. W h e n only the radiopharmaceuticals were compared, there was no significant difference in image quality or clearance rate. Slight differences were observed in image quality between the two radiopharmaceuticals for e a c h injection route; however, only three or six subjects were compared in those analyses. B a s e d on better image quality, a faster clearance rate, and several other factors, the authors hypothesized that intradermal injections more closely replicate a direct intralymphatic injection. However, the same lymphatic bed w a s still a c c e s s e d after both types of injections which is the ultimate goal of lymphoscintigraphy applied to women with B C R L . It w a s not stated whether subjects performed any type of exercise in between imaging scans to facilitate lymph flow. O ' M a h o n e y et al. repeated the above study in women with B C R L and found similar results - lymphatic vessels were more clearly visualized in subjects with B C R L after intradermal compared to subcutaneous  7  injections of  9 9 m  T c - H l g G (44). However, C R s were not significantly different between the  two radiopharmaceuticals.  Typically, lymphoscintigraphy involves a single isotope, but Pain and colleagues developed a dual-isotope lymphoscintigraphy protocol to provide information on the appearance rate of radiopharmaceuticals in mixed venous blood in addition to depot clearance rate (38-41, 4 5 47). Dual-isotope lymphoscintigraphy involves administration of Technetium 99m ( H u m a n Immunoglobulin G (HlgG) into one hand and lndium-111 (  111  99m  Tc)  l n ) - H l g G into the other  hand, repeated imaging over three hours, and bilateral sampling from the medial cubital veins (see ref (38) for full explanation of methods). The appearance rate of tracer in ipsilateral and contralateral mixed-venous blood can be obtained from both arms simultaneously by using two isotopes. Early studies by Pain et al. demonstrated that H l g G and  1 1 1  9 9 m  Tc-  l n - H l g G have a similar clearance rate from a subcutaneous injection depot and  a similar accumulation rate in contralateral mixed venous blood (40, 47). However, a subsequent investigation found significant quantities of protein-free ipsilateral blood samples (38). T h e large amount of protein-free indicates that it is less stable than  9 9 m  111  111  l n present in early  l n in ipsilateral blood  T c - H l g G and should not be used to calculate the  accumulation rate of tracer in ipsilateral blood samples.  Measuring blood accumulation rate of tracer instead of determining storage of tracer within axillary lymph nodes, which is typically quantified, may be advantageous for several reasons. First, lymph is ultimately transported back to the cardiovascular system via lymphaticovenous communications with the subclavian vein. S o m e lymph will also enter the venous system within lymph nodes. Therefore, measuring the accumulation rate of tracer in mixed venous blood gives an indication of how efficient the lymphatic system transports injected radiopharmaceuticals through the upper extremity. S e c o n d , breast cancer treatment often involves lymph node excision and/or irradiation, thereby reducing the number of functional nodes on the treated side. Consequently, assessing the percentage of activity stored in lymph nodes at a specified time-point post-injection may result in an artificially lower percentage on the affected side simply due to fewer lymph nodes. Finally, lymph node retention of tracer is only a 'snapshot' of the amount of tracer present in the axillary lymph nodes at any one time. Despite colloids having good regional lymph node retention (36, 48), these particles will migrate through the lymph nodes and eventually enter the venous circulation. It is unknown how long the radiopharmaceuticals are retained in the  8  lymph nodes and what factors speed or slow their exit from the nodes. A fraction of colloids in the lymph nodes will be phagocitized by the reticuloendothelial system primarily consisting of tissue macrophages (36).  1.1.4  R o l e of the L y m p h a t i c S y s t e m D u r i n g E x e r c i s e  Exercise represents an acute disturbance in homeostasis. For example, cardiac output, mean arterial blood pressure, sympathetic nervous system activity, ventilation, skeletal muscle contractions, hydrogen ion concentration, and body temperature increase in response to exercise of increasing intensity. Additionally, strenuous exercise such a s eccentric muscular contractions or marathon running provokes an acute inflammatory response marked by increases in neutrophil and lymphocyte concentrations, natural killer cell activity, reactive oxygen species, cytokines, and vasoactive amines (49). T h e degree of the inflammatory response has been related to the intensity and duration of exercise (50, 51). Starling's forces (20) that govern filtration and absorption in the microvasculature (see Section 1.1.2) favour absorption at rest, but the rise in capillary pressure that occurs in exercising muscle will favour filtration. In healthy individuals, interstitial e d e m a accumulation usually d o e s not persist beyond the exercise bout. This is b e c a u s e normal physiological responses to exercise such as increased sympathetic activity, skeletal muscular contractions, and respiration are also mechanisms that assist with lymph formation and propulsion (9, 22).  The effect of exercise on lymph formation and transport has been measured directly in animals using cannulation of a lymphatic duct (29, 31). In response to exercise of short duration (walking eight steps) in an intact lymphatic preparation in sheep, the frequency of lymphatic contractions increased and lymph flow doubled relative to baseline values in the 1-5 minutes after the beginning of movement (31). Movement was believed to increase lymph formation but not directly affect lymph propulsion since no correlation w a s found between fluid propulsion and normal walking movements in an isolated preparation.  Exercise of longer duration (2 hours) w a s measured in the hind limbs of sheep by C o a t e s et al. (29). During the first 15 minutes of steady-state exercise, lymph flow in the hind-limb increased 5-fold from resting values and then gradually decreased to a constant 1 3 0 % above baseline for the remaining 30 minutes of exercise. The large initial increase in hind-  9  limb lymph flow was thought to be a result of increased pressure in the working muscles and increased sympathetic activation causing increased lymphatic motility. A combination of a greater vascular surface area and a higher hydrostatic pressure likely contributed to the steady-state lymph flow values observed from 90 to 120 minutes of exercise.  F e w studies have investigated the role of the lymphatic system during exercise in humans. Havas et al. (52) investigated the effects of dynamic and isometric muscle contractions on lymph clearance using lymphoscintigraphy. Lymph clearance was measured in the legs of four sedentary males and four endurance-trained males (each leg counted as an independent observation; thus, n = 8 per group). The authors did not explain what constituted being endurance trained. The exercises included dynamic knee extensions and two types of isometric contractions (leg flexed at 90° and leg fully extended). In total, 100 submaximal contractions were performed in ten minutes for each condition and all conditions were performed on the s a m e day with 65 minutes rest between each. The results showed that lymphatic clearance rate was highest in both the dynamic and isometric legextended conditions compared with the isometric leg-flexed condition. Moreover, the lymphatic clearance rate during the 65 minutes of rest between exercise conditions w a s nearly two-fold higher in the endurance-trained versus sedentary subjects. The higher clearance rate seen in the endurance-trained group was thought to be a result of an increase in capillary density, which is a known adaptation to long-term endurance exercise (53). A higher capillary density would provide a greater surface area for capillary filtration and endothelial conductance. If the higher capillary density accounts for the difference in lymphatic clearance rate between subject groups during rest, then it might also be expected that the clearance rate should be faster in the endurance-trained subjects during exercise. However, the ten minute exercise bouts used by Havas et al. (52) may not have been of sufficient duration and/or intensity to sufficiently tax the lymphatic system and cause clearance rate to differ between subject groups during exercise. Furthermore, the first 1 0 15 minutes of exercise has been shown (29, 54) to result in an initial overshoot of lymphatic clearance rate that is approximately 5-fold higher than rest and then declines to a steadystate value for the remainder of the exercise period that is still two- to three-fold higher than rest. It is possible that this initial overshoot response to exercise is similar for all healthy subjects and does not depend on training status. If this is the c a s e , then the ten-minute exercise bouts as used by Havas et al. (52) could reflect the initial overshoot of lymphatic clearance rate and any differences between endurance-trained and sedentary subjects  10  would be masked during this time. A longer exercise bout allowing steady-state conditions to be achieved may have shown differences between endurance-trained and sedentary subjects. More research is needed to clarify the effect of endurance training on lymphatic function during rest, exercise, and recovery from exercise.  Havas et al. (54) again used lymphoscintigraphy to investigate lymph flow dynamics in the lower limbs of eight males during two hours of steady-state exercise at 7 0 % maximum heart rate. Similar to the results found by Coates et al. (29), the first 15 minutes of exercise showed a clearance rate that was five-fold higher than at rest and remained approximately two- to three-fold higher for the remainder of the two-hour exercise bout. A faster lymphatic clearance rate during exercise is expected. Exercise c a u s e s an increase in arterial blood pressure and cardiac output resulting in greater capillary filtration. Greater capillary filtration leads to a rise in interstitial pressure, which facilitates the entry of fluid and proteins into lymphatic capillaries (9). Furthermore, during exercise, sympathetic nervous system activity increases, thereby increasing lymph propulsion through autoregulation of smooth muscle in contractile lymphatic vessels.  In summary, the lymphatic clearance rate during exercise is elevated compared to rest. Both studies conducted by Havas et al. (52, 54) used subjects who were college-aged males and the effects of short-term exercise on lymphatic clearance in the lower limbs was investigated. It has not been determined if age or s e x alters lymphatic clearance rate during exercise. Also, it is not known if the lymphatic vessels in the upper extremity respond in a similar manner to a given exercise bout as do the lymphatic v e s s e l s in the lower extremity. Nor is it known how the intensity or duration of the exercise affects lymphatic function. Although H a v a s et al. (52) demonstrated a faster lymph clearance rate in endurance-trained males in the recovery period between exercise conditions, more research is needed to elucidate the effects of training status on lymphatic function during short- and long-term exercise.  1.1.5  Breast C a n c e r Related L y m p h e d e m a (BCRL)  B C R L is a chronic swelling that can occur in the ipsilateral hand or arm of women treated for breast cancer (55). Current data suggest that there is a 2 7 % (56, 57) to 4 9 % (58) probability of women developing B C R L over a 20 year period following treatment. B C R L may present  11  months or years after initial treatment and the actual onset may be gradual or rapid (16, 59, 60). W o m e n with B C R L have restricted range of motion in the affected arm, increased risk of infection and impaired limb function. Furthermore, these women report increased anxiety and depression and reduced quality of life (61, 62).  Factors that are known to increase the risk of developing B C R L include dissection of the axillary lymph nodes, radiotherapy to the breast and axilla, pathological nodal status, obesity, and tumour stage (16, 59, 63, 64). There is a greater incidence and severity of subsequent lymphedema when more axillary lymph nodes are excised and/or a larger irradiation field and dose is directed at the axilla (56, 59, 65). A larger radiation d o s e or field applied to the axillary region may result in damage to lymph nodes, since radiation essentially leaves scar tissue in the area. Older surgical techniques involved radical mastectomy whereby all axillary lymph nodes were removed. Due to advances in technology, specifically the sentinel node biopsy, only potentially cancerous lymph nodes are excised when using this technique. Studies comparing complete axillary lymph node dissection with sentinel lymph node biopsy have shown a lower incidence of B C R L with sentinel lymph node biopsy (66-74). For example, Sener et al. (70) have shown that only 3.0% of subjects who underwent sentinel lymphadenectomy alone were determined to have lymphedema compared with 1 7 . 1 % who underwent sentinel lymphadenectomy combined with axillary dissection. The possibility also exists that anatomical differences in lymphatic vessel location and length also contributes to development of B C R L . For example, a long variant that b y p a s s e s axillary lymphatics has been proposed (75). The existence of this long variant may bypass excised or damaged level I and level II axillary lymph nodes, and thereby potentially reduce the risk of developing B C R L (16).  Pathophysiology of BCRL Normal lymphatic function reflects a balance between capillary filtration and lymph formation. In B C R L , the excess extracellular fluid volume may be a c o n s e q u e n c e of an increase in lymph formation relative to what can be accommodated by the initial lymphatics and/or damage to lymphatic vasculature preventing normal lymph transport (60). A s the swelling progresses and becomes chronic, cellular changes ensue. Piller (76) demonstrated a reduction in the activity of macrophages and an increase in fibroblast activity in established lymphedema that likely contribute to the process of the swollen tissue becoming fibrotic. Olszewski (2) investigated the composition of lymph in secondary lower  12  c  limb lymphedema by cannulating an afferent lymphatic trunk in the lower leg and sampling lymph over 24 hrs. Lymph protein and lymph immunoglobulin values were similar between subjects with lymphedema and controls; however, cytokine levels as well as apoptotic D N A were elevated in lymph from lymphedema patients. The elevated lymph levels of cytokines were thought to indicate an intensive inflammatory process while apoptotic D N A may reflect cellular changes in tissues (2).  The original theory regarding the development of B C R L is that the primary insult to the axillary lymphatic system due to axillary dissection and/or irradiation caused global impairment of lymph drainage (16). This traditional view of the pathogenesis of B C R L is analogous to a 'stop-cock' effect. The damage to the axillary lymphatics, primarily lymph nodes and vessels, w a s thought to interrupt lymph flow and thus c a u s e fluid and plasma proteins to accumulate in the affected arm. For this theory to be true, the following findings should be evident in the literature related to B C R L : (i) all breast cancer survivors who receive identical treatment should develop B C R L ; (ii) there should be a similar onset period; (iii) all sections of the arm should be swollen uniformly and the lymph flow rate should be similar throughout the affected arm; and (iv) lymph flow should be slower and protein concentration should be higher in the affected arm compared with the non-affected arm.  A s reported previously, the incidence of B C R L is 2 7 % to 4 9 % and the onset period may vary considerably. This suggests that other physiological factors in the affected arm are also contributing to the development of B C R L . In addition, recent studies by Bates et al. (77) and Stanton et al. (42) have challenged the view that B C R L is a result of global impairment of lymph drainage. Specifically, Bates et al. (77) found that protein concentration was lower in the swollen arm compared with the normal arm, while Stanton et al. (42) discovered that lymph flow per unit volume of tracer distribution was faster in the spared hand of the swollen arm compared with the control arm.  The finding of a lower, rather than higher protein concentration in the affected arm, suggests hemodynamic abnormalities may also contribute to B C R L development (77). L y m p h e d e m a in any tissue develops when there is an imbalance between capillary filtration and lymphatic drainage rate (55, 78). A lower than expected interstitial protein concentration could result from an increased capillary filtration rate c a u s e d by either hyperemia in the affected arm or a rise in capillary pressure (77). In fact, S v e n s o n et al. (79) found evidence of increased  13  blood flow in the affected arm, although there are some methodological concerns with the study. Other factors that could explain the d e c r e a s e d interstitial protein concentration are reduced permeability of the capillary wall to plasma proteins and proteolysis within the interstitial compartment (80).  Regional lymph drainage failure w a s first proposed by Stanton et al. (42) after unexpectedly finding a faster C R in the spared hand of the swollen arm compared to the contralateral side. In this study, which was one of the first to systematically evaluate lymphatic function in patients with B C R L using lymphoscintigraphy,  9 9 m  T c - H l g G was subcutaneously  administered to the swollen forearm or spared hand in patients with B C R L and the corresponding injection site on the contralateral side (the contralateral arm served as controls for all comparisons). A s expected, lymph drainage of the radiopharmaceutical w a s 2 5 % slower in the swollen forearm, but lymph drainage was 1 8 % faster in the spared hand of the swollen arm compared to the contralateral hand. Stanton et al. (81) repeated the study in B C R L subjects with swollen hands and found a significantly slower C R in the ipsilateral hand compared to the contralateral hand. W h e n C R ' v a l u e s in B C R L subjects with swollen hands were compared to those with spared hands, C R in the ipsilateral hands was similar, but C R in the contralateral hands was significantly different ( C R for the contralateral hand of the swollen hand group was 6 6 % greater than C R for the contralateral hand of the spared hand group). It should be noted that subjects in the swollen hand group had a larger arm volume (50% increased arm volume) than the spared hand group (27% increased arm volume). Pain and colleagues, in a series of studies described above, also found evidence of regional lymph drainage failure. Specifically, the subcutaneous C R w a s slower in swollen hands but similar in spared hands of swollen arms when compared to both the contralateral arm and control data (39, 41). T h e s e findings collectively indicate a slower C R with subcutaneous injections to the swollen forearm or swollen hand compared to a similar injection site on the contralateral arm. Yet when subcutaneous injections are administered to the spared region of an affected arm, the clearance rate is similar (Pain), or even faster (Stanton) when compared to the contralateral arm. However, if the contralateral arm is not 'normal' then comparisons between arms in women with B C R L may not be appropriate.  Stanton and coworkers have continued to investigate regional differences in lymph drainage rates (81-83). Previous studies (38, 39, 4 1 , 42) used subcutaneous injections of  14  radiopharmaceuticals and did not find correlations between C R and arm volume. Consequently, Stanton et al. (83) measured subfascial drainage rates by administering 9 9 m  T c - H l g G intramuscularly to the forearms of women with established B C R L in order to test  the hypothesis that epifascial swelling involves an overflow phenomenon or impaired superficial-to-deep drainage. Similar to earlier work using subcutaneous injections (38, 39, 4 1 , 42), a significantly slower C R was found in the swollen forearm compared to the normal forearm (83) even though it has been shown that the e d e m a is primarily restricted to the epifascial compartment (skin and subcutis) (84). Previous work did not find subcutaneous C R s to be correlated to arm volume; however, a significant negative correlation w a s found between subfascial C R and arm volume. Dermal backflow, which has been reported with subcutaneous injections to the hand (42), w a s not evident when radiopharmaceuticals were administered to the subfascial component of the swollen forearm. T h e lack of dermal backflow could mean that either the radioactivity is able to move in the proximal direction or any backflow that is taking place is in a deep area of the forearm and not visible on images taken with the g a m m a camera.  Another approach to understanding the regional distribution of swelling has been to administer subcutaneous injections to the maximally and minimally swollen region of the swollen forearm and corresponding sites on the contralateral forearm (82). Using this approach, no significant difference between C R at the site of maximal and minimal swelling was found. Rather, proximal C R w a s faster than distal C R , irrespective of the site of swelling, on both the ipsilateral and contralateral arms. The greater muscle component in the proximal region of the forearm w a s thought to account for the difference in C R s e e n between the proximal and distal portion of the forearm. The skeletal muscle pump is an extrinsic mechanism known to facilitate lymph formation and propulsion. In fact, subfascial C R has been shown to be two times faster than epifascial C R (85).  The idea of lymph drainage failure being regional rather than uniform throughout the arm suggests that there may be re-routing of lymphatic drainage within the swollen arm, which could account for the higher clearance rate seen in the non-swollen hand. Re-routing of lymphatic drainage is also supported by the appearance of 'dermal backflow' and the finding of a higher density of lymphatic vessels in the dermis of the swollen arm of women with B C R L . T h e greater lymphatic network in the forearms of women with B C R L w a s demonstrated by Mellor and colleagues (86) who also showed that breast c a n c e r survivors,  15  who did not present with B C R L , showed none of the changes in lymphatic density seen in w o m e n with B C R L . T h u s , the increased lymphatic network appeared to be a result of the e d e m a and not a result of breast cancer treatment. Furthermore, when the increased skin area due to lymphedema was taken into account, the total length of lymphatic capillaries in a 1-cm annulus of skin was significantly greater in swollen arms compared to control arms. This enhanced lymphatic density may indicate lymphangiogenesis or re-routing of lymph flow both of which could facilitate lymph drainage around regions where lymphatic v e s s e l s are failing. Angiogenesis has also been documented in the swollen arm during chronic limb swelling a n d , again, the increased microvascular density appeared to be due to e d e m a and not breast cancer treatment (87). Mellor et al. (87) propose that the angiogenesis may contribute slightly to preserving swollen arm volume because an increased microvascular density increases capillary surface area, which should thereby increase the fluid filtered into the dermal interstitium of the whole arm per unit time per unit net Starling force. However, one could also consider that as long as angiogenesis occurs at the s a m e relative rate as lymphangiogenesis, then the augmented lymphatic density should negate the increased fluid load on the lymphatic system from angiogenesis.  Collectively, these studies indicate that regardless of whether the injection is subfascial or epifascial (subcutaneous), C R appears to be impaired when radiopharmaceuticals are administered to swollen tissue. Yet the degree of swelling is only correlated to C R when the injection is subfascial. Caution should also be taken when comparing studies when C R is from different regions of the forearm, a s proximal C R measures faster than distal C R in spite of differences in areas of maximal and minimal swelling. Stanton et al. hypothesize that the strong correlation between subfascial C R and arm swelling indicates that subfascial lymphatic drainage in some way must influence the degree of swelling that occurs in the epifascial compartment (83). F o r example, muscle has a large capillary network that may contribute more to e d e m a fluid than does the skin and subcutis. A s well, the fascia surrounding the muscle may lead to low compliance and prevent e d e m a from occurring in this compartment (83). While lymphatic connections between epifascial and subfascial compartments have been documented in the normal wrist and elbow (75), and leg (88, 89), it is unknown if the direction of flow is one-way (and in what direction) or if it is bi-directional. Theoretically, impaired subfascial to epifascial lymph drainage would show some evidence of dermal backflow, but Stanton et al. did not observe dermal backflow with subfascial administration of radiopharmaceuticals.  16  Another factor that may contribute to the development of B C R L is the presence of functioning lymphaticovenous communications (16). Aboul-Enein e t a l . (90) evaluated women treated for breast cancer with and without B C R L , as well a s healthy subjects, for the presence of lymphaticovenous communications in the upper extremity. Healthy subjects and breast cancer patients with lymphedema showed little lymphaticovenous transfer of the iodinated human serum albumin, while breast cancer patients who did not present with lymphedema demonstrated greater radiopharmaceutical activity in the venous blood within an hour of injection. Furthermore, radiological detection of lymphaticovenous shunts w a s a s s e s s e d in two subjects without B C R L . This study indicates that functioning lymphaticovenous communications in women treated for breast cancer may help prevent the occurrence of B C R L .  In summary, the exact etiology and pathophysiology of B C R L appears to be multi-factorial a n d not fully understood. Recent investigations question the view that simple axillary obstruction is the primary determinant of B C R L and instead suggest that only regional lymph drainage failure may be occurring. If only s o m e lymph vessels of the arm are compromised, then a higher interstitial pressure would help facilitate lymph flow through these failing v e s s e l s . E d e m a could provide this driving interstitial pressure. There is also evidence that hemodynamic factors, such as increased capillary filtration, may also be contributing to the development of B C R L . Further research is needed to determine the pathophysiological mechanisms that underlie B C R L so that appropriate treatments can be developed.  Diagnosis The diagnosis of B C R L typically involves volumetric or circumference measurements as well as symptoms of heaviness and tightness in the affected arm. Additionally, bioelectric impedance (BIA), magnetic resonance imaging (MR), and tissue tonometry are also used to reflect a change in status. There is no consistent operational definition in the literature of what describes clinically significant B C R L ; therefore, research varies in the method used to identify c a s e s of B C R L . Currently, the gold standard for limb volume determination is water displacement volumetry. M e g e n s et al. (91) investigated whether two methods of calculating upper extremity volume (using arm circumferences) could substitute for water displacement volumetry. Direct and calculated measurements of arm volume were both found to be  17  related and reliable; however, they were not determined to be interchangeable since truncated cone calculations of arm volumes exaggerated actual arm volume.  Despite water displacement volumetry being the gold standard, it is neither a portable nor simple method to perform. A s such, the clinical practitioner often uses circumferential measurements. The Steering Committee for Clinical Practice Guidelines for the C a r e and Treatment of Breast C a n c e r in C a n a d a (92) reviewed the relevant literature and recommended four points for measuring arm circumference: (i) the metacarpal-phalangeal joints; (ii) the wrists; (iii) 10cm distal to the lateral epicondyles; and (iv) 15cm proximal to the lateral epicondyles. If a difference of >2.0cm between arms at any of the measurement points is found, treatment for lymphedema may be warranted.  Bioelectrical impedance (BIA) is also used in the diagnosis of B C R L a s it reflects changes in extracellular fluid volume (93-95). Cornish (93) describe the principles of BIA, and briefly, it involves passing a small alternating current through the body segment and measuring the impedance to the flow. In the application of B C R L , the impedance to current flow can be used to determine extracellular fluid volume of the limbs. The increase in lymph volume is described by the ratio of impedance measures from the affected and unaffected limbs, which reflect extracellular fluid content of the respective limbs. A n index greater than 1.00 indicates clinical lymphedema (93). A s reviewed by Ward (96), BIA has shown to be a noninvasive, consistent, and valid measure of B C R L that can be used to measure a change in volume in clinical trials.  Tissue tonometry measures the amount of pressure necessary to depress the skin a specified amount, and thus, provides a measure of tissue resistance (97). P i l l e r a n d Clodius (98) showed a correlation between arm circumference and tissue resistance measured by tonometry. A number of studies have used this method to measure a change in lymphedema status as a result of a therapeutic intervention (98-105).  Although water displacement volumetry, arm circumferences, bioelectrical impedance, and tonometry are non-invasive methods used to quantify lymphedema, they do not indicate changes in lymphatic function. Lymphoscintigraphy was developed to a s s e s s lymphatic status in patients with a variety of conditions that cause lymphatic obstruction as it provides semi-quantitative measures of lymphatic function (36, 106). Now this technique is being  18  used both in the investigation of the pathology of B C R L (38-42, 45-47, 81-83, 107) and in the examination of various therapeutic interventions prescribed to manage B C R L (108-112).  Current Treatment Methods Prescribed  for BCRL  B C R L is essentially an incurable condition, although treatments such as skin care, compression sleeves, pneumatic pumping, manual lymphatic drainage, and low-level laser therapy exist to contain swelling (16, 6 1 , 113). There are other treatments available to patients with lymphedema including medications and surgery, but at present, these play a very small role in the management of patients with this condition. Current research investigating the efficacy of treatments prescribed for B C R L has had equivocal results as discussed below.  Compression  Sleeves  After education, compression sleeves represent the first step in the initial management of patients with lymphedema despite limited objective data supporting their use. G r a d e d compression garments deliver pressures of 20 to 60 mm Hg to facilitate lymph transport (92). Suitable compression garments can be custom-made or prefabricated, and ideally, trained personnel should fit them. S o m e sleeves start at the wrist and end at the upper arm, while other sleeves incorporate the shoulder. S o m e clinicians recommend the use of a compression garment for up to 24 hours per day, while others recommend its use only during waking hours or while exercising. Collins and colleagues (84) used C T scanning to a s s e s s the effect of compression garment therapy in 27 women with B C R L . They found significant d e c r e a s e s in the cross-sectional area of subcutaneous compartments with a larger decrease found in the distal portion of the limb (26%) compared to the proximal portion (9%). Bertelli et al. conducted a randomized control trial investigating the use of a compression sleeve plus electrically stimulated lymphatic drainage compared to the use of a compression sleeve alone. Both modalities reduced limb girth by 17%, which suggested that compression sleeve therapy alone is effective (114).  Intermittent Pneumatic  Compression  There has been only one randomized trial that has evaluated pneumatic compression pumps for the treatment of lymphedema. Dim and colleagues (115) a s s i g n e d 80 women with B C R L to either intermittent pneumatic compression or no treatment. W o m e n in the  19  treatment group completed 10 pump sessions over 2 weeks, followed by a 5 week break, and then another 10 sessions. The mean d e c r e a s e in arm circumference in the treatment group w a s nearly four times that in the control group (1.9 cm and 0.5 c m , respectively); however, the differences between the two groups failed to reach statistical significance at the end of the experimental protocol. There are a number of other studies that have used compression pumps to treat lymphedema and the results have been mixed (116-118). R o c k s o n (60) suggests that this treatment modality can play an important role in the management of patients with B C R L , citing results from several studies that are consistent in showing a reduction in arm volume following treatment with any of the different pumps tested.  Manual Lymphatic Drainage Manual lymph drainage is a massage technique that involves the skin surface only and follows the anatomic lymphatic pathways of the body. A session of manual lymph drainage starts centrally in the neck and trunk to clear out the main lymphatic pathways with the intent of facilitating drainage from the arm (92). Anderson et al. (119), conducted a randomized trial involving 42 women with B C R L and compared standard therapy alone with standard therapy plus manual lymph drainage and training in self-massage. Standard therapy included use of a custom-made sleeve-and-glove compression garment worn during the day, instruction in physical exercises, education in skin care, and information and recommendations about lymphedema. Both groups obtained a significant reduction in limb volume, a decrease in discomfort and increased joint mobility over time; however, no significant differences in were found between the two groups.  Prospective investigations of complete decongestive lymphatic physiotherapy, including manual lymphatic drainage, have validated the efficacy of these interventions for the initial reduction of e d e m a and long-term maintenance of limb volume in B C R L (120, 121). In one of the few studies to use lymphoscintigraphy to evaluate the efficacy of therapeutic interventions for B C R L , S z u b a et al. (109), measured lymphatic function before and after manual lymphatic therapy in 19 women with B C R L . A correlation was found between the ratio of radioactivity within the affected to normal axillae and the percentage reduction in e d e m a volume. However, the study was limited by the variability in radiopharmaceutical uptake in the affected axilla relative to the normal axilla pre- and post-treatment. S o m e of the variability in response could be due to the exercise protocol employed by S z u b a et al. 20  which consisted of squeezing a ball intermittently for 1 minute every 5 minutes during the first 30 minutes of imaging with the intent of stimulating lymph flow. T h e amount of work competed with this type of exercise cannot be accurately quantified and if the effort, or work, differs among subjects or between conditions, this can potentially lead to varying amounts of radiopharmaceutical uptake at the axilla. Kligman et al. (113) conclude that there is enough evidence to suggest that compression therapy and manual lymphatic drainage may improve established lymphedema, but further studies are needed. Anecdotally, manual lymphatic drainage is well tolerated by patients and appears to offer a reasonable treatment option for many.  Low-Level Laser Therapy Low-level laser therapy has been purported to have several therapeutic benefits including the treatment of lymphedema. Carati and colleagues (101) examined the treatment of patients with B C R L with low-level laser therapy using a double blind, placebo controlled trial. One or two cycles of laser treatment was delivered in blocks of nine s e s s i o n s (active laser or placebo) to the axillary region of the treated arm with one block comprised of treatment three times per week for three weeks. The mean affected limb volume at 2-3 months posttreatment when two cycles of laser therapy w a s administered was significantly less than after placebo treatment. However, the mean affected limb volume was not significantly different than pre-treatment values. Immediately post-treatment, extracellular fluid volume, as measured by BIA, w a s significantly lower than pre-treatment values for all conditions (one cycle of laser, two cycles of laser, or placebo). At 2-3 months post-treatment, only the laser conditions demonstrated significantly lower extracellular fluid volume compared to pretreatment values. Piller and Thelander (103) administered 16 treatment s e s s i o n s with lowlevel laser therapy over 10 weeks. Similar to the results of Carati et al., arm volume decreased post-treatment.  1.1.6  E f f e c t s of E x e r c i s e o n B C R L  Until recently, physicians, physiotherapists or health professionals erred on the side of caution and recommended survivors of breast cancer to avoid vigorous upper-body exercise for fear of promoting or worsening B C R L (1). This view stemmed from the belief that simple axillary obstruction of lymph flow w a s the sole cause of B C R L . Thus, if a woman who survived breast cancer engaged in vigorous exercise on a regular basis, then lymph  21  production would increase, corresponding to an eventual increase in arm volume. All recent studies (3, 5, 7, 8, 122, 123) except one (6) have shown no significant change in arm volume with resistance training or upper body aerobic exercise. Although we demonstrated a significant increase in arm volume in breast cancer survivors with and without B C R L from a 20 week exercise program consisting of aerobic training, resistance training, and dragonboat paddling, this was not believed to be construed as reason for concern (6). First, the increase in arm volume was consistent for both arms. S e c o n d , there was a significant gain in upper body muscular strength over the course of the study period. Although changes in muscle volume were not directly measured in our study, A b e et al. (124) demonstrated a significant increase in muscle thickness with resistance training in men and women over a 12 week program. Thus, muscle hypertrophy likely accounted for the increase in arm volume s e e n in our subjects.  All of the above studies investigating the effect of exercise on limb volume used volumetry or circumferences to measure arm volume. J o h a n s s o n et al. (7) measured both volumetry and BIA in women with B C R L in response to a controlled, low intensity, resistance training session. At 24 hours post-exercise, no increase was found in arm volume regardless of whether a sleeve was worn. Further research is needed to determine the short- and longterm c h a n g e s in extracellular fluid volume measured by BIA in response to moderate intensity resistance and/or aerobic exercise.  The fact that exercise has not been shown to increase arm volume is promising but not conclusive. A limitation of these studies performed to date is that the measurement techniques used do not indicate c h a n g e s in lymphatic function. Lymphoscintigraphy w a s developed to a s s e s s lymphatic status in patients with a variety of conditions that c a u s e lymphatic obstruction as it provides semi-quantitative measures of lymphatic function (36, 106).  N o w this technique is being used both in the investigation of the pathology of B C R L  (38-42, 45-47, 81-83, 107) and in the examination of various therapeutic interventions prescribed to manage B C R L (108-112).  A s part of the study conducted by Stanton et al. (42), lymphoscintigraphy was used to investigate the effects of exercise on B C R L . Five subjects performed a total of five minutes of intermittent exercise consisting of squeezing a ball in both hands simultaneously at 20 contractions per minute. Subjects did not wear compression sleeves during the  22  experimental protocol. Lymph clearance w a s measured over five hours post-exercise and no significant change in lymph clearance was found with the intermittent ball squeezing protocol. However, exercise of this type may not be of sufficient duration or intensity to result in a noticeable change in lymph clearance over the course of a five-hour measurement period. For example, Havas et al. (52) demonstrated significant increases in lymphatic clearance in males performing 100 submaximal contractions in 10 minutes of either dynamic knee extensions or isometric contractions with the leg extended. Perhaps, Stanton et al. would have achieved different results with subjects wearing compression sleeves and/or performing a more challenging exercise protocol.  There is the potential that long-term exercise performed by survivors of breast cancer could lead to improved lymph flow; however, this hypothesis needs further research. T h e propulsion of lymph within initial lymphatics is dependent on extrinsic mechanisms (muscular contractions, pulse of nearby arteries, and pressure changes with ventilation), while the propulsion of lymph within contractile lymphatic is dependent on intrinsic mechanisms (sympathetic activation of the spontaneously contracting smooth muscle) (9). Consequently, physiological changes associated with exercise training such as increased muscular contractions, increased sympathetic outflow, and increased ventilation could facilitate lymph return. For example, contraction of the smooth muscle in contractile lymphatic vessels is initiated by pacemaker cells (14) but can also be modulated by sympathetic activation (28, 125). Given that exercise results in an increase in sympathetic activation, then a corresponding increase in the frequency and force of lymphatic pumping would also be expected.  The effect of a larger muscle m a s s may also influence lymph flow even at rest. Modi et al. (82) found faster depot clearance of human serum immunoglobulin in women with B C R L when injected subcutaneously into the proximal forearm compared to the distal forearm, irrespective of the site of swelling. They hypothesized that the larger muscle mass (and thus, larger influence of the skeletal muscle pump) in the proximal forearm region may have accounted for the difference in C R . Perhaps, increasing muscle m a s s can influence lymph flow in the s a m e manner at other sites in the arm.  The possibility of lymphangiogenesis, recruitment of dormant lymphatic v e s s e l s , and opening of lymphaticovenous communications in response to exercise training may also  23  occur. For example, Y o o n et al. (126) demonstrated in an animal model of lymphedema that vascular endothelial growth factor-C ( V E G F - C ) therapy reversed swelling through the generation of new lymphatic vessels (lymphangiogenesis). A s habitual exercise in a healthy population is known to induce angiogenesis through up-regulation of other isoforms of V E G F (127), it is reasonable to expect concurrent lymphangiogenesis through up-regulation of V E G F - C . Lymphangiogenesis and recruitment of dormant v e s s e l s could help to reduce the stress put on the lymphatic vasculature damaged by breast c a n c e r treatment, namely axillary lymph node dissection and radiation to the axilla.  P e r h a p s , breast c a n c e r survivors who were cautioned against performing vigorous, upperbody exercise with the affected arm were fearful of doing even low- to moderate-intensity upper-body exercise. If light to moderate activity is not performed regularly, then the lymphatic vessels of the affected arm may become compromised as a result of the lack of stress put on mechanisms to assist in lymph return. Studies (56-58, 6 1 , 70) investigating the incidence of B C R L have not differentiated between those survivors who regularly engaged in moderate, upper-body physical activity and those who have abstained from upper-body exercise altogether.  Although exercise has not been shown to c a u s e or exacerbate B C R L (3, 5, 7, 8, 122, 123), caution should still be taken by breast cancer survivors with and without B C R L when performing moderate-intensity, upper-body exercise until research can conclusively determine that exercising at these intensities will not lead to the development or worsening of B C R L . Theoretically, wearing a compression sleeve, lifting the arm above the head after exercise, and performing a light, active recovery (i.e., low intensity exercise) should help to alleviate the e d e m a accumulation that may normally occur after exercise.  1.1.7  C o n c l u s i o n s a n d F u t u r e D i r e c t i o n s for R e s e a r c h  The lymphatic system is a one-way transport system that functions to produce, maintain and distribute lymphocytes, as well a s to assist in the regulation of tissue volume and pressure. Lymphatic vessels have similar structural features to the venous system and rely primarily on extrinsic mechanisms such as the skeletal muscle pump, the respiratory pump and the pulse of nearby blood vessels to facilitate lymph return. W o m e n with B C R L were originally cautioned against performing vigorous, upper-body exercise for fear of promoting  24  lymphedema. It w a s originally thought that the primary insult to the axillary lymphatic system (i.e., dissection and/or irradiation) c a u s e d global impairment of lymph drainage similar to a 'stop-cock' effect. Current research suggests that hemodynamic factors may also contribute to the chronic swelling and lymph vessel failure may only be regional. T h u s , the exact etiology and pathophysiology of B C R L appears to be multi-factorial and not fully understood. Both resistance and upper-body exercise have not been shown to lead to significant c h a n g e s in arm volume; however, further research is needed to better understand the effects of short- and long-term exercise on lymphatic function using lymphoscintigraphy.  25  1.2  STATEMENT OF THE RESEARCH PROBLEM  The gold standard for the diagnosis of BCRL remains volumetric displacement of the arm yet this technique does not measure lymphatic function. Consequently, there is a need for a test that will provide information on lymphatic function of the upper extremity in women with BCRL and this forms the basis of this research project. A simple, safe lymphatic challenge test using lymphoscintigraphy to evaluate lymphatic function will serve as a definitive diagnostic tool, and thus, will allow formal assessment of treatment methods currently prescribed. Furthermore, this test could eventually be used to determine the effects of a chronic exercise program on the adaptive response of the lymphatic system. Knowing how exercise affects lymphatic function would allow appropriate exercise prescription guidelines to be developed to prevent and treat BCRL.  1.3  P U R P O S E AND H Y P O T H E S E S OF THE THESIS  The overall purpose of the study was to design a standardized exercise test that could be combined with lymphoscintigraphy to measure changes in lymphatic function in women treated for breast cancer with and without BCRL. Lymphoscintigraphy was used to assess lymphatic function and upper body exercise was used to stress the lymphatic system. In total, three projects were completed. The purpose and hypotheses of each were as follows:  Project 1  Purpose: To determine a useful protocol to challenge the lymphatic system in breast cancer survivors by evaluating the effects of arm crank ergometry and isometric handgrip contractions on radiopharmaceutical clearance from the hands of healthy females. Hypothesis: Arm crank ergometry would result in faster radiopharmaceutical clearance from the injection site as measured by lymphoscintigraphy than the intermittent handgrip protocol.  26  Project 2 Purpose: To determine if varying the intensity of the arm cranking protocol affects radiopharmaceutical clearance rate from the hands of healthy females. A new primary outcome measure - percent uptake of the radiopharmaceuticals at the axillary lymph nodes one-hour post injection relative to the initial dose - w a s also introduced in this study.  Hypothesis: The arm crank protocol of higher intensity will result in faster radiopharmaceutical clearance from the depot and greater uptake at the axillary lymph nodes one-hour post injection than the arm crank protocol of lower intensity.  Project 3 Purpose: Projects 1 and 2 determined that an intermittent, moderate intensity, arm crank ergometry protocol may be useful to challenge the lymphatic system in w o m e n treated for breast cancer. Thus, the purpose of Project 3 was to evaluate lymphatic function both at rest and in response to this intermittent, arm cranking protocol in w o m e n treated for breast cancer with lymphedema ( B C R L ) , breast c a n c e r survivors with no lymphedema (BC), and healthy, age-matched control subjects ( C O N T ) . T h e primary outcome measure was clearance rate (CR), while secondary outcome measures of lymphatic function include radiopharmaceutical uptake at the axilla at 65 min post-injection relative to the initial dose (AX), radiopharmaceutical uptake in the forearm 65 min post-injection relative to the initial dose ( F O R E ) , and time of first appearance of radiopharmaceuticals at the axilla ( A P P ) .  Hypotheses: 1.  C R , A X , F O R E , and A P P on the non-affected side (i.e., contralateral arm) will be equivalent in all subject groups both at rest and during exercise.  2.  Lymphatic function relative to the contralateral arm (assuming contralateral arm lymphatic function is equivalent across groups) will differ between subject groups. Specifically, lymphatic function will be poorest (i.e., slowest C R , slowest A P P , lowest A X , and highest F O R E ) in B C R L while lymphatic function will be highest in C O N T (i.e., fastest C R , fastest A P P , highest A X , and lowest F O R E ) . The lymphatic function of B C will fall between B C R L and C O N T .  3.  Lymphatic function will improve from rest to exercise.  27  1.4  REFERENCES  1.  Kent H. Breast-cancer survivors begin to challenge exercise taboos. C a n a d i a n Medical Association Journal. 1996;155(7):969-71.  2.  Olszewski W L . Pathophysiological aspects of lymphedema of human limbs: I. Lymph protein composition. Lymphatic R e s e a r c h and Biology. 2003;1(3):235-43.  3.  Harris S R , Niesen-Vertommen S L . Challenging the myth of exercise-induced lymphedema following breast cancer: a series of c a s e reports. Journal of Surgical Oncology - Supplement. 2000;74(2):95-8.  4.  M c K e n z i e D C . Abreast in a b o a t - a race against breast cancer. C a n a d i a n Medical Association Journal. 1998;159(4):376-8.  5.  C h e e m a B S B , G a u l C A . Full-body exercise training improves fitness and quality of life in survivors of breast cancer. Journal of Strength and Conditioning R e s e a r c h . 2006;20(1 ):14-21.  6.  Lane K, J e s p e r s e n D, M c K e n z i e D C . The effect of a whole body exercise program and dragon boat training on arm volume and arm circumference in breast cancer survivors. European Journal of C a n c e r C a r e . 2005;14:353-8.  7.  J o h a n s s o n K, Tibe K, Weibull A , Newton R C . Low intensity resistance exercise for breast cancer patients with arm lymphedema with or without compression sleeve. Lymphology. 2005;38(4):167-80.  8.  A h m e d R L , T h o m a s W , Y e e D, Schmitz K H . R a n d o m i z e d controlled trial of weight training and lymphedema in breast cancer survivors. Journal of Clinical Oncology. 2006;24(18):2765-72.  9.  Aukland K, R e e d R K . Interstitial-lymphatic mechanisms in the control of extracellular fluid volume. Physiological Reviews. 1993;73(1):1-78.  10.  S c h m i d - S c h o n b e i n G W . Microlymphatics and lymph flow. Physiological Reviews. 1990;70(4):987-1028.  11.  Marieb E N . Human Anatomy and Physiology. 5th ed. S a n Francisco: Benjamin C u m m i n g s ; 1999.  12.  S c h m i d - S c h o n b e i n G W . The second valve system in lymphatics. Lymphatic R e s e a r c h and Biology. 2003;1(1):25-31.  13.  Trzewik J , Mallipattu S K , Artmann G M , Delano F A , Schmid-Schonbein G W . Evidence for a second valve system in lymphatics: endothelial microvalves. F A S E B . 2001;15:1711-7.  14.  G a s h e v A A . Physiologic aspects of lymphatic contractile function: current perspectives. Annals of the New York A c a d e m y of S c i e n c e s . 2002;979:178-87.  28  15.  Witte M H , J o n e s K, Wilting J , Dictor M, S e l g M, M c H a l e N, et al. Structure function relationships in the lymphatic system and implications for cancer biology. C a n c e r & Metastasis Reviews. 2006;25(2):159-84.  16.  Pain S J , Purushotham A D . Lymphoedema following surgery for breast cancer. British Journal of Surgery. 2000;87(9):1128-41.  17.  Board J , Harlow W . Lymphoedema 1: components and function of the lymphatic system. British Journal of Nursing. 2002;11(5):304-9.  18.  Threefoot S A . The clinical siginifcance of lymphaticovenous communications. A n n a l s of Internal Medicine. 1970;72(6):957-8.  19.  Threefoot S , K o s s o v e r M F , Aiken DW. Radioisotopic detection of lymphaticovenous communications in living animals. Journal of Laboratory and Clinical Medicine. 1965;65:688-97.  20.  Starling E. O n absorption of fluids from connective tissue s p a c e s . Journal of Physiology. 1896;19:312-26.  21.  O l s z e w s k i W , Engeset A . Intrinsic contractility of prenodal lymph v e s s e l s and lymph flow in human leg. American Journal of Physiology. 1980;239:H775-H83.  22.  Zawieja D. Lymphatic biology and the microcirculation: past, present and future. Microcirculation. 2005;12(1):141-50.  23.  M a z z o n i M C , Skalak T C , Schmid-Schonbein G W . Effects of skeletal muscle fiber deformation on lymphatic volumes. American Journal of Physiology. 1990;259:H1860-8.  24.  Swartz M A , Boardman K C . The role of interstitial stress in lymphatic function and lymphangiogenesis. Annals of the New York A c a d e m y of S c i e n c e s . 2002;979:197210.  25.  Swartz M A . The physiology of the lymphatic system. A d v a n c e d Drug Delivery Reviews. 2001;50:3-20.  26.  B a c h C , Lewis G P . Lymph flow and lymph protein concentration in the skin and muscle of the rabbit hind limb. Journal of Physiology. 1973;235(2):477-92.  27.  M c H a l e N G , Roddie IC. The effect of intravenous adrenaline and noradrenaline infusion of peripheral lymph flow in the sheep. Journal of Physiology. 1983;341:51726.  28.  Seabrook T J , Ristevski B, Rhind S G , Shek P N , Zamecnik J , Shephard R J , et al. Epinephrine c a u s e s a reduction in lymph node cell output in sheep. C a n a d i a n Journal of Physiology & Pharmacology. 2001 ;79(3):246-52.  29.  C o a t e s G , O'Brodovich H, G o e r e e G . Hindlimb and lung lymph flows during prolonged exercise. Journal of Applied Physiology. 1993;75(2):633-8.  29  30.  M c G e o w n J G , McHale N G , Roddie IC, Thornbury K. Peripheral lymphatic responses to outflow pressure in anaesthetized sheep. Journal of Physiology. 1987;383:527-36.  31.  M c G e o w n J G , M c H a l e N G , Thornbury K D . The role of external compression and movement in lymph propulsion in the sheep hind limb. Journal of Physiology. 1987;387:83-93.  32.  M c G e o w n J G , M c H a l e N G , Thornbury K D . Effects of varying patterns of external compression on lymph flow in the hindlimb of the anaesthetized sheep. Journal of Physiology. 1988;397:449-57.  33.  O l s z e w s k i W . The lymphatic system in body homeostasis: Physiological conditions. Lymphatic R e s e a r c h and Biology. 2003;1(1):11-21.  34.  Olszewski W , Engeset A, J a e g e r P M , Sokolowski J , Theodorsen L. Flow and composition of leg lymph in normal men during venous stasis, muscular activity and local hyperthermia. Acta Physiologica Scandinavica. 1977;99(2):149-55.  35.  Bourgeois P, Leduc O, Leduc A . Imaging techniques in the management and prevention of posttherapeutic upper limb e d e m a s . Cancer. 1998;83:2805-13.  36.  Krasnow A Z , Hellman R S . Lymphoscintigraphy revisited: 1999. Nuclear Medicine Annual. Philadelphia: Lippincott, Williams and Wilkins; 1999. p. 17-97.  37.  S z u b a A , Shin W S , Strauss H W , R o c k s o n S . The third circulation: Radionuclide lymphoscintigraphy in the evaluation of lymphedema. Journal of Nuclear Medicine. 2003;44:43-57.  38.  Pain S J , Barber R W , Ballinger J R , Solanki C K , Mortimer P S , Purushotham A D , et al. Local vascular a c c e s s of radioprotein injected subcutaneously in healthy subjects and patients with breast cancer-related lymphedema. Journal of Nuclear Medicine. 2004;45(5):789-96.  39.  P a i n S J , Barber R W , Ballinger J R , Solanki C K , Mortimer P S , Purushotham A D , et al. Tissue-to-blood transport of radiolabeled immunoglobulin injected into the web s p a c e s of the hands of normal subjects and patients with breast cancer-related lymphoedema. Journal of V a s c u l a r R e s e a r c h . 2004;41(2):183-92.  40.  P a i n S J , Nicholas R S , Barber R W , Ballinger J R , Purushotham A D , Mortimer P S , et al. Quantification of lymphatic function for investigation of lymphedema: depot clearance and rate of appearance of soluble macromolecules in blood. Journal of Nuclear Medicine. 2002;43(3):318-24.  41.  Pain S J , Purushotham A D , Barber R W , Ballinger J R , Solanki C K , Mortimer P S , et al. Variation in lymphatic function may predispose to development of breast cancerrelated lymphoedema. European Journal of Surgical Oncology. 2004;30:508-14.  42.  Stanton A W , S v e n s s o n W E , Mellor R H , Peters A M , Levick J R , Mortimer P S . Differences in lymph drainage between swollen and non-swollen regions in arms with breast-cancer-related lymphoedema. Clinical S c i e n c e . 2001;101(2):131-40.  30  43.  O'Mahony S , R o s e S, Chilvers A , Ballinger J , Solanki C , Barber R, et al. Finding an optimal method for imaging lymphatic vessels of the upper limb. European Journal of Nuclear Medicine and Molecular Imaging. 2004;31(4):555.  44.  O'Mahony S , Solanki C K , Barber R W , Mortimer P S , Purushotham A D , Peters A M . Imaging of lymphatic vessels in breast cancer-related lymphedema: intradermal versus subcutaneous injection of 99mTc-immunoglobulin. American Journal of Roentgenology. 2006;186(5):1349-55.  45.  Pain S J , Vowler S , Purushotham A D . Axillary vein abnormalities contribute to development of lymphoedema after surgery for breast cancer. British Journal of Surgery. 2005;92(3):311-5.  46.  Pain S J , Barber R W , Solanki C K , Ballinger J R , Britton T B , Mortimer P S , et al. Shortterm effects of axillary lymph node clearance surgery on lymphatic physiology of the arm in breast cancer. Journal of Applied Physiology. 2005;99(6):2345-51.  47.  Pain S J , Barber R W , Ballinger J R , Solanki C K , O'Mahony S O , Mortimer P S , et al. Side-to-side symmetry of radioprotein transfer from tissue s p a c e to systemic vasculature following subcutaneous injection in normal subjects and subjects with breast cancer. European Journal of Nuclear Medicine and Molecular Imaging. 2003;30(5):657-61.  48.  Y u d d A P , Kempt J S , G o y d o s J S , Stahl T J , Feinstein R S . U s e of sentinel node lymphoscintigraphy in malignant melanoma. Radiographics. 1999;19:343-53.  49.  P e d e r s e n B, Hoffman-Goetz L. Exercise and the immune system: regulation, integration, and adaptation. Physiological Reviews. 2000;80(3):1055-81.  50.  Brenner I, Natale V, Vasiliou P, Moldovean A , Shek P, Shephard R. Impact of three different types of exercise on components of the inflammatory response. European Journal of Applied Physiology. 1999;80:452-60.  51.  P e a k e J , Suzuki K, Hordern M, Wilson G , N o s a k a K, C o o m b e s J . P l a s m a cytokine c h a n g e s in relation to exercise intensity and muscle damage. European Journal of Applied Physiology. 2005;95:514-21.  52.  H a v a s E, Parviainen T, Vuorela J , Toivanen J , Nikula T, Vihko V . Lymph flow dynamics in exercising human skeletal muscle as detected by scintography. Journal of Physiology. 1997;504(Pt 1):233-9.  53.  T e s c h P A , Wright J E . Recovery from short term intense exercise: Its relation to capillary supply and blood lactate concentration. European Journal of Applied Physiology and Occupational Physiology. 1983;52:98-103.  54.  H a v a s E, Lehtonen M, Vuorela J , Parviainen T, Vihko V. Albumin clearance from human skeletal muscle during prolonged steady-state running. Experimental Physiology. 2000;85(6):863-8.  55.  Mortimer P S . The pathophysiology of lymphedema. Cancer. 1998;83(12 Suppl American):2798-802.  31  56. •  Hinrichs C S , Watroba NL, Rezaishiraz H, G i e s e W , Hurd T, Fassl K A , et al. L y m p h e d e m a secondary to postmastectomy radiation: incidence and risk factors. A n n a l s of Surgical Oncology. 2004;11 (6):573-80.  57.  O z a s l a n C , Kuru B. Lymphedema after treatment of breast cancer. The American Journal of Surgery. 2004;187(1 ):69-72.  58.  Petrek J A , S e n i e RT, Peters M, R o s e n P P . Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer. 2001 ;92(6):1368-77.  59.  Williams A F , Franks P J , Moffatt C J . Lymphoedema: estimating the size of the problem. Palliative Medicine. 2005;19(4):300-13.  60.  R o c k s o n S G . Addressing the unmet needs in lymphedema risk management. Lymphatic R e s e a r c h and Biology. 2006;4(1):42-6.  61.  Erickson V S , Pearson M L , G a n z P A , A d a m s J , Kahn K L . Arm e d e m a in breast cancer patients. Journal of the National C a n c e r Institute. 2001 ;93(2):96-111.  62.  M c W a y n e J , Heiney S P . Psychologic and social sequelae of secondary lymphedema: a review. Cancer. 2005;104(3):457-66.  63.  Goffman T E , Laronga C , Wilson L, Elkins D. L y m p h e d e m a of the arm and breast in irradiated breast cancer patients: risks in an era of dramatically changing axillary surgery. Breast Journal. 2004;10(5):405-11.  64.  van der V e e n P, De Voogdt N, Lievens P, Duquet W , Lamote J , S a c r e R. L y m p h e d e m a development following breast cancer surgery with full axillary resection. Lymphology. 2004;37(4):206-8.  65.  Williams W H , Witte C L , Witte M H , McNeill G C . Radionuclide lymphangioscintigraphy in the evaluation of peripheral lymphedema. Clinical Nuclear Medicine. 2000;25(6):451-64.  66.  Ververs J M , R o u m e n R M , Vingerhoets A J , Vreugdenhil G , C o e b e r g h J W , Crommelin M A , et al. Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. European Journal of C a n c e r . 2001;37(8):991-9.  67.  Purushotham A D , Upponi S , Klevesath M B , Bobrow L, Millar K, Myles J P , et al. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. Journal of Clinical Oncology. 2005;23(19):4312-21.  68.  R o n k a R H , Pamilo M S , von Smitten K A J , Leidenius M H K . Breast lymphedema after breast conserving treatment. Acta Oncologica. 2004;43(6):551-7.  69.  Schijven M P , Vingerhoets A J J M , Rutten H J T , Nieuwenhuijzen G A P , R o u m e n R M H , van B u s s e l M E , et al. Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. European Journal of Surgical Oncology. 2003;29(4):341-50.  32  70.  S e n e r S F , Winchester D J , Martz C H , Feldman J L , C a v a n a u g h J A , Winchester D P , et al. L y m p h e d e m a after sentinel lymphadenectomy for breast carcinoma. C a n c e r . 2001;92:748-52.  71.  M a n s e l R E , Fallowfield L, Kissin M, G o y a l A , Newcombe R G , Dixon J M , et al. R a n d o m i z e d multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the A L M A N A C Trial. Journal of the National C a n c e r Institute. 2006;98(9):599-609.  72.  Armer J , Fu M R , Wainstock J M , Zagar E, J a c o b s LK. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy. Lymphology. 2004;37(2):7391.  73.  Haid A , K u e h n T, Konstantiniuk P, Koberle-Wuhrer R, K n a u e r M , Kreienberg R, et al. Shoulder-arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer. European Journal of Surgical Oncology. 2002;28(7):705-10.  74.  Leidenius M, Leivonen M, Vironen J , von Smitten K. The c o n s e q u e n c e s of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance. Journal of Surgical Oncology. 2005;92(1):23-31.  75.  Kubik S . The role of the lateral upper arm bundle and the lymphatic watersheds in the formation of collateral pathways in lymphedema. Acta Biologica. 1980;31(13):191-200.  76.  Piller N B . Macrophage and tissue changes in the developmental p h a s e s of secondary lymphoedema and during conservative therapy with benzopyrone. Archives of Histology and Cytology. 1990;53 Suppl:209-18.  77.  Bates D O , Levick J R , Mortimer P S . C h a n g e in macromolecular composition of interstitial fluid from swollen arms after breast cancer treatment, and its implications. Clinical Science. 1993;85(6):737-46.  78.  Bates D O , Levick J R , Mortimer P S . Subcutaneous interstitial fluid pressure and arm volume in lymphoedema. International Journal of Microcirculation: Clinical and Experimental. 1992;11(4):359-73.  79.  S v e n s s o n W E , Mortimer P S , Tohno E, Cosgrove D O . Increased arterial inflow demonstrated by Doppler ultrasound in arm swelling following breast cancer treatment. European Journal of C a n c e r . 1994;30A(5):661-4.  80.  Stanton A W , Holroyd B, Mortimer P S , Levick J R . Comparison of microvascular filtration in human arms with and without postmastectomy o e d e m a . Experimental Physiology. 1999;84:405-19.  81.  Stanton A W B , Modi S, Mellor R H , Peters A M , S v e n s s o n W E , Levick J R , et al. A quantitative lymphoscintigraphic evaluation of lymphatic function in the swollen hands of women with lymphoedema following breast cancer treatment. Clinical S c i e n c e . 2006;110(5):553-61.  33  82.  Modi S , Stanton A W B , Mellor R H , Peters A M , Levick J R , Mortimer P S . Regional distribution of epifascial swelling and epifascial lymph drainage rate constants in breast cancer-related lymphedema. Lymphatic R e s e a r c h and Biology. 2005;3(1):315.  83.  Stanton A W , Mellor R H , C o o k G J , S v e n s s o n W E , Peters A M , Levick J R , et al. Impairment of lymph drainage in subfascial compartment of forearm in breast cancer-related lymphedema. Lymphatic R e s e a r c h and Biology. 2003;1(2):121-32.  84.  Collins C , Mortimer P, D'Ettore H, A'Hern R, Moskovic E. Computed tomography in the a s s e s s m e n t of response to limb compression in unilateral lymphoedema. Clinical Radiology. 1995;50:541-4.  85.  M o d i S , Stanton A W B , Mellor R H , Levick J R , Mortimer P S . Treatment for breast cancer does not impair local lymph drainage in the epifascial and subfascial compartments of the ipsilateral arm. Microcirculation. 2004;11:547.  86.  Mellor R H , Stanton A W , Azarbod P, Sherman M D , Levick J R , Mortimer P S . E n h a n c e d cutaneous lymphatic network in the forearms of women with postmastectomy o e d e m a . Journal of V a s c u l a r R e s e a r c h . 2000;37(6):501-12.  87.  Mellor R H , Stanton A W B , Menadue L, Levick J R , Mortimer P S . Evidence for dermal angiogenesis in breast cancer related lymphedema demonstrated using dual-site fluorescence angiography. Microcirculation. 2002;9:207-19.  88.  Malek P, Kolc J , Belan A . Lymphography of the deep lymphatic system of the thigh. A c t a Radioligica. 1959;51:422-8.  89.  Vitek J , K a s p a r Z. The radiology of the deep lymphatic system of the leg. British Journal of Radiology. 1973;46:120-4.  90.  Aboul-Enein A , E s h m a w y I, Arafa S , A b b o u d A. The role of lymphovenous communication in the development of postmastectomy lymphedema. Surgery. 1984;95(5):562-6.  91.  M e g e n s A M , Harris S R , Kim-Sing C , M c K e n z i e D C . Measurement of upper extremity volume in women after axillary dissection for breast cancer. Archives of Physical Medicine and Rehabilitation. 2001 ;82(12):1639-44.  92.  Harris S R , Hugi M R , Olivotto IA, Levine M, Steering Committee for Clinical Practice Guidelines for the C , Treatment of Breast C . Clinical practice guidelines for the care and treatment of breast cancer: 11. Lymphedema. Canadian Medical Association Journal. 2001;164(2):191-9.  93.  Cornish B. Bioimpedance analysis: scientific background. Lymphatic R e s e a r c h and Biology. 2006;4(1):47-50.  94.  Cornish B H , Bunce IH, Ward L C , J o n e s L C , T h o m a s B J . Bioelectrical impedance for monitoring the efficacy of lymphoedema treatment programmes. Breast C a n c e r R e s e a r c h and Treatment. 1996;38(2):169-76.  34  95.  Cornish B H , Ward L C , T h o m a s B J , Bunce IH. Quantification of lymphoedema using multi-frequency bioimpedance. Applied Radiation and Isotopes. 1998;49(5-6):651-2.  96.  W a r d L C . Bioelectrical impedance analysis: proven utility in lymphedema risk a s s e s s m e n t and therapuetic monitoring. Lymphatic R e s e a r c h and Biology. 2006;4(1):51-6.  97.  Clodius L, Deak L, Piller N B . A new instrument for the evaluation fo tissue tonicity in lymphoedema. Lymphology. 1976;9(1):1-5.  98.  Piller N B , Clodius L. The use of a tissue tonometer as a diagnostic aid in extremity lymphoedema: a determination of its conservative treatment with benzo-pyrones. Lymphology. 1976;9(4):127-32.  99.  Moseley A L , Piller N B , Carati C J . The effect of gentle arm exercise and deep breathing on secondary arm lymphedema. Lymphology. 2005;38(3):136-45.  100.  Bagheri S , Ohlin K, Olsson G , Brorson H. Tissue tonometry before and after liposuction of arm lymphedema following breast cancer. Lymphatic R e s e a r c h and Biology. 2005;3(2):66-80.  101.  Carati C J , Anderson S N , G a n n o n B J , Piller N B . Treatment of postmastectomy lymphedema with low-level laser therapy: a double blind, placebo-controlled trial. C a n c e r . 2003;98(6):1114-22.  102.  S z u b a A , Achalu R, R o c k s o n S G . Decongestive lymphatic therapy for patients with breast carcinoma-associated lymphedema. A randomized, prospective study of a role for adjunctive intermittent pneumatic compression. Cancer. 2002;95(11 ):2260-7.  103.  Piller N B , Thelander A . Treatment of chronic postmastectomy lymphedema with low level laser therapy: a 2.5 year follow-up. Lymphology. 1998;31 (2):74-86.  104.  C h a n g T S , G a n J L , Fu K D , Huang W Y . The use of 5,6 benzo-[alpha]-pyrone (coumarin) and heating by microwaves in the treatment of chronic lymphedema of the legs. Lymphology. 1996;29(3):106-11.  105.  Piller N B , Morgan R G , Casley-Smith J R . A double-blind, cross-over trial of 0-(betahydroxyethyl)-rutosides (benzo-pyrones) in the treatment of lymphoedema of the arms and legs. British Journal of Plastic Surgery. 1988;41 (1 ):20-7.  106.  Witte C L , Witte M H , Unger E C , Williams W H , Bernas M J , McNeill G C , et al. A d v a n c e s in imaging of lymph flow disorders. Radiographics. 2000;20(6):1697-719.  107.  S v e n s s o n W, G l a s s D M , Bradley D, Peters A M . Measurement of lymphatic function with technetium-99m-labelled polyclonal immunoglobulin. European Journal of Nuclear Medicine. 1999;26(5):504-10.  108.  Gothard L, Stanton A , M a c L a r e n J , Lawrence D, Hall E, Mortimer P, et al. N o n randomised phase II trial of hyperbaric oxygen therapy in patients with chronic arm lymphoedema and tissue fibrosis after radiotherapy for early breast cancer. Radiotherapy and Oncology. 2004;70(3):217-24.  35  109.  S z u b a A , Strauss W , Sirsikar S P , R o c k s o n S G . Quantitative radionuclide lymphoscintigraphy predicts outcome of manual lymphatic therapy in breast cancerrelated lymphedema of the upper extremity. Nuclear Medicine Communications. 2002;23(12):1171-5.  110.  de G o d o y J M , Batigalia F, G o d o y M d e F. Preliminary evaluation of a new, more simplified physiotherapy technique for lymphatic drainage. Lymphology. 2002;35(2):91-3.  111.  Miranda F, Jr., P e r e z M C , Castiglioni M L , Juliano Y , Amorim J E , Nakano L C , et al. Effect of sequential intermittent pneumatic compression on both leg lymphedema volume and on lymph transport a s semi-quantitatively evaluated by lymphoscintigraphy. Lymphology. 2001 ;34(3):135-41.  112.  Hwang J H , Kwon J Y , L e e K W , Choi J Y , Kim BT, L e e B B , et al. C h a n g e s in lymphatic function after complex physical therapy for lymphedema. Lymphology. 1999;32(1):15-21.  113.  Kligman L, W o n g R K , Johnston M, Laetsch N S . T h e treatment of lymphedema related to breast cancer: a systematic review and evidence summary. Supportive C a r e in Cancer. 2004;12(6):421-31.  114.  Bertelli G , Venturini M, Forno G , Macchiavello F, Dini D. Conservative treatment of postmastectomy lymphedema: a controlled, randomized trial. Annals of Oncology. 1991;2(8):575-8.  115.  Dini D, Del Mastro L, G o z z a A , Lionetto R, Garrone O, Forno G , et al. T h e role of pneumatic compression in the treatment of postmastectomy lymphedema. A randomized phase III study. Annals of Oncology. 1998;9(2):187-90.  116.  Kim-Sing C , B a s c o V E . Postmastectomy lymphedema treated with the Wright linear pump. C a n a d i a n Journal of Surgery. 1987;30(5):368-70.  117.  Klein M J , Alexander M A , Wright J M , R e d m o n d C K , L e G a s s e A A . Treatment of adult lower extremity lymphedema with the Wright linear pump: statistical analysis of a clinical trial. Archives of Physical Medicine & Rehabilitation. 1988;69:202-6.  118.  P a p p a s C J , O'Donnell T F , Jr. Long-term results of compression treatment for lymphedema. Journal of V a s c u l a r Surgery. 1992;16(4):555-62.  119.  A n d e r s e n L, Hojris I, Erlandsen M, A n d e r s e n J . Treatment of breast-cancer-related lymphedema with or without manual lymphatic drainage--a randomized study. A c t a Oncologica. 2000;39(3):399-405.  120.  Wilburn O, Wilburn P, R o c k s o n S G . A pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema. B M C C a n c e r . 2006;6:84.  121.  Williams A F , V a d g a m a A , Franks P J , Mortimer P S . A randomized controlled crossover study of manual lymphatic drainage therapy in women with breast cancerrelated lymphoedema. European Journal of C a n c e r C a r e . 2002;11(4):254-61.  36  122.  M c K e n z i e D C , Kalda A L . Effect of upper extremity exercise on secondary lymphedema in breast cancer patients: a pilot study. Journal of Clinical Oncology. 2003;21(3):463-6.  123.  Turner J , Hayes S , Reul-Hirche H. Improving the physical status and quality of life of women treated for breast cancer: a pilot study of a structured exercise intervention. Journal of Surgical Oncology. 2004;86(3):141-6.  124.  A b e T, D e H o y o s DV, Pollock M, Garzarella L. Time course for strength and muscle thickness changes following upper and lower body resistance training in men and w o m e n . European Journal of Applied Physiology and Occupational Physiology. 2000;81:174-80.  125.  M c H a l e N G , Roddie IC. The effects of catecholamines on pumping activity in isolated bovine mesenteric lymphatics. Journal of Physiology. 1983;338:527-36.  126.  Y o o n Y , Murayama T, Gravereaux E, Tkebuchava T, Silver M, Curry C , et al. V E G F C therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. Journal of Clinical Investigation. 2003;111(5):717-25.  127.  Gustafsson T, A m e l n H, Fischer H, Sundberg C , Timmons J , J a n s s o n E. V E G F - A splice variants and related receptor expression in human skeletal muscle following submaximal exercise. Journal of Applied Physiology. 2005;98(6):2137-46.  37  C H A P T E R TWO  Lymphoscintigraphy to Evaluate the Effects of Upper Body Dynamic Exercise and Handgrip Exercise on Radiopharmaceutical Clearance from Hands of Healthy Females  2.1  8  INTRODUCTION  Breast cancer related lymphedema ( B C R L ) is a poorly understood complication of breast c a n c e r treatment. The chronic swelling occurs in the ipsilateral hand or arm of w o m e n treated for breast cancer (1) and can result in numerous physiological and psychological sequelae, including restricted range of motion in the affected arm, increased risk of infection, impaired limb function, increased depression, and reduced quality of life (2, 3). Current data suggest the prevalence of this condition to be from 2 7 % (4, 5) to 4 9 % (6). Factors that increase the risk of developing B C R L are dissection of axillary lymph nodes, radiotherapy to the breast and axilla, pathological nodal status, obesity, and tumor stage (710). B C R L is essentially an incurable condition although treatments such a s skin care, manual lymphatic drainage, pneumatic pumping, and compression sleeves exist to contain swelling (7, 11). Exercise was originally thought to exacerbate B C R L ; however, recent studies show no significant change in arm volume with either resistance training or upper body exercise in women treated for breast cancer with and without B C R L (12-17).  The diagnosis of B C R L usually involves volumetric, circumference, or bioelectrical impedance measurements a s well a s symptoms of heaviness and tightness in the affected arm (2, 18-21). In clinical practice, a difference of more than 200 mL (20) measured by water displacement or 2 cm measured by arm circumference at various landmarks (19, 20) may signify mild to moderate lymphedema. Alternatively, a bioelectrical impedance ratio greater than 1.00 may also indicate B C R L (22). Although arm circumference and volume measurements are noninvasive and relatively simple to perform, they do not indicate changes in lymphatic function. Conversely, lymphoscintigraphy does give an indication of lymphatic function. This technique involves radiopharmaceutical labeling of a lymphatic drainage source and w a s developed to a s s e s s lymphatic status in patients with a variety of  Parts of this chapter have been previously published: Lane, K., Worsley, D., & McKenzie, D. Lymphoscintigraphy to evaluate the effects of upper body dynamic exercise and handgrip exercise on radiopharmaceutical clearance from hands of healthy females. Lymphatic Research and Biology, 2005;3(1):16-24. B  38  conditions that c a u s e lymphatic obstruction. It is now being used to investigate the pathophysiology of B C R L (23-29) and to evaluate the efficacy of certain treatment methods prescribed for B C R L (30, 31).  Several reviews have suggested the use of a standardized lymphoscintigraphy stress protocol when investigating lymphatic dysfunction (28, 32, 33). Although all studies examining the lymphatic function of women treated for breast cancer include forearm exercise, s u c h a s clenching the fists or squeezing a rubber ball, (23-27, 29, 31) it is unknown if this type of exercise significantly increases lymph flow compared to rest in normal subjects or subjects with lymphatic disease. Therefore, the purpose of the study was to evaluate the effects of arm crank ergometry (AC) and handgrip contractions (HG) on radiopharmaceutical clearance from the hands of healthy females. Lymphoscintigraphy was used to a s s e s s lymphatic function and upper body exercise w a s used to stress the lymphatic system. Healthy, college-aged females were recruited so that a normal response of the lymphatic system to exercise of different modes could be investigated.  2.2  MATERIALS AND METHODS  2.2.1  Subjects  Six healthy females between the ages of 1 8 - 3 0 years participated in the study. Prior to testing, informed consent was obtained from each subject and the study w a s approved by the Clinical Screening Committee for R e s e a r c h and Other Studies Involving Human Subjects at the University of British Columbia.  2.2.2  Experimental design  A repeated-measures design was used to compare the effect of two exercise conditions on lymphatic clearance rate ( C R ) from each hand. The independent variable w a s the exercise condition, arm cranking (AC) or handgrip contractions (HG), while the dependent variable w a s the lymphatic C R from each hand during exercise. The subjects were designated to treatment order by a randomized draw to prevent any sequencing effects from occurring. At  39  least 48 hours separated each test to prevent fatigue from biasing data and to allow decay of the radiopharmaceutical.  2.2.3  Experimental procedures  Imaging Lymphoscintigraphy was used to quantify lymphatic function and was performed at V a n c o u v e r General Hospital, Department of Nuclear Medicine. Subjects were asked to arrive hydrated and rested. The s a m e technician prepared and administered subcutnaeous injections of the radiopharmaceutical technetium-99m (  99m  Tc)-antimony colloid to all of the  subjects on e a c h testing day. During early pilot work prior to the start of this study, filtered 9 9 m  T c sulfur colloid w a s being used as the radiopharmaceutical for the lymphoscintigraphy  procedure. However, clearance rate at rest showed little movement of this particle. Consequently,  9 9 m  T c - antimony colloid was chosen, as it is a smaller particle that is  preferentially taken up by the lymphatic system. Filtered sulfur colloid yields particles 10100 nm in size whereas antimony colloid yields particles between 3 and 30 nm (34).  A total of 18 M B q of  9 9 m  T c antimony colloid in 0.05 mL was administered subcutaneously to  the first and fourth web s p a c e s of each hand prior to the start of the exercise protocol. After administration, subjects placed both hands prone on a gamma camera equipped with a low energy, ultra high resolution collimator (Sopha Medical Vision, W a u k e s h a , Wisconsin). Only the forearms and the hands were in the field of view of the camera and a single camera head w a s used. O n e minute static acquisitions with a 2 0 % energy window w a s centered on a 140 keV peak. The initial image w a s acquired within 1 minute of the injection and sequential images were acquired every 10 minutes post-injection over a total period of 60 minutes.  The images were processed using S i e m e n s Icon software (Version 8.5, S i e m e n s Medical S y s t e m s Inc., Hoffman Estates IL). A region of interest (ROI) was drawn around e a c h of the injection sites to give the number of activity counts. The counts from the first and fourth web s p a c e s of e a c h hand were added together and corrected for physical decay of the following equation:  40  9 9 m  T c using  whereby A = activity after an elapsed time (min), A = activity in original sample, X = t  0  0.693/363 min physical half-life of  99m  T c , and t = elapsed time from the original image. The  corrected count at each time point was divided by the corrected count measured immediately after injection and was plotted against time. C R from the injection site was linear, and so, the equation given by Havas et al. (35) was used to calculate CR:  C R = [((A -A )A - )IOO] r r w o ) 1  1  0  1  0  whereby A = the radioactivity (counts min" ) at the beginning of the period of interest, A i = 1  0  the radioactivity at the end of the period of interest, and T and T-i are the times (min) at A 0  0  and A-i, respectively. C R is expressed as the percent of activity initially administered per minute  Exercise  (%min" ). 1  Protocols.  On separate days, subjects did one of two exercise conditions that began immediately after the first imaging scan and continued from 0 to 60 minutes (Fig 2.1). The exercise conditions for A C were six repeated bouts of 5 minutes at 0.6 W kg" on a calibrated arm crank 1  ergometer (model 881 e, Monark, Sweden) followed by 5 minutes of rest, and for HG were twelve repeated bouts of 75 contractions in 2.5 minutes at 50% maximum voluntary contraction (MVC) followed by 2.5 minutes of rest. HG was performed with the right hand only using an isometric dynamometer (Almedic, Quebec City, Quebec) at a duty cycle of one contraction every 2 seconds, while the left hand served as the control (CONT). For both A C and HG, all imaging scans were performed during rest periods. During early pilot work prior to the start of this study, a handgrip protocol consisting of 30 contractions at 30% MVC in 1 minute followed by 9 minutes of rest was used. This protocol was not found to differ substantially from resting data and it was thought that the exercise stimulus was too conservative. Thus, the handgrip protocol was adjusted by increasing the intensity and the number of contractions and investigated in the current study.  2.2.4  Statistical A n a l y s i s  A 2 x 2 (hand x exercise) within-subjects, repeated measures analysis of variance (ANOVA) was used to determine if there were differences in C R between the right and left hands for each condition (AC and HG) during exercise. Statisica version 5.1 was used and  41  +0  5  +10 mm  AC  exercise rest 1 min static acquisition (taken in last minute of rest)  Figure 2.1  Graphical representation of the arm cranking (AC) and intermittent handgrip (HG) protocols. T h e 10 min segment of the protocol outlined above w a s repeated six times.  42  significance w a s set at p<0.05. Post-hoc analysis for any main effects was performed using Tukey's test of honest significant differences. Data is reported as mean ± standard deviation.  2.3  RESULTS  Six healthy females completed the study (age = 29.2 ±1.9 years; height = 165.4 ±4.5 c m ; body weight = 55.6 ±7.1 kg; BMI = 20.3 ±2.1 k g m " ; M V C = 32.7 ±2.7 kg). Figure 2.1 shows 2  that a significantly higher clearance rate w a s observed with the right and left hands for A C (right -0.27 ±0.03% per min; left -0.29 ±0.06% per min) compared to both H G (-0.18 ±0.03% per min) and C O N T (-0.14 ±0.05% per min; p=0.000). The left hand on Fig. 2.2 for H G is equivalent to the control hand or C O N T . No significant difference was found during A C between the right and left hands (p=0.503) nor w a s a significant difference found between H G and C O N T (p=0.091).  Figure 2.3 shows individual C R as a function of time for A C (counts for the right and left hands averaged at e a c h time point), H G (right hand only), and C O N T (left hand only for H G protocol).  2.4  DISCUSSION  T h e primary finding of this study is that significantly quicker clearance of  99m  Tc-antimony  colloid from the hands of healthy females was evident during upper body dynamic exercise using an arm crank ergometer compared to intermittent handgrip contractions using a handgrip dynamometer. In fact, the handgrip exercise resulted in a clearance rate that w a s equivalent to the resting or control arm. This study is unique in that it is the first to report if performing exercise with the upper limb between imaging scans can stimulate lymph flow as measured by clearance of  99m  T c - a n t i m o n y colloid from the injection site.  43  F i g u r e 2.2  T h e effects of arm cranking (AC) and intermittent handgrip (HG) on clearance rate (CR) from the hands of healthy females (n=6). § denotes a significantly greater (p<0.05) clearance rate for A C (right and left arms) compared to both H G and C O N T . N O T E : T h e left hand is a control ( C O N T ) , and thus, did not do the exercise protocol.  44  80  » 0  10  20  30  40  50  60  Time (min)  F i g u r e 2.3  Individual depot activity (%) time (min) curves for arm cranking with the counts averaged for the right and left hand at each time point (Panel A - A C ) , intermittent handgrip exercise (Panel B - H G ) , and a control arm (Panel C C O N T ) from the hands of healthy females (n=6).  45  Typically, when lymphoscintigraphy is used to investigate the pathophysiology of B C R L , the protocol has subjects performing intermittent forearm exercise, such as clenching the fists or squeezing a rubber ball, between imaging scans (23-27, 29, 31). Although repeated forearm muscle contractions should theoretically stimulate lymph flow by way of the skeletal muscle pump, this has not been investigated to date. Other studies (35-38) have examined the effects of muscle activity on lymph clearance using lymphoscintigraphy, but e a c h one has used a leg model and male subjects. Thus, it is unclear if the lymphatic v e s s e l s in the upper extremity respond in a similar manner to a given exercise bout as do the lymphatic vessels in the lower extremity or if there is a gender effect. Further, clenching the fist or squeezing a rubber ball does not allow the amount of work completed to be precisely quantified. If the effort, or work, differs among subjects, then this can potentially lead to varying rates of radiopharmaceutical clearance from the injection sites. Consequently, handgrip exercise w a s used in the present study as it closely mimics the muscle groups activated during fist clenching and it allows the amount of work to be precisely quantified. Upper body dynamic exercise using an arm crank ergometer was also included in order to s e e how a different type of exercise condition affects clearance rate.  In the present study, the C R observed during H G (-0.18% per min) w a s similar to that observed in the lower limb of males performing isometric knee extension exercise (-0.20% per min) but higher than the C R observed for isometric knee flexion exercise (0.06% per min) (35). Further, the upper limb C R during A C (-0.28% per min, average C R for right and left hands) w a s higher than that reported for males during submaximal dynamic knee extensions (-0.16% per min) (35) or 2 hours of steady-state running (-0.18% per min) (36). A s Table 2.1 shows, the present study and those of Havas et al. (35, 36) vary in terms of muscle groups activated, type and intensity of exercise performed, body position of subjects, gender of subjects, and location and type of radiopharmaceutical injection. T h e relative contribution of e a c h of the factors listed in Table 2.1 to lymph function during acute dynamic exercise warrants further investigation.  It is expected that radiopharmaceutical clearance rate will increase in response to acute exercise. The lymphatic system must rely on both intrinsic and extrinsic mechanisms to propel lymph through the vessels against gravity. Intrinsic mechanisms involve spontaneous, intermittent contraction of smooth muscle lining the contractile lymphatics (37, 39), whereas extrinsic mechanisms include active and passive limb movements, breathing,  46  T a b l e 2.1 Comparison of methods used in present study and those of Havas et al. (35, 36).  Clearance Rate (%-min' ) 1  Havas et al. (35) Dynamic knee extensions = -0.16  Present Study A C = -0.29 H G = -0.20  H a v a s e t a l . (36) -0.18 (averaged over entire exercise bout)  Isometric knee extensions = -0.20  C O N T = -0.13  Isometric knee flexion = -0.06 Type of Exercise  Intensity of Exercise  Dynamic knee extensions  H G = handgrip exercise using a dynamometer  Isometric knee flexion  A C = 0.6 W kg"  100 submaximal contractions at 10 contractions / min at 3 0 % maximal voluntary effort  7 0 % maximum heart rate  10 minutes  120 minutes  1  H G = 5 0 % maximum voluntary effort Duration of Exercise  Treadmill running (average running s p e e d not reported)  A C = A r m cranking (70 R P M ) using an upper body ergometer  A C = 5 min work followed by 5 min rest repeated 6 times (30 min total duration)  Isometric knee extensions  H G = 2.5 min work followed by 2.5 min rest repeated 12 times (30 min total duration) Body Position during Exercise  Upright  Supine  Upright  G e n d e r of Subjects  Female  Male  Male  Training Status of Subjects  Recreationally active  Sedentary and endurance trained  Endurance trained  Type of Radioisotope  99mn  Location of Injection  Subcutaneous depot in 1 ' & 4 web space  T c antimony colloid  s  T c human serum albumin  Vastus lateralis muscle  t h  47  T c human serum albumin Vastus lateralis muscle  and the pulse of nearby arteries (40). Thus, the theoretical reason for performing exercise during lymphoscintigraphy is to take advantage of several of the physiological c h a n g e s associated with exercise, such as increased skeletal muscle contractions, ventilation, sympathetic nervous system activity, and blood flow that influence lymph formation and propulsion. For example, dynamic exercise results in vasodilation in the active musculature and an increase in cardiac output which both serve to increase muscle blood flow, and thus, capillary filtration. A n increase in capillary filtration leads to a higher interstitial pressure which facilitates lymph formation (40, 41).  The skeletal muscle pump is another example of how dynamic exercise affects lymph formation, and thus, lymph transport. For instance, an increase in mean lymph flow w a s shown in males performing foot contractions (37). It is likely that foot contractions c a u s e d an increase in pressure exerted on the foot tissues, thereby compressing the initial lymphatics and forcing lymph in the proximal direction to contractile lymphatics. W h e n the lymph vessel wall of contractile lymphatics is stretched by the accumulating lymph, a reflexive contraction of the smooth muscle endothelium ensues (41).  A normal physiological response to dynamic exercise is an increase in sympathetic nervous system activity. In the context of the lymphatic system, an increase in sympathetic nervous system activity would increase the frequency and force of the spontaneous peristaltic smooth muscle contractions that occur in the larger contractile lymphatics (40). Modulation of the pacemaker cells by sympathetic activation has been demonstrated in an animal model (42, 43). Furthermore, the increase in lymph formation by way of increased capillary filtration or increased skeletal muscle contractions or both should also increase the contraction frequency of the smooth muscle (40, 41). The effect of movement causing a rise in lymph formation and a concomitant increase in contraction frequency of lymphatic smooth muscle has been verified in both human (37) and animal (44) research. The finding that A C resulted in a faster lymphatic clearance rate than H G may be explained by the fact that arm cranking utilizes a larger muscle mass, and thus, larger muscle pump than fist clenching. A C involves the forearm flexors and extensors, biceps brachii, triceps brachii, and the muscles of the upper back and shoulders, whereas H G only involves the forearm flexor muscle group. Consequently, the skeletal muscle pump may not have been activated to the s a m e degree during H G and this may have affected the clearance rate  48  observed. In addition, there are hemodynamic differences between arm cranking and handgrip exercise that may have contributed to the variation in clearance rates. Intermittent handgrip exercise sporadically occludes the artery, slowing capillary filtration, whereas dynamic exercise enhances capillary filtration.  The lymph clearance rate during H G did not statistically differ from C O N T and the lymph clearance during C O N T (-0.15% per min) w a s higher than other resting data previously reported (0.09% per min (35)). Two explanations may account for this finding. First, the discrepancy in results may be due to differences between the present study and that by Havas et al. (35) including the muscle group used, body position, gender, and type and location of radiopharmaceutical injection (Table 1). S e c o n d , the control arm during H G may not in fact reflect a true resting condition. Muscle activation in the contralateral limb has been shown to occur when performing a muscle contraction with the ipsilateral limb (45). If contralateral muscle activation were occurring when subjects were completing the H G protocol, then this would have artificially enhanced radiopharmaceutical clearance in the control arm.  In summary, significantly faster clearance of  99m  T c - a n t i m o n y colloid from the hands of  healthy females w a s evident during intermittent upper body dynamic exercise using an arm crank ergometer compared to intermittent isometric exercise using a handgrip dynamometer. The results indicate that A C may be more effective in promoting lymphatic clearance from the hand and may be a useful protocol to challenge the lymphatic system in breast cancer survivors when one wishes to examine the functional status of the lymphatic system.  49  2.5  REFERENCES  1.  Mortimer P S . The pathophysiology of lymphedema. C a n c e r . 1998;83:2798-802.  2.  Erickson V S , Pearson M L , G a n z P A , A d a m s J , Kahn K L . Arm e d e m a in breast cancer patients. Journal of the National C a n c e r Institute. 2001 ;93(2):96-111.  3.  M c W a y n e J , Heiney S P . Psychologic and social sequelae of secondary lymphedema: a review. C a n c e r . 2005;104(3):457-66.  4.  Hinrichs C S , Watroba NL, Rezaishiraz H, G i e s e W , Hurd T, Fassl K A , et al. Lymphedema secondary to postmastectomy radiation: incidence and risk factors. Annals of Surgical Oncology. 2004;11(6):573-80.  5.  O z a s l a n C , Kuru B. Lymphedema after treatment of breast cancer. The American Journal of Surgery. 2004;187(1 ):69-72.  6.  Petrek J A , S e n i e RT, Peters M, R o s e n P P . L y m p h e d e m a in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer. 2001 ;92(6):1368-77.  7.  Pain S J , Purushotham A D . Lymphoedema following surgery for breast cancer. British Journal of Surgery. 2000;87(9):1128-41.  8.  Goffman T E , Laronga C , Wilson L, Elkins D. Lymphedema of the arm and breast in irradiated breast cancer patients: risks in an era of dramatically changing axillary surgery. Breast Journal. 2004;10(5):405-11.  9.  van der V e e n P, De Voogdt N, Lievens P, Duquet W , Lamote J , S a c r e R. L y m p h e d e m a development following breast cancer surgery with full axillary resection. Lymphology. 2004;37(4):206-8.  10.  Williams A F , Franks P J , Moffatt C J . L y m p h o e d e m a : estimating the s i z e of the problem. Palliative Medicine. 2005;19(4):300-13.  11.  M c K e n z i e D C . Abreast in a b o a t - a race against breast cancer. C M A J . 1998;159(4):376-8.  12.  Harris S R , Niesen-Vertommen S L . Challenging the myth of exercise-induced lymphedema following breast cancer: a series of c a s e reports. Journal of Surgical Oncology - Supplement. 2000;74(2):95-8.  13.  M c K e n z i e D C , Kalda A L . Effect of upper extremity exercise on secondary lymphedema in breast cancer patients: a pilot study. Journal of Clinical Oncology. 2003;21(3):463-6.  14.  Turner J , Hayes S , Reul-Hirche H. Improving the physical status and quality of life of women treated for breast cancer: a pilot study of a structured exercise intervention. Journal of Surgical Oncology. 2004;86(3):141-6.  50  15.  C h e e m a B S B , Gaul C A . Full-body exercise training improves fitness and quality of life in survivors of breast cancer. Journal of Strength & Conditioning R e s e a r c h . 2006;20(1):14-21.  16.  A h m e d R L , T h o m a s W, Y e e D, Schmitz K H . Randomized controlled trial of weight training and lymphedema in breast cancer survivors. Journal of Clinical Oncology. 2006;24(18):2765-72.  17.  J o h a n s s o n K, Tibe K, Weibull A , Newton R C . Low intensity resistance exercise for breast cancer patients with arm lymphedema with or without compression sleeve. Lymphology. 2005;38(4):167-80.  18.  Harris S R , Hugi M R , Olivotto IA, Levine M, Steering Committee for Clinical Practice Guidelines for the C , Treatment of Breast C . Clinical practice guidelines for the care and treatment of breast cancer: 11. Lymphedema. C M A J . 2001 ;164(2):191-9.  19.  R o c k s o n S G , Miller LT, Senie R, Brennan M J , Casley-Smith J R , Foldi E, et al. American C a n c e r Society Lymphedema Workshop. Workgroup III: Diagnosis and management of lymphedema. Cancer. 1998;83(12 Suppl American):2882-5.  20.  S p a r a c o A , Fentiman IS. 9. Arm lymphoedema following breast cancer treatment. International Journal of Clinical Practice. 2002;56(2): 107-10.  21.  W a r d L C . Bioelectrical impedance analysis: proven utility in lymphedema risk a s s e s s m e n t and therapuetic monitoring. Lymphatic R e s e a r c h and Biology. 2006;4(1):51-6.  22.  Cornish B. Bioimpedance analysis: scientific background. Lymphatic R e s e a r c h & Biology. 2006;4(1):47-50.  23.  Pain S J , Barber R W , Ballinger J R , Solanki C K , Mortimer P S , Purushotham A D , et al Tissue-to-blood transport of radiolabeled immunoglobulin injected into the web s p a c e s of the hands of normal subjects and patients with breast cancer-related lymphoedema. Journal of V a s c u l a r R e s e a r c h . 2004;41(2):183-92.  24.  Pain S J , Barber R W , Ballinger J R , Solanki C K , O'Mahony S O , Mortimer P S , et al. Side-to-side symmetry of radioprotein transfer from tissue s p a c e to systemic vasculature following subcutaneous injection in normal subjects and subjects with breast cancer. European Journal of Nuclear Medicine and Molecular Imaging. 2003;30(5):657-61.  25.  Pain S J , Nicholas R S , Barber R W , Ballinger J R , Purushotham A D , Mortimer P S , et al. Quantification of lymphatic function for investigation of lymphedema: depot clearance and rate of appearance of soluble macromolecules in blood. Journal of Nuclear Medicine. 2002;43(3):318-24.  26.  Pain S J , Purushotham A D , Barber R W , Ballinger J R , Solanki C K , Mortimer P S , et al Variation in lymphatic function may predispose to development of breast cancerrelated lymphoedema. European Journal of Surgical Oncology. 2004;30:508-14.  51  27.  Stanton A W , S v e n s s o n W E , Mellor R H , Peters A M , Levick J R , Mortimer P S . Differences in lymph drainage between swollen and non-swollen regions in arms with breast-cancer-related lymphoedema. Clinical S c i e n c e . 2001;101(2):131-40.  28.  S z u b a A , Shin W S , Strauss H W , R o c k s o n S . The third circulation: Radionuclide lymphoscintigraphy in the evaluation of lymphedema. Journal of Nuclear Medicine. 2003;44:43-57.  29.  Williams W H , Witte C L , Witte M H , McNeill G C . Radionuclide lymphangioscintigraphy in the evaluation of peripheral lymphedema. Clinical Nuclear Medicine. 2000;25(6):451-64.  30.  Gothard L, Stanton A, M a c L a r e n J , Lawrence D, Hall E, Mortimer P, et al. N o n randomized phase II trial of hyperbaric oxygen therapy in patients with chronic arm lympoedema and tissue fibrosis after radiotherapy for early breast cancer. Radiotherapy and Oncology. 2004;70:217-24.  31.  S z u b a A , Strauss W , Sirsikar S, R o c k s o n S G . Quantitative radionuclide lymphoscintigraphy predicts outcome of manual lymphatic therapy in breast cancerrelated lymphedema of the upper extremity. Nuclear Medicine Communications. 2002;23:1171-5.  32.  Kramer E L . Lymphoscintigraphy: Biology. 2004;2(1):32-7.  33.  Partsch H. Practical aspects of indirect lymphography and lymphoscintigraphy. Lymphatic R e s e a r c h and Biology. 2003;1(1):71-3.  34.  Y u d d A P , Kempf J S , G o y d o s J S , Stahl T J , Feinstein R S . U s e of sentinel node lymphoscintigraphy in malignant melanoma. Radiographics. 1999;19:343-53.  35.  H a v a s E, Parviainen T, Vuorela J , Toivanen J , Nikula T, Vihko V . Lymph flow dynamics in exercising human skeletal muscle a s detected by scintography. Journal of Physiology. 1997;504(Pt 1):233-9.  36.  H a v a s E, Lehtonen M, Vuorela J , Parviainen T, Vihko V . Albumin clearance from human skeletal muscle during prolonged steady-state running. Experimental Physiology. 2000;85(6):863-8.  37.  O l s z e w s k i W , Engeset A. Intrinsic contractility of prenodal lymph v e s s e l s and lymph flow in human leg. American Journal of Physiology. 1980;239:H775-H83.  38.  O l s z e w s k i W , Engeset A , J a e g e r P M , Sokolowski J , Theodorsen L. Flow and composition of leg lymph in normal men during venous stasis, muscular activity and local hyperthermia. Acta Physiologica Scandinavica. 1977;99(2):149-55.  39.  M c H a l e N G , Meharg M K . Co-ordination of pumping in isolated bovine lymphatic vessels. Journal of Physiology. 1992;450:503-12.  40.  Aukland K, R e e d R K . Interstitial-lymphatic mechanisms in the control of extracellular fluid volume. Physiological Reviews. 1993;73(1):1-78.  Defining a clinical role. Lymphatic R e s e a r c h and  52  41.  Zawieja D. Lymphatic biology and the microcirculation: past, present and future. Microcirculation. 2005;12(1):141-50.  42.  M c H a l e N G , Roddie IC. The effect of intravenous adrenaline and noradrenaline infusion of peripheral lymph flow in the sheep. Journal of Physiology. 1983;341:51726.  43.  Seabrook T J , Ristevski B, Rhind S G , Shek P N , Zamecnik J , Shephard R J , et al. Epinephrine c a u s e s a reduction in lymph node cell output in sheep. C a n a d i a n Journal of Physiology & Pharmacology. 2001;79(3):246-52.  44.  M c G e o w n J G , M c H a l e N G , Thornbury K D . The role of external compression and movement in lymph propulsion in the sheep hind limb. Journal of Physiology. 1987;387:83-93.  45.  Y u e G , C o l e K J . Strength increases from the motor program: comparison of training with maximal voluntary and imagined muscle contractions. Journal of Neurophysiology. 1992;67(5):1114-23.  53  CHAPTER THREE  Lymphoscintigraphy  to E v a l u a t e the Effect of H i g h V e r s u s  Intensity U p p e r B o d y D y n a m i c E x e r c i s e o n L y m p h a t i c in Healthy F e m a l e s  3.1  Low  Function  0  INTRODUCTION  Quantitative lymphoscintigraphy is developing into an important tool for investigating lymphatic dysfunction, particularly in w o m e n with breast cancer related lymphedema ( B C R L ) (1-9). This technique typically involves administering a radiopharmaceutical into a subcutaneous depot and imaging the limb using a gamma (y) c a m e r a at various time points from 0 minutes to 6 hours post-injection. The radiopharmaceutical is generally a technetium labeled macromolecule or colloid that is of sufficient size (i.e., between 4 and 100 nm) to enter the lymphatic capillaries and not blood capillaries (5, 10).  Most studies examining lymphatic function in w o m e n treated for breast c a n c e r have subjects perform intermittent forearm exercise such a s clenching the fists or squeezing a rubber ball between imaging scans to stimulate lymph flow ( 1 - 4 , 7 , 8 , 1 1 ) . W e have previously shown arm crank exercise to be more effective than intermittent handgrip exercise in enhancing depot clearance rate ( C R ) of  99m  T c - a n t i m o n y colloid from the hands of  healthy females (12). Although there was a trend towards faster C R during handgrip exercise (-0.18 % min" vs. -0.14 % m i n " , respectively), the intermittent handgrip protocol 1  1  used by our lab resulted in C R values that were not statistically different than the control arm.  Little is known about the effects of arm cranking exercise on lymphatic function and what constitutes a normal response to acute exercise. This information is needed before using quantitative lymphoscintigraphy to evaluate lymphatic function in women with B C R L . Therefore, the purpose was to determine the effect of low intensity versus high intensity upper body exercise on lymphatic function in healthy females. Lymphatic function w a s a s s e s s e d by two outcome variables: C R from the injection site and uptake of tracer in the  Parts of this chapter have been previously published: Lane, K., Dolan, D., Worsley, D., & McKenzie, D. Lymphoscintigraphy to evaluate the effect of high versus low intensity upper body dynamic exercise on lymphatic function in healthy females. c  Lymphatic Research and Biology. 2006: 4(3): 159-65.  54  axillary lymph nodes 65 minutes post-injection (AX). Healthy, college-aged females were recruited so that a normal response of the lymphatic system to arm cranking exercise of different intensities could be investigated.  3.2  MATERIALS AND  3.2.1  Subjects  METHODS  Eight healthy females (all right hand dominant) between the ages of 18-32 years participated in the study (age = 27.2 years ±2.6; body m a s s = 59.7 kg ±9.6; height = 169.1 cm ±8.7; BMI = 20.8 kg m ±2.3). Prior to testing, informed consent w a s obtained from e a c h 2  subject and the study w a s approved by the Clinical Screening Committee for R e s e a r c h and Other Studies Involving Human Subjects at the University of British Columbia.  3.2.2  Experimental Design  A within-subjects design was used to compare differences in lymphatic function during arm cranking of high (HI) and (LO) intensity. The independent variable was the exercise protocol (HI and L O ) while the dependent variable was depot clearance rate ( C R ) and percent uptake of the radiopharmaceutical at the axillary lymph nodes 65 min post-injection (AX). T h e subjects were designated to treatment order by a randomized draw to prevent any sequencing effects from occurring. At least 24 hours separated e a c h test in order to prevent fatigue from biasing data and to allow full d e c a y of the radioisotope.  3.2.3  Experimental Procedures  Imaging Lymphoscintigraphy w a s used to quantify lymphatic function and was performed at V a n c o u v e r General Hospital, Department of Nuclear Medicine. Subjects were asked to arrive hydrated and rested. The s a m e technician prepared and administered subcutaneous injections of the radiopharmaceutical Technetium-99m ( subjects on each testing day.  99m  99m  Tc)-antimony colloid to all of the  T c - a n t i m o n y colloid is 3-50 nanometers in size.  55  Four injections with a total activity of 18 M B q , each dose in 0.05 mL, were introduced into the first and fourth web s p a c e s of each hand prior to the start of the exercise protocol. Subjects placed both hands prone on a g a m m a camera equipped with a low energy, ultra high resolution collimator (Sopha Medical Vision, W a u k e s h a , Wisconsin). Only the forearms and the hands were in the field of view of the camera and a single camera head was used. O n e minute static acquisitions with a 2 0 % energy window centered on a 140 kV peak were taken within one minute of the injection and again every 10 minutes post-injection over a total period of 60 minutes. In addition, at 65 minutes post-injection a whole body s c a n w a s taken in order to calculate A X . Subjects were in the supine position for the whole body s c a n and the c a m e r a head was centered on the axilla. The images were stored on a hard drive as a 256 x 256 Word frame format for later analysis.  T h e images were processed using S i e m e n s Icon software (Version 8.5, S i e m e n s Medical S y s t e m s Inc., Hoffman Estates, Illinois). T h e region of interest (ROI), or the selection of pixels for analysis, was drawn around each of the injection sites to give the number of activity counts. T h e two counts from e a c h hand were added together and corrected for physical decay of  9 9 m  T c using the following equation: A, = A e "  xt  0  whereby A , = activity after an elapsed time (min), A = activity in original sample, X = 0  0.693/363 min physical half-life of  9 9 m  T c , and t = elapsed time from the original image. T h e  corrected count at each time point w a s divided by the corrected count measured immediately after injection and was plotted against time. C R from the injection site w a s linear and expressed a s a slope (% administered activity min" ). W e have shown symmetry 1  in C R and A X between arms during arm cranking exercise in normal subjects (Chapter Four); therefore, a n average value between the right and left arms w a s used in the present study.  ROIs were also drawn around both axillary lymph node regions from the images generated from the two whole-body scans. T h e s e were corrected for physical d e c a y of  9 9 m  T c and  compared to the initial amount of radioactivity at the injection site to determine A X .  Exercise Protocols O n separate days, subjects did one of two A C protocols that began immediately after the first imaging s c a n and continued until 60 min post-injection. All exercise protocols were  56  performed on a calibrated Lode arm ergometer (Angio single set model, T h e Netherlands). The A C protocols were a s follows: HI - twelve repeated sets of arm cranking for 2.5 minutes at 0.6 W k g " followed by 2.5 minutes of rest, and L O - twelve repeated sets of arm cranking 1  for 2.5 minutes at 0.3 W k g " followed by 2.5 minutes of rest. Heart rate w a s recorded every 1  10 minutes throughout both conditions using a Polar T31 heart rate monitor (Polar Electro Inc, Lake S u c c e s s , NY).  3.2.4  Statistical A n a l y s e s  A paired t-test was used to determine differences in C R , A X , and H R between high and low intensity arm cranking exercise. S P S S version 11 was used to analyze the data and significance w a s set at p ^ 0.05. Data is reported a s mean ± standard deviation (SD).  3.3  RESULTS  3.3.1  Lymphatic Function  A n average value between the right and left arms w a s used in the present study since there w a s no significant difference between arms at either intensity and we have shown symmetry in C R and A X between arms during arm cranking exercise in normal subjects (Chapter Four).  Figure 3.1 shows a significant difference in C R between HI (-0.235%'min" ±0.059) and L O 1  (-0.191%'min" ±0.051; p=0.003). The coefficient of variation for C R between 1  measurements from the right and left arms of the s a m e subject for the high intensity and low intensity conditions w a s 11.7% and 25.0%, respectively.  Significantly greater amounts of tracer were evident in the axilla 65 min post-injection (HI: 6.3% ±1.6, L O : 4 . 8 % ± 1 . 1 , p=0.004, Fig 3.2). Moderate correlations were found between C R and A X for both conditions (HI: r = - 0 . 7 8 ; L O : r =-0.84).  Figure 3.3 shows individual C R a s a function of time for both exercise conditions (HI - panel A ; L O - panel B).  57  LO  HI  Figure 3.1  T h e effects of high (HI) versus low (LO) intensity arm cranking on clearance rate from the hands of healthy females (n=8). § denotes a significantly greater (p<0.05) value.  58  LO  HI  F i g u r e 3.2  T h e effects of high (HI) versus low (LO) intensity arm cranking on radiopharmaceutical uptake at the axilla 65 min post-injection relative to the initial d o s e (AX) in healthy females (n=8). § denotes a significantly greater (p<0.05) value.  59  Figure 3.3  Individual depot activity (%)-time (min) curves for high intensity (HI - panel A ) and low intensity (LO - panel B) arm cranking with the counts averaged for the right and left hand at each time point.  60  3.3.2  Heart R a t e Data  High intensity arm cranking exercise resulted in a significantly greater heart rate averaged over the 60 min intermittent protocol (115 beats per minute (bpm) ±10.1) than did low intensity arm cranking exercise (94 bpm ±10.8; p=0.000).  3.4  DISCUSSION  This study demonstrated significantly faster clearance of  99m  T c - a n t i m o n y colloid from the  hands of healthy females during intermittent arm crank exercise of high intensity (HI) compared to low intensity (LO). A s well, a significantly greater amount of tracer w a s present in the axilla 65 min post-injection after HI.  Studies using lymphoscintigraphy to a s s e s s lymphatic function in women with B C R L often include intermittent forearm exercise between imaging s c a n s such as squeezing a rubber ball or clenching the fist to stimulate lymph flow. There are several concerns with doing this type of exercise. First, the amount of work performed when fist clenching cannot be precisely quantified. Thus, if e a c h subject performs the task at a different intensity, then lymph flow rate could be affected thereby introducing artificial variation into the data. S e c o n d , fist clenching recruits a small muscle mass and induces local muscle fatigue without a significant effect on regional blood flow. W e have shown (12) that intermittent handgrip exercise ( H G : twelve repeated bouts of 75 contractions in 2.5 minutes at 5 0 % maximum voluntary contraction ( M V C ) followed by 2.5 minutes rest) resulted in C R values that were significantly slower than arm cranking exercise (5.0HI: six repeated bouts of 5.0 min arm cranking exercise at 0.6 W k g " followed by 5.0 minutes rest). Moreover, the 1  handgrip protocol yielded C R values that were similar to the control or resting arm. This indicates that an intermittent handgrip protocol may not be the most effective means of stimulating lymph flow between imaging scans.  T h e arm cranking protocol used by our lab previously (5.0HI, described above) only differed from HI in the present study in terms of the duty cycle (i.e., 5.0 minutes or 2.5 minutes of exercise followed by equal rest repeated over 60 minutes). Both the intensity and total volume of exercise completed over 60 minutes were identical between the two arm cranking 61  protocols. 5.0HI resulted in a faster C R compared to the high intensity protocol used in the present study  (-0.28 % m i n " vs. -0.24 % min" , respectively). The slight discrepancy in C R 1  1  data could be due to different subjects taking part in e a c h study and simply reflect normal variation. Or, possibly, intermittent exercise bouts of longer duration may have a more prominent effect on enhancing C R when the intensity of exercise is held constant.  Comparable C R values were found between the low intensity arm cranking task used in the present study and the intermittent handgrip protocol used previously (-0.19 % m i n " and 1  0.18 % m i n " , respectively) (12). Several mechanisms such a s an increase in skeletal 1  muscle contractions, sympathetic nervous system activity, ventilation, and c h a n g e s in interstitial pressure are thought to stimulate lymph formation and lymph propulsion (13, 14). The extent to which each mechanism influences lymph transport in the upper extremity during different modalities of exercise is unknown. Likely, arm cranking exercise increases lymph flow by a combination of each of the aforementioned mechanisms, while rhythmic handgrip contractions does so predominantly by way of activation of the skeletal muscle pump and increased sympathetic nervous activity.  Regardless of the mechanism employed  to facilitate lymph transport, it appears that both moderate intensity handgrip contractions and low intensity arm cranking exercise similarly affect lymphatic function in the upper extremity.  Faster radiopharmaceutical clearance from the injection site is expected during high intensity opposed to low intensity arm cranking exercise. Typical physiological responses to exercise of increasing intensity include augmented blood flow, sympathetic nervous system activity, ventilation, and skeletal muscle contractions. A s each of these physiological responses to exercise are also thought to be mechanisms that assist with lymph formation and propulsion (13, 14), then a concomitant increase in lymph flow with increased exertion would be expected. Increased exertion by the subjects was corroborated by the significantly higher heart rate during HI compared to L O .  The percentage of radiopharmaceuticals in the axillary lymph nodes relative to the initial dose may be a potential indicator of lymphatic drainage in individuals with lymphatic dysfunction (5, 10, 15, 16). Although symmetry in A X between upper extremities has been demonstrated during arm cranking exercise (Chapter Four), it is unknown if A X is sensitive enough to discriminate between changes in exercise intensity. HI resulted in significantly  62  greater amount of radiopharmaceuticals measured in the axilla 65 min post-injection compared to L O . This would be expected considering C R was also faster during HI arm cranking protocol and, in fact, C R and A X were correlated (HI: r = -0.78; L O : r = -0.84). There are s o m e limitations, however, to considering A X as an outcome measure. Despite colloid particles having good regional lymph node retention (10, 17), A X is only a 'snapshot' of the amount of tracer present in the axillary lymph nodes at any one time. Colloids will migrate through the lymph nodes and eventually enter the systemic circulation which can be' confirmed in our subjects by visualization of activity in the liver at 65 min post-injection. It is unknown how long the radiopharmaceuticals are retained in the lymph nodes and if exercise affects retention time.  In conclusion, high intensity arm cranking exercise performed by healthy females resulted in significantly faster clearance of  99m  T c - a n t i m o n y colloid from the hands and significantly  greater uptake of tracer in the axilla post-exercise compared to low intensity exercise. Further, the coefficient of variation for C R w a s 11.7% during high intensity exercise and 2 5 . 0 % during low intensity exercise. Thus, the lymphatic system of healthy females has a predicable response to higher intensity exercise - function is increased and the variability in data is reduced.  A clinical application of this study is that a standardized lymphoscintigraphy exercise protocol has been developed that can now be applied to breast cancer survivors with and without B C R L in order to evaluate lymphatic function under a 'stressed' situation. This approach is similar to the way exercise is used by the cardiologist or respirologist to diagnose pathologies that are latent at rest.  63  3.5  REFERENCES  1.  Williams W H , Witte C L , Witte M H , McNeill G C . Radionuclide lymphangioscintigraphy in the evaluation of peripheral lymphedema. Clinical Nuclear Medicine. 2000;25(6):451-64.  2.  Stanton A W , S v e n s s o n W E , Mellor R H , Peters A M , Levick J R , Mortimer P S . Differences in lymph drainage between swollen and non-swollen regions in arms with breast-cancer-related lymphoedema. Clinical S c i e n c e . 2001;101(2):131-40.  3.  Pain S J , Nicholas R S , Barber R W , Ballinger J R , Purushotham A D , Mortimer P S , et al. Quantification of lymphatic function for investigation of lymphedema: depot clearance and rate of appearance of soluble macromolecules in blood. Journal of Nuclear Medicine. 2002;43(3):318-24.  4.  Pain S J , Barber R W , Ballinger J R , Solanki C K , O'Mahony S O , Mortimer P S , et al. Side-to-side symmetry of radioprotein transfer from tissue s p a c e to systemic vasculature following subcutaneous injection in normal subjects and subjects with breast cancer. European Journal of Nuclear Medicine and Molecular Imaging. 2003;30(5):657-61.  5.  S z u b a A , Shin W S , Strauss HW, R o c k s o n S . The third circulation: Radionuclide lymphoscintigraphy in the evaluation of lymphedema. Journal of Nuclear Medicine. 2003;44:43-57.  6.  Pain S J , Barber R W , Ballinger J R , Solanki C K , Mortimer P S , Purushotham A D , et al. Local vascular a c c e s s of radioprotein injected subcutaneously in healthy subjects and patients with breast cancer-related lymphedema. Journal of Nuclear Medicine. 2004;45(5):789-96.  7.  Pain S J , Purushotham A D , Barber R W , Ballinger J R , Solanki C K , Mortimer P S , et al. Variation in lymphatic function may predispose to development of breast cancerrelated lymphoedema. European Journal of Surgical Oncology. 2004;30:508-14.  8.  S z u b a A , Strauss W , Sirsikar S , R o c k s o n S G . Quantitative radionuclide lymphoscintigraphy predicts outcome of manual lymphatic therapy in breast cancerrelated lymphedema of the upper extremity. Nuclear Medicine Communications. 2002;23:1171-5.  9.  Gothard L, Stanton A , M a c L a r e n J , Lawrence D, Hall E, Mortimer P, et al. N o n randomized phase II trial of hyperbaric oxygen therapy in patients with chronic arm lympoedema and tissue fibrosis after radiotherapy for early breast cancer. Radiotherapy and Oncology. 2004;70:217-24.  10.  Krasnow A Z , Hellman R S . Lymphoscintigraphy revisited: 1999. Nuclear Medicine Annual. Philadelphia: Lippincott, Williams & Wilkins; 1999. p. 17-97.  11.  Pain S J , Barber R W , Ballinger J R , Solanki C K , Mortimer P S , Purushotham A D , et al. Tissue-to-blood transport of radiolabeled immunoglobulin injected into the web s p a c e s of the hands of normal subjects and patients with breast cancer-related lymphoedema. Journal of V a s c u l a r Research. 2004;41(2):183-92. 64  12.  Lane K, Worsley D, M c K e n z i e D. Lymphoscintigraphy to evaluate the effects of upper body dynamic exercise and handgrip exercise on radiopharmaceutical clearance from the hands of healthy females. Lymphatic R e s e a r c h and Biology. 2005;3(1):16-24.  13.  Aukland K, R e e d R K . Interstitial-lymphatic mechanisms in the control of extracellular fluid volume. Physiological Reviews. 1993;73(1):1-78.  14.  Zawieja D. Lymphatic biology and the microcirculation: past, present and future. Microcirculation. 2005;12(1):141-50.  15.  Bourgeois P, Leduc O, L e d u c A . Imaging techniques in the management and prevention of posttherapeutic upper limb e d e m a s . Cancer. 1998;83:2805-13.  16.  Mortimer P S . Evaluation of lymphatic function: abnormal lymph drainage in venous d i s e a s e . International Angiology. 1995;14(3 Suppl 1):32-5.  17.  Y u d d A P , Kempf J S , G o y d o s J S , Stahl T J , Feinstein R S . U s e of sentinel node lymphoscintigraphy in malignant melanoma. Radiographics. 1999;19:343-53.  65  CHAPTER FOUR  S y m m e t r y in L y m p h a t i c F u n c t i o n b e t w e e n the R i g h t a n d Left U p p e r Extremities d u r i n g Intermittent A r m C r a n k E x e r c i s e in Healthy S u b j e c t s  4.1  INTRODUCTION  Traditionally, quantification of lymphatic function has been confined to the measurement of circumferences or volume displacement to reflect change in status. Lymphoscintigraphy has added another dimension of lymphatic function and recently, Pain et al. (1) used quantitative lymphoscintigraphy to demonstrate that there is symmetry in lymphatic function between the upper extremities in normal subjects. This validates the common use of expressing the volume or lymphatic function of the affected arm relative to the normal arm, when investigating unilateral lymphatic disease such a s breast cancer related lymphedema ( B C R L ) . Although Pain et al. instructed subjects to perform a standardized exercise protocol consisting of 30 fist clenches between e a c h set of readings, we have previously shown arm crank exercise to be more effective in enhancing depot clearance rate ( C R ) from the hands compared to hand grip exercise (2). In fact, we demonstrated that handgrip exercise yields C R values that were not statistically different than rest. A s several reviews have suggested the use of a standardized stress protocol to investigate lymphatic dysfunction using lymphoscintigraphy (3-5), it is important to ensure there is symmetry in lymphatic function during exercise. Therefore, the purpose of the study w a s to evaluate the effects of arm crank ergometry on two measures of lymphatic function (radiopharmaceutical clearance rate and percent uptake of tracer in the axillary lymph nodes 65 minutes postinjection) in healthy subjects. A secondary purpose was to evaluate the reliability of the standardized stress protocol. A s this study w a s designed to investigate symmetry in lymphatic function between arms during arm cranking exercise, both males and females were recruited. There is no theoretical reason to suggest that lymphatic function between arms is modified by sex.  66  4.2  MATERIALS AND METHODS  4.2.1  Subjects  Fifteen healthy females and six healthy males between the ages of 23-35 years participated in the study (age = 25.9 years ± 3.4; body weight = 65.7 kg ± 11.8; height = 173.1 cm ± 9.3; BMI = 21.8 kg m ± 2.3). S e v e n subjects also participated in a reliability study and 2  performed the exercise protocol on two separate days separated by a minimum of 48 hours. Prior to testing, informed consent was obtained from each subject and the study w a s approved by the Clinical Screening Committee for R e s e a r c h and Other Studies Involving Human Subjects at the University of British Columbia.  4.2.2  Lymphoscintigraphy  Lymphoscintigraphy was used to quantify lymphatic function and was performed at V a n c o u v e r G e n e r a l Hospital, Division of Nuclear Medicine. Subjects were asked to arrive hydrated and rested. The s a m e technician prepared and administered subcutaneous injections of the radiopharmaceutical Technetium-99m (  99m  Tc)-antimony colloid to e a c h  subject on each testing day. The radiochemical purity of the radiopharmaceutical w a s greater then 9 5 % .  99m  A total of 18 M B q of  T c - a n t i m o n y colloid is 3-50 nanometers in size.  99m  T c - a n t i m o n y colloid in 0.05 mL w a s administered to the first and  fourth w e b s p a c e s of each hand prior to the start of the exercise protocol. Subjects placed both hands prone on a g a m m a camera equipped with a low energy, ultra high resolution collimator (Sopha Medical Vision, W a u k e s h a , Wisconsin, U S A ) . Only the forearms and the hands were in the field of view of the camera and a single camera head was used. A n initial one minute static acquisition with a 2 0 % energy window centered on a 140 keV peak w a s acquired within one minute of the injection. Sequential images were taken every 10 minutes thereafter over a period of 60 minutes to allow for the calculation of depot clearance rate (CR). A s well, a one minute static acquisition of the axilla was taken immediately postexercise (approximately 65 minutes post-injection) to determine the radiopharmaceutical uptake in the axilla relative to the initial activity at the depot (AX). This image w a s taken with subjects lying supine.  67  4.2.3  Exercise Protocol  T h e exercise protocol started immediately after the first static image w a s acquired and involved repeated bouts of arm cranking for 2.5 minutes at 0.6 Watts per kilogram body weight (W kg" ) followed by 2.5 min of rest on a calibrated L O D E arm ergometer (Angio 1  single set model, The Netherlands). This protocol w a s demonstrated to result in greater depot C R compared to hand grip exercise in a previous study conducted by our lab (2).  4.2.4  Data A n a l y s i s  T h e images were processed using S i e m e n s Icon software (Version 8.5, S i e m e n s Medical S y s t e m s Inc., Hoffman Estates IL, U S A ) . The region of interest (ROI) w a s drawn around the injection sites of e a c h hand to give the number of activity counts per hand. This w a s corrected for physical decay of  9 9 m  T c using the following equation: A, = A e "  At  0  whereby A = activity after an elapsed time (min), A = activity in original sample, A = t  0.693/363 min physical half-life of  0  9 9 m  " T c , and t = elapsed time from the original image. The  corrected count at each time point w a s divided by the corrected count measured immediately after injection and was plotted against time. Depot C R from e a c h hand w a s linear and expressed a s a linear constant (% administered activitymin" ). 1  4.2.5  Statistical A n a l y s i s  Linear regression using Statistica version 5.1 w a s used to a s s e s s symmetry in C R and A X . Significance w a s set at p<0.05 and data is reported as mean ± standard deviation.  4.3  RESULTS  Fifteen healthy females and 6 healthy males completed the study. All 21 subjects were included in the analysis of C R while 12 subjects had A X measured. All data w a s analyzed for a curvilinear versus a linear fit and a linear fit w a s found to best represent all data sets.  There was a strong correlation between the right and left upper extremities for both C R (y = 0.95x-0.02; r = 0.83; p = 0.001; n = 2 1 ; Fig. 4.1) and A X (y = 0.90x+0.56; r = 0.81; p = 0.001;  68  Figure 4.1  Correlation in depot clearance rate (CR) between right and left upper extremities in healthy subjects (n=21).  69  1  j  •  0  2  y = 0.90x + 0.56; r = 0.81; p = 0.001  0 4  6  8  10  Right AX (%, relative to initial dose)  F i g u r e 4.2  Correlation in tracer uptake (AX) between right and left axillary lymph nodes 65 minutes post-injection relative to initial dose in healthy subjects (n=12).  70  Day 1 C R (%'min" ) 1  -0.40  -0.35  -0.30  -0.25  -0.20  -0.15  -0.10  -0.05  0.00  r = 0.94  Figure 4.3  Reliability of depot clearance rate (CR) during moderate intensity arm cranking exercise performed on two separate days (n=7).  71  n = 12; Fig. 4.2).  All subjects except one were right handed; thus, there w a s symmetry in  dominant versus non-dominant arms as well. T h e correlations were essentially the s a m e for both C R and A X whether the data was analyzed as right versus left upper extremity or dominant hand versus non-dominant hand.  Figure 4.3 shows intra-subject reliability of C R (r = 0.94, n = 7).  4.4  DISCUSSION  T h e present study demonstrated symmetry in depot clearance rate ( C R ) a n d tracer uptake at the axillary lymph nodes 65 minutes post-injection (AX) between upper extremities during arm cranking exercise in normal subjects. This extends the findings of Pain et al. (1) who found side-to-side symmetry in depot clearance rate and blood appearance rate at rest. Additionally, this study demonstrates high intra-subject reliability in C R (r = 0.94).  Only one other study has presented information on symmetry between limbs during exercise. H a v a s et al. (6) investigated lymphatic clearance rate in the legs of eight males during two types of isometric leg contractions (knees flexed and knees extended) and also dynamic knee extensions. The authors treated e a c h leg a s an independent observation due to the weak and non-significant correlation found in clearance rates between the legs. However, there are several factors that may explain the difference in findings amongst the present study and those by H a v a s et al. First, the weak correlation found by H a v a s et al. included clearance rate data pooled together for all three exercise conditions (i.e., n=24). Consequently, the reader does not know the variability for each type of muscular contraction. P e r h a p s , isometric leg contractions produce greater variability between the legs than did dynamic knee extensions. This scenario could produce an overall weak correlation despite one exercise condition showing symmetry between limbs. S e c o n d , the type of radiopharmaceutical used and location of injection differed between the studies. H a v a s et al. injected  9 9 m  T c human serum albumin directly into the vastus lateralis muscle of  subjects, whereas subcutaneous injections of  99m  T c - a n t i m o n y colloid were administered in  the present study. Other variations that may account for the discrepancy in findings may be the type and intensity of exercise performed, body position of subjects, and limbs used. The  72  relative contribution of these factors to lymph function during acute dynamic exercise warrants further investigation.  It w a s expected that C R and A X would be comparable between upper extremities in normal subjects during upper body exercise. Bilateral exercise such a s arm cranking involves the s a m e muscle groups in each extremity - the forearm flexors and extensors, biceps brachii, triceps brachii, and the muscles of the upper back and shoulders. Subjects were also instructed not to favour their dominant arm during the arm cranking exercise protocol. Considering that the frequency and intensity of muscle contractions were similar between arms, the effect of the muscle pump on lymph flow should also be comparable.  Other factors that may affect the formation and propulsion of lymph are interstitial pressure, capillary filtration, muscle blood flow, blood pressure, and sympathetic nervous system activity (7). A g a i n , these factors should be similarly influenced by arm cranking exercise in each extremity in normal subjects. For example, arm cranking exercise results in an increase in muscle blood flow in both arms due to vasodilation in the active musculature and an overall increase in cardiac output. A n increase in muscle blood flow leads to greater capillary filtration, and correspondingly, higher interstitial pressure. This increase in interstitial pressure facilitates the entry of fluid and proteins into the initial lymphatic vessels through endothelial microvalves (7).  In conclusion, side-to-side symmetry in both clearance of  99m  T c - a n t i m o n y colloid from the  hands of healthy subjects ( C R ) and uptake of tracer at the axillary lymph nodes 65 min postinjection (AX) was evident during intermittent upper body dynamic exercise. T h e results indicate that when investigating the effect of exercise on lymphatic function in w o m e n with breast cancer related lymphedema, the untreated arm can be used as e a c h subject's own control during exercise conditions.  73  4.5  R E F E R E N C E S  1.  Pain S J , Barber R W , Ballinger J R , Solanki C K , O'Mahony S O , Mortimer P S , et al. Side-to-side symmetry of radioprotein transfer from tissue s p a c e to systemic vasculature following subcutaneous injection in normal subjects and subjects with breast cancer. European Journal of Nuclear Medicine and Molecular Imaging. 2003;30(5):657-61.  2.  Lane K, Worsley D, M c K e n z i e D. Lymphoscintigraphy to evaluate the effects of upper body dynamic exercise and handgrip exercise on radiopharmaceutical clearance from the hands of healthy females. Lymphatic R e s e a r c h and Biology. 2005;3(1):16-24.  3.  S z u b a A , Shin W S , Strauss H W , R o c k s o n S . The third circulation: Radionuclide lymphoscintigraphy in the evaluation of lymphedema. Journal of Nuclear Medicine. 2003;44:43-57.  4.  Partsch H. A s s e s s m e n t of abnormal lymph drainage for the diagnosis of lymphedema by isotopic lymphangiography and by indirect lymphography. Clinics in Dermatology. 1995;13(5):445-50.  5.  Kramer E L . Lymphoscintigraphy: Defining a clinical role. Lymphatic R e s e a r c h and Biology. 2004;2(1):32-7.  6.  H a v a s E, Parviainen T, Vuorela J , Toivanen J , Nikula T, Vihko V . Lymph flow dynamics in exercising human skeletal muscle a s detected by scintography. Journal of Physiology. 1997;504(Pt 1):233-9.  7.  Aukland K, R e e d R K . Interstitial-lymphatic mechanisms in the control of extracellular fluid volume. Physiological Reviews. 1993;73(1):1-78.  74  C H A P T E R FIVE  U p p e r Extremity L y m p h a t i c F u n c t i o n at R e s t a n d d u r i n g E x e r c i s e in B r e a s t C a n c e r S u r v i v o r s with a n d without L y m p h e d e m a  5.1  INTRODUCTION  Over the past five years there has been a significant increase in research investigating the pathophysiology of breast cancer related lymphedema ( B C R L ) using lymphoscintigraphy (112). Despite the increase in active research, B C R L is still a poorly understood complication of breast cancer treatment. Current data suggest 2 8 % of women treated for breast cancer will develop B C R L (13, 14), although the incidence can vary from 1 3 % (15) to 4 9 % (16) depending on the operational definition of B C R L . W o m e n with B C R L have restricted range of motion in the affected arm, increased risk of infection, and impaired limb function. Furthermore, these women report increased anxiety and depression and reduced quality of life (17). B C R L is essentially an incurable condition although treatments such a s compression sleeves (18-20), pneumatic pumping (21-25), manual lymphatic drainage (2630), and low-level laser therapy (31, 32) exist to contain swelling.  Exercise was originally thought to exacerbate B C R L ; however, all recent studies (33-38) except one (39) have shown no significant change in arm volume with resistance training or upper body aerobic exercise. Our finding of a significant increase in arm volume in breast cancer survivors with and without B C R L after a 20 week exercise program consisting of aerobic training, resistance training, and dragonboat paddling was not construed to be reason for concern (39). The changes in arm volume were consistent for both arms and there w a s a significant gain in upper body muscular strength over the course of the study period. A b e et al. (40) demonstrated a significant increase in muscle thickness with resistance training in men and w o m e n over a 12 week program. Although w e did not measure muscle volume directly, the training programs were comparable. T h u s , muscle hypertrophy likely accounted for the increase in arm volume seen in our subjects.  A limitation of research investigating the effect of regular exercise on the development or exacerbation of lymphedema is that measures of arm circumference or volume have been used to indicate a change in status. While arm volume is a simple and non-invasive measurement to perform, it does not provide information on changes in lymphatic function. 75  Lymphoscintigraphy, on the other hand, does give an indication of lymphatic function. This technique was developed to a s s e s s lymphatic status in patients with a variety of conditions that c a u s e lymphatic obstruction and is now being used to investigate the pathophysiology of B C R L . Typically, lymphoscintigraphy applied to B C R L involves administering a radiopharmaceutical to the finger w e b - s p a c e or forearm and imaging the upper extremity using a g a m m a c a m e r a at various time points post-injection. T h e radiopharmaceutical is generally a technetium labeled macromolecule or colloid that is of sufficient size (i.e., between 4 and 100 nm) to enter the lymphatic capillaries and not blood capillaries (41-43).  T o date, all studies using lymphoscintigraphy to examine lymphatic function in women treated for breast cancer have been essentially performed at rest. Intermittent forearm exercise, such a s clenching the fists or squeezing a rubber ball between imaging s c a n s , has been u s e d in several studies to stimulate lymph flow (4, 6, 7, 10, 44-46). However, w e have previously shown depot clearance rate (CR) in healthy females to be similar whether rest or hand grip exercise w a s performed (47). There are several advantages to measuring lymphatic function in breast cancer survivors with and without B C R L during moderate intensity exercise. First, a standardized exercise protocol can help to decrease variability in the data especially when the intensity and duration of the activity is quantified. For example, we have demonstrated a lower coefficient of variation (CV) for depot C R during moderate intensity arm cranking exercise versus low intensity exercise (48). S e c o n d , evaluating the lymphatic system in a 'stressed' situation can help to diagnose pathologies that may be latent at rest similar to the way exercise is used by a cardiologist or respirologist.  In order to determine an appropriate upper body exercise protocol that could be combined with lymphoscintigraphy to describe lymphatic function in women treated for breast cancer, we have completed a series of studies in healthy, college-aged females (Chapters 2-4). Collectively, these studies demonstrated the following: 1) arm cranking was superior to intermittent hand grip exercise in enhancing C R (Chapter 2), 2) moderate intensity arm cranking exercise (same protocol used in the present study) w a s superior to low intensity arm cranking exercise in enhancing C R and uptake of radiopharmaceuticals in the axilla (Chapter 3), 3) C R and uptake of radiopharmaceuticals in the axilla were symmetrical between arms (Chapter Four), 4) moderate intensity arm cranking exercise results in a lower C V than low intensity arm cranking exercise (Chapter 3), and 5) there is a high intrasubject reliability in arm cranking C R (Chapter Four).  76  Thus, the purpose of this exploratory study w a s to evaluate upper extremity lymphatic function at rest and during intermittent, moderate intensity exercise in breast cancer survivors (BC), breast cancer survivors with B C R L ( B C R L ) , and age-matched controls ( C O N T ) . T h e primary outcome measure of lymphatic function is defined a s the radiopharmaceutical clearance rate of Technetium-99m (  99m  Tc)-antimony colloid from a  subcutaneous injection site in the hand (CR). S e c o n d a r y outcome measures of lymphatic function include uptake of radiopharmaceuticals at the axilla 65 min post-injection relative to the initial dose (AX); uptake of radiopharmaceuticals in the forearm 65 min post-injection relative to the initial dose ( F O R E ) ; and, time of first appearance of radiopharmaceuticals at the axilla ( A P P ) .  The hypotheses to be tested were: 1) Lymphatic function will be similar between groups in the contralateral arm, 2) Lymphatic function relative to the contralateral arm will be poorest in w o m e n with B C R L (i.e., slowest C R and A P P , lowest A X , and highest F O R E ) and highest in control subjects (i.e., fastest C R and A P P , highest A X , and lowest F O R E ) . W o m e n treated for breast cancer without lymphedema will have lymphatic function that falls between those with B C R L and healthy controls. 3)  Lymphatic function will increase from rest to exercise in all subject groups.  5.2  MATERIALS AND METHODS  5.2.1  Subjects  Three subject groups (breast cancer survivors with lymphedema, B C R L , n=10; breast cancer survivors no lymphedema, B C , n=22; healthy age-matched females with no history of breast cancer, C O N T n=17) were included in the prospective, cross-sectional analysis. Both B C and B C R L included women diagnosed in the past 25 years with Stage l-III breast cancer and treatment. T h o s e with B C R L had clinically significant lymphedema defined as a difference of greater than 2.0 cm at either of the following measuring points (20) - 1 0 c m distal to the lateral epicondyles or 15 c m proximal to the lateral epicondyles. C O N T included healthy females with no history of breast cancer that were matched by age to B C 77  and B C R L . For control subjects, the right or left arm w a s randomly designated a s the ipsilateral arm using a random numbers generator. Descriptive data is provided in Table 5.1 while details of breast cancer treatment is provided in Table 5.2.  Prior to testing, informed consent w a s obtained from each subject and the study w a s approved by the Clinical Screening Committee for R e s e a r c h and Other Studies Involving H u m a n Subjects at the University of British Columbia.  S a m p l e size w a s determined using a webpage developed by the Department of Math at York University to calculate power and sample size for between-group A N O V A designs ( h t t p : / / w w w . m a t h . v o r k u . c a / S C S / O n l i n e / p o w e r ) . The primary outcome measure, C R , w a s used to calculate the sample size. B a s e d on C R values observed in college-aged females performing the s a m e exercise protocol (48) and pilot work testing several subjects with B C R L , the anticipated difference between means was 0.07 % min" and the anticipated 1  standard deviation w a s set at 0.06 % min" . P o w e r and type I error w a s selected to be 8 0 % 1  and 5%, respectively. Using these parameters, a minimum of 16 subjects w a s required per group.  5.2.2  Experimental Design  A prospective, exploratory, between-groups design w a s used to compare differences in lymphatic function in the three subject groups. The independent variables were the intermittent exercise protocol and rest, while the dependent variable w a s lymphatic function. T h e primary outcome measure of lymphatic function was depot clearance rate ( C R ) , while secondary outcomes measures included time of first appearance of radiopharmaceuticals at the axilla ( A P P ) , and uptake of the radiopharmaceuticals at 65 minutes post-injection relative to the initial dose at the axilla (AX) and forearm ( F O R E ) .  5.2.3  Experimental Procedures  Imaging Lymphoscintigraphy was used to quantify lymphatic function and was performed at V a n c o u v e r General Hospital, Department of Nuclear Medicine. Subjects were a s k e d to arrive hydrated and rested. They were also asked to avoid caffeine in the six hours before the start of the study. The same technician prepared and administered subcutaneous 78  S a m p l e characteristics (mean ± standard deviation) of subjects with breast cancer related lymphedema ( B C R L ) , breast cancer (BC), and controls (CONT).  Table 5.1  BCRL  BC  CONT  10  22  17  Age(yrs)  61.6 ±11.0  55.4 ±7.2  56.8 ±9.6  Weight (kg)  80.7±15.6  70.3 ±9.9  68.9 ±13.4  Height (m)  1.63 ±0.04  1.65 ±0.06  1.63 ±0.03  BMI (kg m )  30.4 ± 5 . 8  §  25.7 ±3.3  26.0 ±4.6  Exercise P o w e r Output (Watts)  39.9±10.3  41.0 ±4.8  38.1 ±4.5  Exercise Heart Rate (beatsmin" )  129.8 ±16.0  128.6 ±17.2  126.5 ±18.4  n  2  §  1  Arm Circumference (%, ipsilateral arm relative to contralateral arm)  §  Forearm  115.8 ±10.8  §  100.6±3.4  99.1 ±3.9  Upper arm  110.5 ±12.9  §  100.5 ±2.6  99.6 ±2.1  significantly different from B C and C O N T (p<0.05)  79  T a b l e 5.2  Subject 1 2 3 4 5 6 7 8 9 10  BCRL or BC BCRL BCRL BCRL BCRL BCRL BCRL BCRL BCRL BCRL BCRL  Age  BMI  (yrs) 50  28.2  52  37.5  46  33.0.  59  40.6  65  25.0  74  28.8  74  29.7  77  29.2  64-  20.4  55  31.9  Ipsilateral Arm left rt left left left left rt rt rt rt  Year of Diagnosis  "ype of >urgery  1996  m  2000  m  2005  m  2004  m  2003  m  2000  I I  1984 1993 2001 2004  Nodes Excised 19 20 16 14 7 20 4 16 25 . 21  m  I m  Nodes Positive 0 1 2 i 0 •3 0 7 2 4  RT to Axilla y •y y n  y y y \y y y  CT y y y y y y n y y y  BC 50 27 rt 2004 m n/a 0 y y BC 53 31 left 2001 I 10 0 y y 13 BC 55 21 rt 1994 I 10 2 y y 14 BC 59 26 left 2000 I 1 1 y y 15 BC 59 23 rt 2000 m 13 0 n y 16 BC 53 22 left 2005 m 7 1 n y 17 BC 59 31 left 1995 m 13 0 n -n 18 BC 59 24 rt 2000' m 40** 2 n y 19 BC 66 22 rt 1998 I 14 3 n y 20 BC 44 26 rt 2005 m 0 . 13 • y y 21 BC 45 23 rt 2001 I 9 1 y y 22 BC 47 26 rt 2000 m 0 0 n n 23 BC 54 30 rt 1991 n m 10 0 n 24 BC 58 25 .9 left 1996 I 13 2 y y 25 BC 58 28 .2 left 1999 m 6 0 n n 26 BC 58 32 .0 left 1990 m 4 4 y y 27 BC 60 23 .2 left 2005 I 19** 3 y y 28 BC 72 21 .3 left 1995 m 16** 0 n y 29 BC 54 24 .0 rt 2004 m 19** 2 y y 30 BC 63 25 .5 rt 1983 m 0 0 n n 31 BC 44 22 .3 rt 2005 m 0 0 y y 32 BC 48 25 .0 rt 2005 m 12 2 y y *l=lumpectomy, m mastectomy, • - • — r-' / vuiuinc-iiiucaoc it contralateral side, *BC subjects with similar number of axillary lymph nodes dissected as all BCRL subjects. 11  12  :  : :  •  J  •  ,  . . . ^ . ^ « _ * ^ ^  H I  BCRL Duration 10 yr 5 yr 1 yr 2yr 3 yr 6 yr 18 yr . 12 yr 1 yr 1 yr  Increase in volume (%) Forearm Upper Arm 125 100 •' 108 107 115 100 102 109 117 103 133 116 127 142 123 119 111 102 102 107 98 102 100 100 99 92 104 103 105  102 101 100 98 101 108 99 102 98 -  100 98 105 99 100 98 98 103 102 98 101 109  102 101 103 100 100 95 96 101 99 101 102 103  injections of the radiopharmaceutical day.  99m  99m  T c - a n t i m o n y colloid to all of the subjects on e a c h testing  T c - a n t i m o n y colloid is 3-50 nanometers in size.  Four injections with a total activity of 18 M B q , e a c h dose in 0.05 mL, were introduced into the first a n d fourth w e b s p a c e s of e a c h hand prior to the start of the exercise protocol. Subjects placed both hands prone on a g a m m a camera equipped with a low energy, ultra high resolution collimator (Sopha Medical Vision, W i s c o n s i n , U S A ) . Only the forearms and the hands were in the field of view of the c a m e r a and a single c a m e r a head w a s used. O n e minute static acquisitions with a 2 0 % energy window centered on a 140 kV peak were taken within one minute of the injection and again every ten minutes post-injection over a total period of 60 minutes to allow for the calculation of C R . A P P was determined from a one minute static acquisition taken of the axilla every ten minutes until radiopharmaceuticals were visualized in axillary lymph nodes on both sides ( N O T E : this variable w a s introduced after the first s e v e n subjects had completed the study). Subjects were seated with the camera heads in a vertical orientation for A P P . At 65 minutes post-injection, a whole body s c a n was taken in order to calculate A X and F O R E . Subjects were in the supine position for the upper body s c a n and the camera head was centered on the axilla. The images were stored on a hard drive as a 256 x 256 Word frame format for later analysis.  The images were processed using S i e m e n s Icon software (Version 8.5, S i e m e n s Medical S y s t e m s Inc., Illinois, U S A ) . T h e region of interest (ROI), or the selection of pixels for analysis, w a s drawn around each of the injection sites to give the number of activity counts and e a c h ROI w a s corrected for physical decay of  9 9 m  T c using the following equation: A, = A e "  At  0  whereby A = activity after an elapsed time (min), A = activity in original sample, A = 0.693/363 t  min physical half-life of  0  9 9 m  T c , and t = elapsed time from the original image. All ROIs for C R  and A X were normalized to a n area of 1500 pixels while all R O I s for F O R E were normalized to an area of 3000 pixels.  C R w a s calculated from images of the depot sites. The two counts from each hand were included in the s a m e ROI and the corrected count at each time point w a s divided by the corrected count measured immediately after injection and was plotted against time. C R from the injection site w a s linear ( R = 0.95 during exercise for all subject groups) a n d , therefore, 2  expressed as a slope (% administered activitymin" ). 1  81  ROIs were also drawn around the axilla and forearms from the images generated from the upper body s c a n taken at 65 min post-injection. T h e s e were expressed relative to the initial amount of radioactivity at the injection site to determine A X and F O R E . Since no markers were used to indicate the position of the wrist, elbow, and axilla for e a c h image, then the ROI for the forearm had to be estimated. This was done by measuring the distance from the proximal portion of the activity at the injection site to the distal portion of activity in the axillary lymph nodes in the normal, or contralateral arm, and dividing it into two symmetrical, rectangular R O I s with the most distal rectangular ROI representing the forearm. Future research should use markers to identify anatomical landmarks on the upper extremity.  A P P was determined from images of the axilla taken every 10 minutes throughout the 60 minute protocol. Background activity w a s determined for e a c h set of images and R O I s were drawn around the axilla on each side. O n c e activity in the ROI of the axilla doubled background activity, A P P was noted. Experimenters were not blinded to the subjects or experimental condition when doing ROI.  Exercise  & Rest  Conditions  O n separate days, subjects did either the intermittent exercise protocol (twelve repeated sets of arm cranking for 2.5 min at 0.6 W k g ' followed by 2.5 min of rest) or seated rest. T h e exercise 1  began immediately after the first imaging s c a n and continued to 60 min post-injection and w a s performed on a calibrated Lode arm ergometer (Angio single set model, The Netherlands). Heart rate (HR) w a s recorded every 10 minutes throughout using a Polar T31 heart rate monitor (Polar Electro Inc, Lake S u c c e s s , NY). Not all subjects were able to complete the prescribed power output for E X (five B C R L subjects, one B C subject, and one C O N T subject). For these subjects, power output w a s decreased by 10-15 Watts so they could complete the 60 minute intermittent, exercise challenge.  5.2.4  Statistical A n a l y s e s  Statistical analysis w a s conducted using the Statistical P a c k a g e for the Social S c i e n c e s ( S P S S ) version 11.0 ( S P S S Inc., Chicago, IL) and significance was set at p < 0.05. Descriptive statistics (mean ± standard deviation) were calculated for subject characteristics. Differences in height, weight, BMI, age, exercise power output, exercise heart rate, and forearm and upper  82  arm circumferences (ipsilateral arm relative to contralateral arm) were compared using one-way analysis of variance ( A N O V A ) .  T o determine if lymphatic function in the unaffected, or contralateral arm, of w o m e n treated for breast cancer is normal (i.e., similar to control data), a 3x2 mixed model A N O V A w a s used to determine differences in lymphatic function ( C R , A X , F O R E , and A P P ) between groups at rest and during exercise. A s contralateral arm function in both breast cancer groups was determined to be normal, then the contralateral arm served as e a c h subject's own control and w a s used for all subsequent analyses.  3x2 mixed model A N O V A on ipsilateral relative to contralateral arm lymphatic function w a s used to determine changes between subject groups at rest and during exercise. Post-hoc analysis for any main effects was performed using Tukey's test of honest significant differences.  5.3  RESULTS  Recruitment began in October 2003 and ended in June 2006. Seventeen w o m e n with B C R L expressed interest in the study; however, only ten subjects decided to take part. Of those, two did not want to undergo a second test which was the resting protocol in both c a s e s . Thirty-five w o m e n with breast cancer (no B C R L ) expressed interest in the study and 22 subjects took part. Of those, one did not want to undergo a second test (the rest protocol) and one subject has no exercise data due to technical reasons. Subjects who expressed interest but declined to participate were a s k e d their reason and every w o m a n who declined sited the administration of radiopharmaceuticals with a needle a s their reason for not participating. (Women treated for breast c a n c e r are often told by their health care professionals to avoid needles on the treated side to minimize risk of lymphedema development). The A P P measure was added after the first seven subjects were tested, and so, was not available for every subject. Finally, a number of data points were unavailable due to technical problems.  All data w a s c h e c k e d for normality of distribution. T h e Shapiro-Wilk normality tests indicated that each variable w a s normally distributed for B C and C O N T at rest and during exercise. For  83  B C R L subjects, A X and A P P were not normally distributed; however, this may be due to the small sample size. Data compared by A N O V A s were checked to ensure the assumption of sphericity w a s not violated. Although data for F O R E had unequal variance between groups, the assumption of sphericity, a s calculated by S P S S , was not violated.  Other research using lymphoscintigraphy with breast cancer patients show mono-exponential time-activity curves (4, 7, 9-11, 44); however, we have demonstrated linear relationships between C R and time (47, 48). This difference in time-activity relationships is explained by the use of different radiopharmaceuticals. For example, a smaller radiopharmaceutical such as 99m  T c - a n t i m o n y colloid would likely have a faster C R than a larger radiopharmaceutical such as  human serum albumin (41). In the present study, R values between C R and time during 2  exercise for the three subject groups - B C R L , B C , and C O N T - were 0.92, 0.94, and 0.92 for the contralateral arm, respectively, and 0.94, 0.95, and 0.95 for the ipsilateral arm, respectively.  5.3.1  Subject Characteristics  Characteristics of the study participants are summarized in Table 5.1. A g e , height, exercise power output, and exercise heart rate were similar between groups. Subjects with B C R L had a significantly greater weight (p=0.050), BMI (p=0.018), forearm circumference (p=0.000), and upper arm circumference (p=0.000) compared to both B C and C O N T . Details of breast cancer treatment are provided in Table 5.2.  5.3.2  Contralateral A r m Lymphatic Function  Contralateral arm lymphatic function ( C R , A X , and F O R E ) in women treated for breast cancer ( B C and B C R L ) w a s not significantly different than results obtained for the control group (Fig. 5.1). T h u s , the contralateral arm served as e a c h subject's own control for subsequent analyses.  The addition of exercise c a u s e d C R and A X to significantly increase ( C R : p=0.000; A X : p=0.003). A s expected, F O R E did not change from rest to exercise (p=0.553). Post-hoc analysis revealed that B C and C O N T displayed significant increases in C R and A X from rest to exercise, but B C R L only achieved significant increases in C R . B C R L subjects showed a trend towards an increase from rest to exercise in A X (6.4% ±3.1 vs. 7.4% ±3.0, p=0.249); however, statistical significance w a s not achieved.  84  F i g u r e 5.1  Lymphatic function as represented by depot clearance rate ( C R , P a n e l A), uptake in the axillary lymph nodes at 65 min post-injection ( A X , P a n e l B), and uptake in the forearm at 65 post-injection ( F O R E , Panel C ) at rest and during exercise in the normal, or contralateral arm, of w o m e n treated for breast c a n c e r with lymphedema ( B C R L ) , w o m e n treated for breast c a n c e r with no lymphedema (BC), and age-matched controls ( C O N T ) . Resting data is indicated in grey boxes while exercise data is in white boxes. The box plot indicates the distance between the 75th percentile and 25th percentile (box), the median value (solid back line), and the highest and lowest values (whiskers), excluding outliers (circles) and extreme outliers (asterisks). § denotes a significant difference between resting and exercise C R values for all subject groups. A significant difference (§) between resting and exercise A X values w a s found for B C and C O N T a s well. A s expected, no difference w a s found between rest a n d exercise F O R E values for any group.  85  Panel A - C R  1—,  OBO  CR rest • N -  8  19  8  17  19  CONT  BC  BCRL  CR exer cise  17  § Indicates significant difference (p<0.05) between conditions  Panel B - A X 20  Oi  o  15  T3  O  ~  10  3  5  H H I AX rest I N =  6  6 BCRL  19  19 BC  17  17 CONT  § Indicates significant difference (p<0.05) between conditions  86  I AX ex  Panel C - F O R E 4.0  o  3.0  T5  'E o  >  2.0  <u i_ \p O N  LU  Qi O  1.0  • I  0.0 7  7  BCRL  18  18  16  16  CONT  BC  87  FORE re st I FORE exercise  Appendix D s h o w s the relationship between C R and A X for the contralateral arm for resting (Panel A ) and exercise conditions (Panel B). A significant relationship w a s found for at rest (contralateral C R vs. contralatereral A X : r= -0.439, p=0.004, n=44) and during exercise (contralateral C R vs. contralateral A X : r = -0.309, p=0.049, n=44).  5.3.3  Ipsilateral Relative to Contralateral A r m C R  Fractional removal rate of  99m  T c - a n t i m o n y colloid from the subcutaneous depot over the 60 min  exercise and rest protocol in ipsilateral and contralateral arms for each subject group are presented in Figure 5.2. B o x plots showing ipsilateral relative to contralateral C R at rest a n d during exercise are shown in Figure 5.3. W h e n lymphatic function in the ipsilateral arm is stated relative to the contralateral arm, then a value of 100% indicates similar lymphatic function between arms.  There w a s no difference in ipsilateral relative to contralateral C R between groups at rest or during exercise (p=0.703). Further, this ratio did not change from rest to exercise (p=0.648). Individual C R data for w o m e n with B C R L and B C is in Figure 5.4. T h e coefficient of variation (CV) for C R between measurements from the right and left arms of the s a m e C O N T subject during rest and exercise was 30.4% and 14.4%, respectively.  For B C R L , there w a s a non-significant inverse relationship between exercise C R and forearm circumference (r = -0.457, p=0.184, n=10) and between exercise C R and upper arm circumference (r = -0.200, p=0.580, n=10). This w a s also true for B C (exercise C R and forearm circumference: r= -0.038, p=0.879, n=19; exercise C R and upper arm circumference: r= 0.190, p=0.437, n=19). Correlations between exercise C R and forearm/upper arm circumference for B C R L are presented in Figure 5.5.  5.3.4  Ipsilateral Relative to Contralateral A X  Figure 5.6 s h o w s uptake at the axilla 65 min P.I. relative to the initial dose (AX) for the ipsilateral relative to the contralateral arm. There was a significant difference in A X between groups at rest (p=0.001) and during exercise (p=0.002). Specifically, B C R L at rest demonstrated significantly lower A X (27.2% ±24.1) compared to both B C (74.8% ±39.8) and C O N T (104.9% ±52.1). During exercise, B C R L subjects also had significantly lower A X (26.5% ±33.6)  88  Figure 5 2  Plot of fractional removal rates of - T c antimony colloid from the subcutaneous depot of the affected, or ipsilateral arm (solid line) and normal, or contralateral arm (dashed line) of women treated for breast cancer with lymphedema (Panel A - B C R L ) w o m e n treated for breast cancer with no lymphedema (Panel B - B C ) , and age-matched controls (Panel C - C O N T ) at rest and during exercise. 9 9 m  89  6 00  U "rt  5 00  *3S  4—'  ^  _rt  400 J  O  U o  3 00  *37  Q2  CD  > al  2 00  "rt  Ol  rt -2  100 OS  19  BCRL  Figure 5.3  17  19  17  i l c R rest  •  CR exercise  CONT  BC  Ratio of ipsilateral to contralateral arm depot clearance rate ( C R ) in w o m e n treated for breast cancer with lymphedema ( B C R L ) , w o m e n treated for breast cancer (BC), and age-matched controls ( C O N T ) at rest and during exercise. Resting data is indicated in grey boxes while exercise data is in white boxes. A ratio of 100% indicates symmetry between arms. A ratio greater than 100% indicates faster C R on the ipsilateral compared to contralateral side while a ratio less than 100% indicates slower C R on the ipsilateral compared to contralateral side. The box plot indicates the distance between the 75th percentile and 25th percentile (box), the median value (solid back line), and the highest and lowest values (whiskers), excluding outliers (circles), and extreme outliers (asterisks). No significant difference was found between groups at rest or during exercise.  90  Figure 5.4  C l e a r a n c e rate (CR) during exercise for all pairs of contralateral and ipsilateral arms of w o m e n treated for breast cancer with lymphedema (Panel A - B C R L ) and w o m e n treated for breast cancer (Panel B - B C ) . T h e numbers indicate the patient represented by each pair of points (same subject number a s in Table 1).  91  Panel B - Upper Arm  160 E 140  E B 120 g  100  o 80 60 E 1_  40  a.  20  < 3  r = - 0 . 2 0 0 ; p = 0.580; n = 10  20  40  60  80  100  120  140  160  180  200  CR (%, relative to contralateral arm)  Figure 5.5  Scattergram of clearance rate ( C R ) plotted against arm circumference (forearm, P a n e l A ; upper arm, Panel B) for ipsilateral relative to contralateral arms in patients with B C R L during exercise (n=10).  92  compared to both B C (70.4% ±45.4) and C O N T (98.4% ±43.5). There w a s no difference between B C and C O N T at rest or during exercise.  The ratio of ipsilateral relative to contralateral A X did not change from rest to exercise (p=0.773).  Individual A X data for women with B C R L and B C is in Figure 5.7.  A non-significant inverse relationship was observed between exercise A X and arm circumference in subjects with B C R L (AX vs. forearm circumference: r = -0.479, p=0.230, n=8; A X vs. upper arm circumference: r = -0.354, p=0.390, n=8). The s a m e relationship w a s seen in B C ( A X vs. forearm circumference: r = -0.399, p=0.090, n=19; A X vs. upper arm circumference: r = -0.238, p=0.326, n=19). Correlations for B C R L between exercise A X and forearm/upper arm circumference are presented in Figure 5.8.  5.3.5  Ipsilateral Relative to Contralateral F O R E  Uptake in the forearm 65 min P.I. relative to the initial dose ( F O R E ) for the ipsilateral relative to contralateral arm is presented in Figure 5.9. A significant main effect for groups was found (p=0.000). Post-hoc analysis revealed that at rest, B C R L had significantly greater F O R E (247.3% ±136.6) than both B C (90.9% ±21.2) a n d C O N T (92.4% ±20.4). Similarly, during exercise B C R L had significantly greater F O R E (470.1% ±294.0) than both B C (93.5% ±26.8) and C O N T (95.1% ±13.6). There was no difference between B C and C O N T at rest or during exercise.  B C R L demonstrated a significant increase in F O R E from rest to exercise (p=0.027). F O R E in the ipsilateral relative to contralateral arm did not change from rest to exercise in either B C (p=0.854) or C O N T (p=0.711).  5.3.6  Time of Radiopharmaceutical Appearance at the Axillary Lymph Nodes (APP)  One-minute s c a n s of the axillary lymph nodes were taken at 10-minute intervals until radioactivity w a s visualized in the axillary lymph nodes (Fig. 5.10). If radiopharmaceuticals were not visualized in the axillary nodes by the end of the protocol, then 60 min was entered a s the value for that arm. This was particularly evident in subjects with B C R L . For example, at rest,  93  4 00  E ra  TO i OJ  4—' O  *37  Oi6  2 00  03 5  CL) >  100  O i  X <  O i  J A X rest • A X N =  6  6  BCRL  19  19  BC  17  exercise  17  CONT  # denotes significant difference (p<0.05) between groups  Figure 5 . 6  Ratio of ipsilateral to contralateral arm radiopharmaceuticals uptake in the axilla 65 min post-injection (AX) women treated for breast cancer with lymphedema ( B C R L ) , women treated for breast cancer with no lymphedema (BC), and agematched controls ( C O N T ) at rest and during exercise. Resting data is indicated in grey boxes while exercise data is in white boxes. A ratio c l o s e to 1 0 0 % indicates symmetry between arms. A ratio greater than 100% indicates greater A X on the ipsilateral compared to contralateral side while a ratio less than 100% indicates lower A X on the ipsilateral compared to contralateral side. The box plot indicates the distance between the 75th percentile and 25th percentile (box), the median value (solid back line), and the highest and lowest values (whiskers), excluding outliers (circles) and extreme outliers (asterisks). # denotes a significantly lower A X both at rest and during exercise in B C R L subjects compared to both B C and C O N T subjects.  94  20  F i g u r e 5.7  Radiopharmaceutical uptake in the axilla 65 min post-injection (AX) during exercise for all pairs of contralateral and ipsilateral arms of w o m e n treated for breast c a n c e r with lymphedema (Panel A - B C R L ) and w o m e n treated for breast cancer (Panel B - B C ) . T h e numbers indicate the patient represented by e a c h pair of points (same subject number as in Table 1).  95  \  0  i  0  -  - r  20  -  ;  40  •  60  ,  80  -  -  ,  100  AX (%, relative to contralateral arm)  F i g u r e 5.8  Scattergram of radiopharmaceuticals uptake in the axilla 65 min post-injection (AX) plotted against arm circumference (Panel A - forearm; P a n e l B - upper arm) with circumferences expressed relative to contralateral arm in patients with breast cancer related lymphedema ( B C R L ) during exercise (n=10).  96  #  rt  #  i  1000  800  "rt  i_ ai  _rt  iz c o u a; _rt <u  4 00  UJ  O  4  600  2 00  4 FORE re st  Q . 6  N =  7  7  BCRL  18  *•16 18  BC  FORE exe rcise 16  16  CONT  § Indicates significant difference (p<0.05) between conditions # denotes significant difference (p<0.05) between groups  Figure  5.9  Ratio of ipsilateral to contralateral arm radiopharmaceuticals uptake in the forearm 65 min post-injection ( F O R E ) in women treated for breast cancer with lymphedema ( B C R L ) , women treated for breast cancer (BC), and age-matched controls ( C O N T ) at rest and during exercise. Resting data is indicated in grey boxes while exercise data is in white boxes. A ratio close to 100% indicates symmetry between arms. A ratio greater than 100% indicates greater F O R E on the ipsilateral compared to contralateral side while a ratio less than 100% indicates less F O R E on the ipsilateral compared to contralateral side. The box plot indicates the distance between the 75th percentile and 25th percentile (box), the median value (solid back line), and the highest and lowest values (whiskers), excluding outliers (circles) and extreme outliers (asterisks). § denotes a significant increase in F O R E from rest to exercise in B C R L only. # denotes a significantly higher F O R E in B C R L at rest and during exercise compared to both B C and C O N T . 97  five of eight subjects with B C R L had no radiopharmaceuticals observable in the ipsilateral axillary lymph nodes at 60 minutes. The addition of exercise resulted in one of the aforementioned subjects showing activity in ipsilateral axillary lymph nodes (data w a s not available for the other two subjects during exercise due to a change in data acquisition protocol). Radiopharmaceuticals were visualized in all other subjects except one B C subject at rest. This B C subject who did not show activity in the lymph nodes during rest, did show activity in the lymph nodes at 25 minutes during exercise.  Ipsilateral A P P w a s significantly different between groups (p=0.000). At rest, A P P w a s significantly slower in women with B C R L (52.1 min ±11.9) compared to both B C (25.8 min ±13.7) a n d C O N T (21.5 min ±9.4). A g a i n , A P P w a s significantly slower in women with B C R L during exercise (44.3 min ±16.2) versus both B C (12.7 min ±6.0) and C O N T (13.5 min +5.5). There were no differences between B C and C O N T for both exercise and rest conditions.  Contralateral A P P w a s not significantly different between groups. T h e addition of exercise caused A P P to significantly increase (p=0.000). Post-hoc analysis revealed that only B C and C O N T displayed significant increases in A P P from rest to exercise. B C R L showed a trend towards a n increase from rest to exercise (17.9 min ±4.9 vs. 13.6 min ±3.8 min, p=0.078); however, statistical significance w a s not achieved.  5.3.7  Effect of E x e r c i s e o n Ipsilateral L y m p h a t i c F u n c t i o n  The effect of exercise on the ratio of ipsilateral to contralateral lymphatic function w a s included in all a n a l y s e s described above; however, changes in the contralateral arm could potentially mask c h a n g e s observed in the ipsilateral arm. Consequently, paired t-tests were performed between ipsilateral lymphatic function at rest and ipsilateral lymphatic function during exercise in B C R L and B C . Ipsilateral C R significantly increased in both B C R L (p=0.002) and B C (p=0.000). A X did not significantly increase in B C R L (p=0.531) while significance w a s just reached in B C (p=0.050). F O R E w a s not expected to change from rest to exercise and this trend w a s observed in B C (p=0.881). However, ipsilateral F O R E did significantly increase in B C R L from rest to exercise (p=0.004). Finally, all groups demonstrated significantly faster A P P in the ipsilateral arm from rest to exercise (p=0.000).  98  Figure 5.10  Time of first radiopharmaceutical appearance ( A P P ) at rest and during exercise in the normal, or contralateral arm (Panel A), and the affected, or ipsilateral arm (Panel B), of women treated for breast cancer with lymphedema ( B C R L ) , women treated for breast cancer with no lymphedema (BC), and age-matched controls ( C O N T ) . Resting data is indicated in grey boxes while exercise data is in white boxes. A lower A P P appearance of radiopharmaceuticals at the axilla w a s visualized on the images faster. Note on Panel B, the median for B C R L is 60 minutes. This indicates that radiopharmaceuticals were not visualized in the axilla on the affected (ipsilateral) side by the time the last image w a s taken. The box plot indicates the distance between the 75th percentile and 25th percentile (box), the median value (solid back line), and the highest and lowest values (whiskers), excluding outliers (circles), and extreme outliers (asterisks). § denotes a significantly faster A P P during exercise versus rest in B C and C O N T . # denotes a significantly slower A P P in B C R L subjects at rest and during exercise compared to both B C and C O N T .  99  Panel A - Contralateral A r m 70  #  65 60 55 •  50  —  *  —  •  45 40 35 30 25 20 15 10 1 ^ 1 APP rest  5 0  I  7  7  BCRL  13  13  13  13  CONT  BC  § denotes significant difference (p<0.05) between conditions # denotes significant difference (p<0.05) between groups  100  IAPP  exerc ise  P a n e l B - Ipsilateral A r m  # •  #  *10  Ol7  *»8  bsJAPP rest I 7  7  BCRL  13  13  BC  101  13  13  CONT  I APP exercise  5.3.8  E f f e c t o f the N u m b e r of A x i l l a r y L y m p h N o d e s D i s s e c t e d o n L y m p h a t i c F u n c t i o n  Correlations were performed between the number of axillary lymph nodes dissected ( A L N D ) and lymphatic function during exercise (Appendix D). W h e n all women treated for breast cancer ( B C and B C R L , n=32) were included, no relationship was evident between A L N D and C R (r = 0.109, p = 0.565, n=30) but a significant inverse relationship was found between A L N D and A X (r = -0.408, p=0.031, n=28). W h e n this relationship was analyzed in B C R L only, still no relationship was observed between either A L N D and C R (r = 0.168, p=0.643, n=10)or A L N D and A X (r= 0.602, p=0.114, n=8). In B C only, no significant relationship was s e e n between A L N D and C R (r = -0.355, p=0.125, n= 20) although significance w a s reached between A L N D and A X (r = -0.448, p=0.047, n=19). All B C and B C R L subjects were stratified according to whether radiation therapy was performed, and the correlations were repeated. For those who had radiation therapy, no significant relationship w a s observed between exercise C R and A L N D (r = 0.049, p=0.828, n=22), but a significant inverse relationship w a s evident between exercise A X and A L N D (r = -0.450, p=0.046, n=20). For those who did not have radiation therapy, no significant relationships were observed between either C R and A L N D (r = -0.324, p=0.434, n=8) or A X and A L N D (r = -0.560, p=0.148, n=8).  5.4  DISCUSSION  This is the first study to measure lymphatic function during intermittent, moderate exercise in w o m e n treated for breast cancer with and without B C R L and age-matched, healthy controls. The principal findings of this prospective, exploratory study are the following: 1) contralateral arm lymphatic function w a s similar between groups; 2) C R in the ipsilateral arm relative to the contralateral arm did not differ between subject groups at rest or during exercise; 3) A X w a s significantly lower in women with B C R L compared to both B C and C O N T during rest and exercise conditions; 4) F O R E was significantly higher in women with B C R L compared to both B C and C O N T during rest and exercise conditions; a n d , 5) the addition of exercise increased ipsilateral C R , A X , and A P P in B C subjects and increased ipsilateral C R , F O R E , and A P P in B C R L subjects (an increase in F O R E is not expected with exercise).  102  5.4.1  Ipsilateral Relative to Contralateral A r m C l e a r a n c e Rate  Contrary to the hypothesis, lymphatic function, a s measured by depot C R , w a s not impaired in w o m e n treated for breast cancer with and without B C R L at rest nor during exercise. In fact, the mean ratio between the affected, or ipsilateral arm, and the normal, or contralateral arm, during exercise w a s 1 0 1 % for B C R L and 9 8 % for B C subjects indicating symmetry between arms. It is difficult to make direct comparisons between the findings in the present study and other research primarily due to differences in lymphoscintigraphic protocols (i.e., particulate administered, location of injection, type, intensity, and duration of exercise such as fist clenching or ball squeezing performed intermittently between imaging scans, etc.). Moreover, no study has investigated lymphatic function during moderate intensity exercise in w o m e n treated for breast cancer. Although several investigations had subjects with B C R L perform intermittent forearm exercise, such as clenching the fists or squeezing a rubber ball between imaging s c a n s to stimulate lymph flow (4, 6, 7 , 1 0 , 44-46), we have previously shown depot clearance rate (CR) in healthy females to be similar whether rest or hand grip exercise w a s performed (47).  Despite differences in methodology between the present study and those published in the literature, current research has indicated that resting C R in women with B C R L may depend on whether radiopharmaceuticals are administered to swollen or spared tissue of the affected arm. For example, administering radiopharmaceuticals subcutaneously (2-4, 7, 10, 11) or subfascially (9) to swollen tissue has demonstrated slower lymph drainage compared to a similar injection site on the contralateral arm. Yet when injections are administered to the spared region of the swollen arm, C R is similar (4, 7) or even faster (10). Although hand volume w a s not measured in the present study, three o f t e n subjects with B C R L had noticeably slower C R during exercise in the ipsilateral arm compared to the contralateral arm, while another three had noticeably faster C R in the ipsilateral arm during exercise. The remaining four subjects had comparable C R between arms. There is the possibility that the B C R L subjects with a slower C R were also the o n e s with swollen hands, while subjects who displayed a similar or faster C R had spared hands. Future research investigating the effects of exercise on lymphatic function should ensure that hand volume, a s well a s arm volume, is measured and considered as a confounding variable.  The use of C R in understanding lymphatic function is further complicated by the finding that proximal forearm C R is faster than distal C R , irrespective of the site of swelling on both the ipsilateral and contralateral arms (2). This was shown by Modi et al. who administered 103  subcutaneous injections to the forearm at sites of maximal and minimal swelling and corresponding sites on the contralateral forearm in 11 women with established B C R L . No difference was found between C R at the site of maximal and minimal forearm swelling, rather the proximal forearm C R was faster than distal C R . T h e authors hypothesized that the greater muscle component in the proximal region of the forearm likely contributed to the faster C R s e e n in this portion of the forearm. The skeletal muscle pump is an extrinsic mechanism known to facilitate lymph formation and propulsion (49). In fact, subfascial C R has been shown to be two times faster than epifascial C R (1).  Other reasons, such a s differences in breast cancer treatment, may also account for the lack of statistical difference in C R between groups. For example, as listed in Table 5.2, the number of axillary lymph nodes dissected (ALND), inclusion of radiotherapy, and type of breast surgery differed between groups. The mean A L N D for B C R L w a s 16 (range: 4 to 25) and 11 for B C (range: 0 to 40). Further, nine o f t e n women with B C R L had radiotherapy that included the axilla,, while 14 of 22 B C subjects reported radiation therapy to the s a m e region. Both radiotherapy to the axilla and extent of A L N D are risk factors for the development of lymphedema (16); consequently, these confounding variables may need to be controlled when analyzing C R . However, a significant relationship was not observed between exercise C R (ipsilateral relative to contralateral arm) and A L N D when all subjects treated for breast cancer ( B C and B C R L ) were included in the analysis. There w a s still no significant relationship between exercise C R and A L N D when women treated for breast cancer were stratified according to whether radiation therapy was performed. There has been no report of similar analyses performed on C R and ALND/radiation therapy in previous research.  The Effect of Exercise  on Clearance  Rate  This is the first study to investigate the ability of the lymphatic system to respond to an exercise stimulus in women treated for breast cancer with and without B C R L . In the present study, C R approximately doubled in all groups from rest to exercise. This response to exercise is comparable to data we have collected in healthy, college-aged females (Lane, unpublished comparison of data from (47) and (48)).  It is expected that C R will increase from rest to exercise in those with uncompromised lymphatic function. Typical physiological responses to exercise of increasing intensity include augmented blood flow, sympathetic nervous system activity, ventilation, and skeletal muscle contractions.  104  A s e a c h of these physiological responses to exercise are also thought to be mechanisms that assist with lymph formation and propulsion (49), then a concomitant increase in lymph flow with increased exertion is likely. Although subjects with B C R L had a comparable increase in C R as control subjects, this did not result in more radiopharmaceuticals reaching the axillary lymph nodes on the ipsilateral side (as will be discussed later). The results of this study indicate that when radiopharmaceuticals are administered to a subcutaneous hand depot in those with compromised lymphatic function (i.e., subjects with B C R L ) , comparable increases in C R are observed between those with compromised and uncompromised lymphatic function.  Individual  B C R L results demonstrated that seven of eight subjects tested had a noticeably faster C R with exercise.  In summary, the rate at which radiopharmaceuticals clear from the injection depot (i.e., C R ) is a typical outcome variable used to describe lymphatic function in women treated for breast cancer. However, C R on its own may not be a suitable measure to evaluate lymphatic function in this population. W e demonstrated no differences in C R at rest or during exercise in breast cancer survivors with and without B C R L compared to age-matched control subjects. E v e n when other factors were considered (i.e., radiotherapy to axilla and the number of lymph nodes excised), C R did not differ between groups. This would indicate that the lymphatic obstruction resulting in the development of B C R L does not affect subcutaneous C R from the hand. However, the small sample of subjects with B C R L and the variability in ipsilateral relative to contralateral C R may have reduced the power necessary to detect differences between groups.  5.4.2  Ipsilateral Relative to Contralateral A X a n d A P P  In the a b s e n c e of taking blood samples, the time of first appearance of radiopharmaceuticals at the axilla ( A P P ) and the percentage of radiopharmaceuticals in the axillary lymph nodes relative to the initial d o s e at a set time-point post-injection (AX) may be potential indicators of the efficiency of the lymphatic drainage system (41, 42, 50, 51). There are some limitations, however, to considering A X and A P P as outcome measures. For example, lymph node retention of tracer is only a 'snapshot' of the amount of tracer present in the axillary lymph nodes at any one time. Despite colloids having good regional lymph node retention (41, 52), these particles will migrate through the lymph nodes and eventually enter the systemic circulation. It is unknown how long the radiopharmaceuticals are retained in the lymph nodes and what factors s p e e d or slow tracer exit from a lymph node. Another limitation of A X and A P P  105  is that breast cancer treatment often involves lymph node excision and/or radiation therapy, thereby reducing the number of functional nodes on the treated (ipsilateral) side. Consequently, analyzing the axillary lymph nodes may result in an artificially lower percentage on the ipsilateral side simply due to fewer functional lymph nodes.  Pain and colleagues have published several papers using dual-isotope lymphoscintigraphy to measure the rate of accumulation of tracer in contralateral venous samples (3-7, 44). Briefly, this technique involves administration of and  1 1 1  9 9 m  T c - Human Immunoglobulin G (HlgG) into one hand  l n - H l g G into the other hand, repeated imaging over three hours, and bilateral sampling  from the medial cubital veins (see ref (3) for full explanation of methods). B e c a u s e two isotopes are used and blood is sampled at various time points post-injection, the appearance rate of tracer in mixed-venous blood can be obtained from both arms simultaneously. T h e a p p e a r a n c e rate can then be used to indicate how efficient the lymphatic system transports injected radiopharmaceuticals through the upper extremity. While there are apparent advantages to using dual isotope lymphoscintigraphy, the disadvantages are that it is more invasive than using A X / A P P and still a s s u m e s (as with any lymphoscintigraphy protocol) that the majority of particulate administered reaches mixed venous blood via the lymphatic system.  Despite the limitations in using A X and A P P , we have demonstrated a moderate but significant inverse relationship between contralateral C R and contralateral A X (rest: r= -0.439, exercise: r = -0.309). T h u s , the faster the radiopharmaceutical clears from the injection depot, the greater the percentage of activity stored at the axillary lymph nodes 65 minutes post-injection and this observation provides a basis for using A X a s an outcome variable. The observation of a stronger relationship at rest compared to exercise may be due to the differences in transit time of radiopharmaceuticals through axillary lymph nodes. The specific factors that affect transit time and storage are unknown; however, it is likely that exercise s p e e d s tracer exit from lymph nodes to central circulation.  A s hypothesized, our results demonstrated the lowest A X values and the slowest A P P times in B C R L compared to both B C and C O N T . Although A X did not significantly differ between B C and C O N T , there was a trend towards a lower A X in B C . A s mentioned previously, a breast cancer survivor will likely have fewer functional lymph nodes on the ipsilateral side than a control subject due to axillary lymph node dissection and/or radiation therapy. In fact, a s a group, B C R L had the highest mean number of A L N D (16 for B C R L and 11 for B C ) . However,  106  ALND does not solely explain the lower AX seen in BCRL compared to BC. First, a significant relationship between A X and ALND (r = -0.41) was only evident when all subjects treated for breast cancer (BC and BCRL) were included in the analysis. Sub-analysis revealed that B C R L subjects had a positive relationship between AX and ALND (r = 0.60, non-significant), but BC showed an inverse relationship (r = -0.45, p=0.05). An inverse relationship would be expected between A X and ALND. Second, when comparing the BCRL group to BC subjects with a similar number of axillary lymph nodes excised (n=4, denoted by * on Table 5.2), a lower A X in BCRL subjects was still observed (23% vs. 56%, respectively). Further, these same four BC subjects at rest had a faster mean A P P compared to BCRL subjects (33 minutes and 54 minutes, respectively). During exercise, mean A P P in the selected BC subjects and B C R L subjects was 15 and 44 minutes, respectively. (It should be noted that exercise A P P values were not available in three BCRL subjects and two of the four BC subjects due to A P P being introduced after the first seven subjects were tested). Thus, evidence that the number of functional lymph nodes is not the only variable contributing to the development of BCRL is provided by the following: 1) both AX and A P P are impaired in BCRL compared to BC subjects with similar numbers of lymph nodes excised, and, 2) the lack of a strong relationship between AX and ALND in BCRL.  The Effect of Exercise on AX  Age-matched control subjects had a 1.8% increase in ipsilateral A X from rest to exercise, while B C R L had a 0.3% increase and BC had a 1.4% increase. Although we have not measured A X at rest in healthy, college-aged females, a significant increase was seen from low to moderate intensity arm cranking exercise (48). The increase in AX from rest to moderate intensity exercise indicates the capacity of the axillary lymph nodes to store greater amounts of radiopharmaceuticals and increased transport through lymphatic vessels. It is unknown if lymph nodes have a maximum capacity for radiopharmaceutical storage. Despite the limitations of using A X as an outcome variable as described earlier, a normal response to exercise appears to be an increase in A X by - 2 % as demonstrated by CONT subjects. However, BCRL as a group only showed a negligible change in A X on the ipsilateral side from rest to exercise. Moreover, there were other individual BC and CONT subjects that did not demonstrate a noticeable change from rest to exercise. For example, considering the average increase for ipsilateral A X in BC subjects from rest to exercise was 1.5%, five (of six) BCRL, ten (of 19) BC, and four (of 17) CONT did not increase AX by this value. Perhaps, the inability of lymph nodes at the axilla to increase storage of radiopharmaceuticals during exercise may indicate a latent  107  pathology. Further research is needed to evaluate the suitability of comparing rest and exercise A X to identify latent pathologies.  5.4.3  Ipsilateral Relative to Contralateral F O R E  F O R E w a s investigated to determine the presence of dermal backflow in the arms of women treated for breast cancer. Stanton et al. (10) describe dermal backflow a s a rerouting of lymph towards skin that is represented by diffuse activity in the ipsilateral arm with intense amounts of activity at the periphery of the image. Only the forearm was included in the region of interest for this measure due to a large number of subjects displaying localized foci of activity in the upper arm (likely epitrochlear lymph nodes). A s hypothesized, women with B C R L had significantly greater F O R E compared to both B C and C O N T . Further, dermal backflow w a s observed in e a c h B C R L subject at rest and during exercise. Other studies administering subcutaneous injections of radiopharmaceuticals to the hand of women with B C R L have also observed dermal backflow regardless if the hand of the affected arm was swollen or spared (10, 11). However, dermal backflow w a s not seen with subfascial injections to the forearm (9). Considering that dermal backflow has been observed in both swollen and spared hands, Stanton and colleagues hypothesize that the a c c e s s point for radiopharmaceuticals to dermal lymphatic routes is likely near the hand or the wrist.  The Effect of Exercise on FORE A s expected, F O R E did not change from rest to exercise in B C and C O N T ; however, there w a s a significant increase in F O R E in women with B C R L . T a k e n with the C R and A X data, this would indicate the following: In women with B C R L , radiopharmaceuticals are able to clear from the hand at the s a m e rate as other subject groups, but instead of reaching the axilla, the activity gets trapped in the dermis as evidenced by the significantly lower A X and significantly higher F O R E . Theoretically then, the obstruction to lymphatic system drainage in our subjects with B C R L does not impair C R from the hand depot, but does impair the ability for radiopharmaceuticals to travel through deeper lymphatic vessels to the axillary lymph nodes. The exercise protocol in the present study does not appear to overcome the resistance to the obstruction in those with B C R L , as F O R E w a s shown to increase from rest to exercise.  108  5.4.4  Contralateral A r m Lymphatic Function  The majority of research using lymphoscintigraphy has focused on the evaluation of lymphatic function in patients after completion of breast cancer treatment. However, there is the possibility that pre-operative differences in lymphatic function exist and the unaffected, or contralateral arm, may not be normal (7, 11). For example, Stanton et al. (11) compared B C R L subjects with a swollen hand to B C R L subjects with a spared hand. A significant difference in contralateral arm C R w a s observed between subjects (swollen hand = -0.157 % min" vs. spared hand = 1  0.095 % min" ) while ipsilateral arm C R w a s similar. Although both subjects were alike in terms 1  of age and treatment, they differed substantially in terms of arm volume. Specifically, the swollen hand group had a 5 0 % increase in ipsilateral arm volume, while those with a spared hand had a 2 7 % increase in ipsilateral arm volume. Perhaps, differences that contribute to the severity of B C R L affect contralateral arm lymphatic function.  Pain et al. (7) has also observed variations in contralateral arm function. T h e y observed a lower, but non-significant, contralateral arm C R and contralateral arm blood gain rate in B C R L subjects with a swollen hand compared to B C R L subjects with a spared hand - opposite to what was found by Stanton et al. (10). It should be noted that the B C R L subjects included in the study by Pain et al. (7) included four subjects with a smaller ipsilateral arm volume at the time of the study, so it can be argued that these subjects did not have clinically significant B C R L .  Hand volume w a s not measured in the present study, so contralateral lymphatic function cannot be compared between B C R L subjects with a spared or swollen hand. Rather, contralateral lymphatic function w a s compared between subjects with B C R L , breast c a n c e r survivors with no B C R L , and age-matched controls. Comparing lymphatic function in w o m e n with B C R L to other females who have undergone similar treatment, but without the presentation of lymphedema, may be a more appropriate comparison to evaluate contralateral arm lymphatic function. Moreover, we have shown the coefficient of variation with resting C R in C O N T subjects to be higher than that calculated for exercise C R (30.4% and 14.4%, respectively). Considering that both Pain et al. (7) and Stanton et al. (10) obtained their data at rest, the observed C R values may have greater variability reflected in the equivocal findings.  The results of this study indicate no significant differences in contralateral lymphatic function at rest or during exercise as a s s e s s e d by C R , A X , A P P , and F O R E . However, the contralateral response to exercise did differ between subject groups. For example, a significant increase in 109  lymphatic function was observed in B C and C O N T for each variable (except F O R E which was not expected to change with exercise). But B C R L did not show a significant increase in A X and A P P from rest to exercise, although a trend towards an increase was observed for both variables (AX: 6.4% vs. 7.4%; A P P : 17.9 min vs. 13.6 min). Again, the small sample size of B C R L subjects reduced the power to detect a significant difference in both A X and A P P data between resting and exercising conditions to 2 0 % . It must also be considered that systemic changes in lymphatic function occurred due to the development of lymphedema and that contralateral arm lymphatic function was not normal in subjects with B C R L .  5.4.5  Clinical  Implications  Factors that are known to increase the risk of developing B C R L include dissection of the axillary lymph nodes, radiotherapy to the breast and axilla, pathological nodal status, obesity, and tumour stage (53-56). Overall, B C R L subjects in this study presented with more risk factors than B C subjects. For example, as shown in Table 5.2, eight of 10 subjects with B C R L had greater than 14 lymph nodes excised. This compares to five of 22 B C subjects. Further, all B C R L subjects except one and 14 of 22 B C subjects had radiotherapy to the axilla. Using BMI to screen for obesity revealed 10% of B C R L subjects were normal weight, 5 0 % were overweight, 2 0 % have C l a s s I obesity, and 2 0 % have Class II obesity. O n the other hand, 4 5 % of B C subjects were normal weight, 3 6 % of B C subjects were overweight, 1 8 % have C l a s s I obesity, and none were identified as having C l a s s II obesity. Future research should investigate whether a weight loss intervention can help to reduce arm swelling in subjects with B C R L .  Another important finding of this study is that not all subjects treated for breast cancer have similar lymphatic function during exercise. To give one example, mean (±SD) ipsilateral A X in B C R L during exercise was 1.5% ±2.4; however, one subject with B C R L (Subj. #9, Fig. 5.11) had an A X value of 6.0% in the ipsilateral arm despite having the most lymph nodes excised in the B C R L group (25 vs B C R L mean of 16). Subject #9, compared to others in the B C R L group, was also unique in other aspects: she had the lowest BMI (20.4 vs. B C R L mean of 30.4 kg m ), 2  was only one of two B C R L subjects who reported performing moderate intensity exercise more than 4 days per week, and had a region of swelling confined to the distal portion of the forearm. Interestingly, Subject #9's lymph nodes on the ipsilateral side appear to be closer to the neck than the axilla. This is likely not a genetic abnormality as her identical twin sister ( C O N T , Fig. 5.11) was also investigated and has symmetrical lymph nodes in the axillary region.  110  B C R L #2  BCRL #9  CONT (Subject 9's identical twin)  • BCRL • BMI = 37.5 • d o e s not e x e r c i s e • A X =1.2%  • BCRL • BMI = 20.4 • regular exercise 4-6 days/wk • A X = 5.1%  • BMI = 20.4 • regular e x e r c i s e 4-6 days/wk • A X = 4.0%  axilla  elbow  »  hand  treated side  F i g u r e 5.11  t  treated side  Individual lymphoscintigrams taken at 65 min post-injection from two subjects with breast cancer related lymphedema ( B C R L , Subject #2 and #9) and Subject #9's identical twin (control subject).  111  Although aerobic fitness was not a s s e s s e d in this study, there is the possibility that the regular exercise performed by Subject #9 resulted in adaptations to the lymphatic system, such as the generation of new lymphatic vessels (lymphangiogenesis) around the d a m a g e d axillary lymphatics. Y o o n et al. (57) demonstrated in an animal model of lymphedema that vascular endothelial growth factor-C ( V E G F - C ) therapy reversed swelling through lymphangiogenesis. A s habitual exercise in a healthy population is known to induce angiogenesis through up-regulation of other isoforms of V E G F (58), it is reasonable to expect concurrent lymphangiogenesis through up-regulation of V E G F - C . Lymphangiogenesis could help to reduce the stress put on the lymphatic vasculature damaged by axillary lymph node dissection and radiation to the axilla. Perhaps, the regular exercise performed by Subject #9 resulted in the creation of new lymphatic v e s s e l s draining into lymph nodes found near the neck on the ipsilateral side. This speculation requires further research.  S o m e of the individual variability in lymphatic function, both between arms and in response to exercise, may indicate latent lymphatic pathology and could potentially account for the finding that only - 2 9 % of breast cancer patients develop lymphedema (13, 14). Conceivably, a small proportion of the population may have atypical lymphatic function that goes undiagnosed until treatment for a disease, such a s breast cancer, compromises and challenges the normal performance of the lymphatic system. T h o s e with normal lymphatic function may be able to compensate for the increased resistance faced by the axillary lymphatic vasculature when lymph nodes are excised and/or irradiated a s part of breast cancer treatment by a number of potential m e c h a n i s m s . First, lymphaticovenous communications may open allowing fluid and plasma proteins to bypass obstructed lymphatic vessels and instead a c c e s s local blood vessels. Lymphaticovenous communications are thought to exist in normal, healthy individuals but may not be functional unless there is chronic obstruction of lymphatic vessels or nodes (59). If the lymphatic system were under chronic stress due to obstruction, then the opening of lymphaticovenous communications would allow lymph to bypass the obstructed area. This w a s demonstrated in early research by Threefoot et al. (60) who used a dog model with the major lymphatic channeJs obstructed for over five d a y s to demonstrate the presence of lymphaticovenous communications. In humans, lymphatic-venous microsurgery has resulted in an average reduction in e x c e s s volume of 6 9 % (61). S e c o n d , there is the possibility of anatomical differences in lymphatic vessel location and length. For example, a long variant that bypasses axillary lymphatics has been proposed (62). The existence of this long variant may  112  bypass excised or d a m a g e d level I and level II axillary lymph nodes, and thereby, potentially reduce the risk of developing B C R L (54).  The majority of research using lymphoscintigraphy has focused on the evaluation of lymphatic function in patients after completion of breast cancer treatment. However, one study has used lymphoscintigraphy to evaluate pre-operative changes in lymphatic function. In order to determine early pathophysiological responses to surgery, Pain et al. (5) used dual-isotope lymphoscintigraphy to evaluate lymphatic function in sixteen women diagnosed with breast cancer before, and three months after, axillary clearance surgery. C l e a r a n c e rate and blood appearance rate did not change as a result of surgery; however, the variability in data increased from pre- to post-surgery ( C R coefficient of variation: 2 4 % and 4 4 % , respectively; blood appearance rate coefficient of variation: 4 9 % and 7 3 % , respectively). This study indicates that there are no early changes in lymphatic function as a result of axillary surgery. However, the variability in data may be due to the measurement of C R and blood appearance rate during rest. Additionally, future studies should follow breast cancer patients over a longer period postsurgery a s Armer et al. (63) found that lymphedema incidence rates were higher one-year postdiagnosis versus six months post-diagnosis, regardless of the method of defining clinically significant lymphedema.  5.4.6  U s i n g E x e r c i s e to Identify Latent L y m p h a t i c P a t h o l o g i e s  Exercise is often used in clinical research to reduce variability in data and determine if the physiological system in question has a latent pathology that is only uncovered during a stressed situation. The coefficient of variation (CV) for the primary outcome measure, C R , between the right and left arms of the s a m e C O N T subjects during both exercise and rest w a s 14.4% and 30.4%, respectively. The exercise C V for C O N T (14.4%) is similar to what we have found previously for healthy, college-age, females performing the s a m e exercise stimulus ( C V = 11.7%). B C subjects and controls, on average, had improved lymphatic function compared to subjects with B C R L . However, there w a s considerable variability between ipsilateral and contralateral arms for each measure of lymphatic function as shown in the figures presenting individual data. The variability in data may be in part due to limitations to the study described in the following section; however, it is also possible that early stage lymphatic dysfunction w a s developing. Although identifying latent lymphatic pathologies with exercise w a s not a main objective of this thesis, we have retrospectively analyzed the data to determine if evaluating  113  lymphatic function during a stressed situation, such a s exercise, has the potential to identify latent lymphatic pathologies.  Overall, our results demonstrate that in women with B C R L , radiopharmaceuticals are able to clear from the hand at the s a m e rate as other subject groups, but instead of reaching the axilla, the activity gets trapped in the dermis. A s shown by the variance in data, especially the outliers and extreme outliers, some B C subjects and controls also score values of lymphatic function similar to those with B C R L . If we considered only one measure of lymphatic function and a subject scored an atypical value, then we would not know if this atypical value simply reflects normal variance in the data or if early stage development of B C R L is taking place. However, if we consider several measures of lymphatic function and a subject has more than one atypical measure, then we may feel more confident in identifying this subject a s having early stage development of B C R L . One study to date has developed an empirical scoring system b a s e d on visual inspection of lymphoscintigrams to quantify changes in lymphatic function in subjects with B C R L as a result of manual lymphatic drainage treatment (46). This scoring system, developed by S z u b a and colleagues and presented in Appendix D, gives a score from zero to five for visualization of lymph nodes on the ipsilateral side (0 points = symmetrical bilateral lymph node visualization; 5 points = no lymph node visible on the affected side). Additionally, a score of zero to three is used for visualization of dermal backflow on the affected side (0 points = no dermal backflow; 3 points = circumferential dermal backflow involving more than one limb segment). T h e two scores are summed together to give a total score out of eight. T h u s , the scoring system developed by S z u b a et al. considers visualization of axillary lymph nodes and visualization of dermal backflow in one score of lymphatic function.  W e have attempted to modify this scoring system by using objective measures rather than visual interpretation of the data. Specifically, we use A X (%, relative to contralateral arm) to represent axillary lymph nodes and F O R E (%, relative to contralateral arm) to represent dermal backflow. T h e s a m e range in scores (0-5 points for A X ; 0-3 points for F O R E ) is used a s to S z u b a and colleagues. For our scoring system, we used the 9 5 % confidence interval of control subjects as a score of zero for both A X and F O R E , while the remaining scores were empirically determined. T o illustrate the applicability of our scoring system, consider a subject who presents with an A X value of 10% in the ipsilateral arm relative to the contralateral arm and a F O R E value of 2 0 0 % in the ipsilateral arm relative to the contralateral arm. This subject essentially has a very small amount of radiopharmaceutical reaching the axilla and instead it  114  appears to be getting trapped in the forearm region. Using our empirically derived scoring system, the subject would receive 5/5 points for A X and 2/3 points for F O R E giving a total score of 7/8. It should be noted that both the scoring system developed by S z u b a and the one used in the present study have not been validated as tools for identifying breast cancer related lymphedema.  Applying our empirically derived scoring system to subjects in the present study shows the m e a n score during rest and exercise conditions in subjects with B C R L w a s 5.4 ±2.3 and 6.0 ±1.9, respectively, out of a total possible score of eight (Appendix D, Table D-14). T h e mean B C R L score minus one standard deviation (i.e., score of 3) w a s used to identify individuals who may be at risk for developing lymphedema. Using this criterion, all but one subject with B C R L (Subject #10) w a s correctly classified as having lymphedema at rest and all B C R L subjects were classified as having lymphedema during exercise. With rest and exercise, there were four B C subjects (rest: Subjects #20, #21, #27, #28; exercise: #17, #19, #20, #21) identified a s having a similar score to those with B C R L . However, only two were subjects identified both at rest and during exercise. Three C O N T subjects at rest (#34, #37, #38) and during exercise (Subject #37, #38, #41) were identified to be at risk for developing B C R L and two were the s a m e subjects. Again, not all C O N T subjects identified at rest were also identified during exercise.  Our modified scoring system may have clinical implications. Perhaps, B C subjects identified at rest and during exercise are in the early phases of developing B C R L and should be monitored closely (i.e., regular arm circumference measurements and regular physiotherapy specific to preventing B C R L ) . T h o s e C O N T subjects who were identified may have lymphatic pathologies that will remain latent until there is some disruption of the lymphatic system (i.e., due to breast cancer treatment). Although our modified scoring system did not correctly predict the s a m e subjects both at rest and during exercise to be at risk for developing lymphedema, this would not be unexpected. T h e variability in the rest condition may have incorrectly identified B C and C O N T subjects as resulted in false positives. Further, there may have been other subjects who were only identified with exercise because their lymphatic system was not able to respond to the demands of exercise. Additional research is needed to validate the use of this scoring system.  115  5.4.7  Limitations  Efforts were made to control extraneous variables that may influence lymphatic function. All subjects arrived at the testing location at the s a m e time of day and were asked to drink normal amounts of water in the three days prior. T h e y were also a s k e d to avoid caffeine and exercise during the day of measurement. However, other factors may also have an influence on lymphatic function s u c h a s medications, menopausal status (anecdotally, one control subject reported having a hot flash during the rest protocol and rest C R was similar to exercise C R ) , hypertension, and location of arm swelling in w o m e n with B C R L . A brief medical history w a s taken from each subject, but neither blood pressure nor hand swelling was recorded.  Not all subjects could complete the exercise bout at the prescribed load of 0.6 W kg" . This 1  included five B C R L subjects, one B C subject, and one C O N T subject. Intensity w a s dropped by 10-15 Watts when the subjects complained of volitional fatigue or when exercise heart rate reached 8 5 % of their age predicted maximum. Intensity was dropped to ensure the subject could complete the 60 minute intermittent, exercise protocol.  Another limitation of this study was the small number of subjects with B C R L who volunteered. W o m e n treated for breast cancer are told by health professionals to avoid repeated injections in the ipsilateral arm. A s this study involved two injections per hand on two separate occasions, this w a s a c a u s e for concern for many potential women treated for breast cancer (both B C a n d , particularly, B C R L ) . Often the only subjects with B C R L who volunteered were referred by their oncologist or were involved in previous studies conducted by our lab.  5.4.8  Conclusions  The main objectives of this study were: 1) to investigate whether contralateral lymphatic function in w o m e n treated for breast cancer with and without B C R L is equivalent to controls; 2) to examine lymphatic function relative to the contralateral arm between groups at rest and in response to exercise; and, 3) to determine if the lymphatic system can respond to a n exercise stimulus when lymphatic function has been compromised by breast cancer treatment.  W e found contralateral lymphatic function to be similar between groups; however, the ability of the lymphatic system to respond to an exercise stimulus by increasing A X and speeding A P P w a s impaired in the contralateral arm of those with B C R L . The inability of A X and A P P to  116  change with the addition of exercise may have been a result of the small sample of B C R L subjects or that systemic changes in lymphatic function due to the development of lymphedema resulted in an abnormal A X and A P P response to exercise.  Despite subjects with B C R L having similar clearance of  99m  T c - a n t i m o n y colloid from the hand  depot during exercise, we identified impairment to radiopharmaceuticals reaching ipsilateral axillary lymph nodes. Rather, we observed significantly greater activity in the forearm region of w o m e n with B C R L . Additionally, w e found that the number of axillary lymph nodes dissected (both when all w o m e n treated for breast cancer were included and when only breast c a n c e r patients who were treated with radiation therapy were included) was inversely related to A X , but had no relationship to C R . Axillary lymph node dissection and radiation therapy w a s not all that explained the significantly lower A X in B C R L compared to controls since subjects treated for breast cancer with similar numbers of axillary lymph nodes dissected had a large variation in AX.  Not all aspects of the lymphatic system appear to respond normally to an exercise stimulus in subjects with B C R L . Although ipsilateral C R and A P P improved from rest to exercise in B C R L , ipsilateral A X did not change and F O R E increased (a higher percentage of F O R E in the ipsilateral arm relative to the contralateral arm - i.e., a ratio greater than 1 0 0 % - is not a normal response and indicates dermal backflow).  In conclusion, B C R L is still a poorly understood complication of breast cancer treatment. A s shown in the present study, subjects with B C R L had, on average, a greater number of axillary lymph nodes dissected, more instances of radiation therapy to the axilla, and more c a s e s of overweight and obesity. Compression sleeves, intermittent pneumatic compression, manual lymphatic drainage, and low-level laser therapy are recommended as treatment options for B C R L . However, the majority of studies evaluating the efficacy of these treatment options have used measures of arm volume or circumference to indicate a change in lymphedema status. This study demonstrates the usefulness of a lymphatic stress test which combines moderate intensity upper body exercise with lymphoscintigraphy. The lower co-efficient of variation shown during exercise compared to rest m a k e s it a sensitive and useful clinical tool to investigate the efficacy of c o m m o n treatment modalities for B C R L . Furthermore, exercise has the potential to be a useful clinical tool in identifying breast cancer survivors at risk for developing lymphedema. Although identifying latent lymphatic pathologies with exercise was not a main objective of this  117  thesis, we modified a scoring system developed by S z u b a and colleagues (28) to complement the clinical expression of this disease. Further research is needed to develop a validated scoring system for identifying women treated for breast cancer at risk for developing lymphedema.  118  REFERENCES  Modi S , Stanton A W B , Mellor R H , Levick J R , Mortimer P S . Treatment for breast c a n c e r does not impair local lymph drainage in the epifascial and subfascial compartments of the ipsilateral arm. Microcirculation. 2004;11:547. Modi S , Stanton A W B , Mellor R H , Peters A M , Levick J R , Mortimer P S . Regional distribution of epifascial swelling and epifascial lymph drainage rate constants in breast cancer-related lymphedema. Lymphatic R e s e a r c h and Biology. 2005;3(1 ):3-15. Pain S J , Barber R W , Ballinger J R , Solanki C K , Mortimer P S , Purushotham A D , et al. Local vascular a c c e s s of radioprotein injected subcutaneously in healthy subjects and patients with breast cancer-related lymphedema. Journal of Nuclear Medicine. 2004;45(5):789-96. Pain S J , Barber R W , Ballinger J R , Solanki C K , Mortimer P S , Purushotham A D , et al. Tissue-to-blood transport of radiolabeled immunoglobulin injected into the web s p a c e s of the hands of normal subjects and patients with breast cancer-related lymphoedema. Journal of V a s c u l a r R e s e a r c h . 2004;41(2):183-92. Pain S J , Barber R W , Solanki C K , Ballinger J R , Britton T B , Mortimer P S , et al. Short-term effects of axillary lymph node clearance surgery on lymphatic physiology of the arm in breast cancer. Journal of Applied Physiology. 2005;99(6):2345-51. Pain S J , Nicholas R S , Barber R W , Ballinger J R , Purushotham A D , Mortimer P S , et al. Quantification of lymphatic function for investigation of lymphedema: depot clearance and rate of appearance of soluble macromolecules in blood. Journal of Nuclear Medicine. 2002;43(3):318-24. Pain S J , Purushotham A D , Barber R W , Ballinger J R , Solanki C K , Mortimer P S , et al. Variation in lymphatic function may predispose to development of breast cancer-related lymphoedema. European Journal of Surgical Oncology. 2004,30:508-14. Pain S J , Vowler S , Purushotham A D . Axillary vein abnormalities contribute to development of lymphoedema after surgery for breast cancer. British Journal of Surgery. 2005;92(3):311-5. Stanton A W , Mellor R H , C o o k G J , S v e n s s o n W E , Peters A M , Levick J R , et al. Impairment of lymph drainage in subfascial compartment of forearm in breast cancerrelated lymphedema. Lymphatic R e s e a r c h and Biology. 2003; 1(2): 121-32. Stanton A W , S v e n s s o n W E , Mellor R H , Peters A M , Levick J R , Mortimer P S . Differences in lymph drainage between swollen and non-swollen regions in arms with breast-cancerrelated lymphoedema. Clinical Science. 2001;101(2):131-40. Stanton A W B , Modi S , Mellor R H , Peters A M , S v e n s s o n W E , Levick J R , et al. A quantitative lymphoscintigraphic evaluation of lymphatic function in the swollen hands of women with lymphoedema following breast cancer treatment. Clinical S c i e n c e . 2006;110(5):553-61.  119  12.  Stanton A W B , S v e n s s o n W E , Mellor R H , Peters A M , Mortimer P S , Levick J R . Apparent relation between ipsilateral hand swelling a n d contralateral hand lymph drainage in breast cancer related lymphoedema ( B C R L ) . Journal of V a s c u l a r R e s e a r c h . 2002;39(Suppl. 1):75.  13.  O z a s l a n C , Kuru B. L y m p h e d e m a after treatment of breast cancer. T h e American Journal of Surgery. 2004;187(1):69-72.  14.  Hinrichs C S , Watroba NL, Rezaishiraz H, G i e s e W , Hurd T, F a s s l K A , et al. L y m p h e d e m a secondary to postmastectomy radiation: incidence and risk factors. Annals of Surgical Oncology. 2004;11(6):573-80.  15.  M a n s e l R E , Fallowfield L, Kissin M, G o y a l A , Newcombe R G , Dixon J M , et al. R a n d o m i z e d multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the A L M A N A C Trial. Journal of the National C a n c e r Institute. 2006;98(9):599-609.  16.  Petrek J A , S e n i e R T , Peters M, R o s e n P P . L y m p h e d e m a in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer. 2001 ;92(6):1368-77.  17.  Erickson V S , Pearson M L , G a n z P A , A d a m s J , Kahn K L . Arm e d e m a in breast cancer patients. Journal of the National C a n c e r Institute. 2001 ;93(2):96-111.  18.  Bertelli G , Venturini M, Forno G , Macchiavello F, Dini D. Conservative treatment of postmastectomy lymphedema: a controlled, randomized trial. A n n a l s of Oncology. 1991;2(8):575-8.  19.  Collins C D , Mortimer P S , D'Ettorre H, A'Hern R P , Moskovic E C . C o m p u t e d tomography in the a s s e s s m e n t of response to limb compression in unilateral lymphoedema. Clinical Radiology. 1995;50(8):541-4.  20.  Harris S R , Hugi M R , Olivotto IA, Levine M, Steering Committee for Clinical Practice Guidelines for the C , Treatment of Breast C . Clinical practice guidelines for the care and treatment of breast cancer: 11. Lymphedema. C a n a d i a n Medical Association Journal. 2001;164(2):191-9.  21.  Dini D, Del Mastro L, G o z z a A , Lionetto R, Garrone O, Forno G , et al. The role of pneumatic compression in the treatment of postmastectomy lymphedema. A randomized phase III study. Annals of Oncology. 1998;9(2):187-90.  22.  Kim-Sing C , B a s c o V E . Postmastectomy lymphedema treated with the Wright linear pump. C a n a d i a n Journal of Surgery. 1987;30(5):368-70.  23.  Klein M J , Alexander M A , Wright J M , R e d m o n d C K , L e G a s s e A A . Treatment of adult lower extremity lymphedema with the Wright linear pump: statistical analysis of a clinical trial. Archives of Physical Medicine and Rehabilitation. 1988;69(3 Pt 1):202-6.  24.  P a p p a s C J , O'Donnell T F , Jr. Long-term results of compression treatment for lymphedema. Journal of Vascular Surgery. 1992;16(4):555-62.  120  25.  R o c k s o n S G . Addressing the unmet needs in lymphedema risk management. Lymphatic R e s e a r c h and Biology. 2006;4(1 ):42-6.  26.  A n d e r s e n L, Hojris I, Erlandsen M, A n d e r s e n J . Treatment of breast-cancer-related lymphedema with or without manual lymphatic d r a i n a g e - a randomized study. A c t a Oncologica. 2000;39(3):399-405.  27.  Kligman L, W o n g R K , Johnston M, Laetsch N S . The treatment of lymphedema related to breast cancer: a systematic review and evidence summary. Supportive C a r e in C a n c e r . 2004;12(6):421-31.  28.  S z u b a A , Strauss W , Sirsikar S P , R o c k s o n S G . Quantitative radionuclide lymphoscintigraphy predicts outcome of manual lymphatic therapy in breast cancerrelated lymphedema of the upper extremity. Nuclear Medicine Communications. 2002;23(12):1171-5.  29.  Wilburn O , Wilburn P, R o c k s o n S G . A pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema. B M C C a n c e r . 2006;6:84.  30.  Williams A F , V a d g a m a A , Franks P J , Mortimer P S . A randomized controlled crossover study of manual lymphatic drainage therapy in women with breast cancer-related lymphoedema. European Journal of C a n c e r C a r e . 2002;11(4):254-61.  31.  Carati C J , A n d e r s o n S N , G a n n o n B J , Piller N B . Treatment of postmastectomy lymphedema with low-level laser therapy: a double blind, placebo-controlled trial. C a n c e r . 2003;98(6):1114-22.  32.  Piller N B , Thelander A . Treatment of chronic postmastectomy lymphedema with low level laser therapy: a 2.5 year follow-up. Lymphology. 1998;31(2):74-86.  33.  Harris S R , Niesen-Vertommen S L . Challenging the myth of exercise-induced lymphedema following breast cancer: a series of c a s e reports. Journal of Surgical Oncology - Supplement. 2000;74(2):95-8.  34.  M c K e n z i e D C , Kalda A L . Effect of upper extremity exercise on secondary lymphedema in breast cancer patients: a pilot study. Journal of Clinical Oncology. 2003;21 (3):463-6.  35.  Turner J , Hayes S , Reul-Hirche H. Improving the physical status and quality of life of women treated for breast cancer: a pilot study of a structured exercise intervention. Journal of Surgical Oncology. 2004;86(3):141-6.  36.  C h e e m a B S B , G a u l C A . Full-body exercise training improves fitness and quality of life in survivors of breast cancer. Journal of Strength & Conditioning R e s e a r c h . 2006;20(1):1421.  37.  A h m e d R L , T h o m a s W , Y e e D, Schmitz K H . R a n d o m i z e d controlled trial of weight training and lymphedema in breast cancer survivors. Journal of Clinical Oncology. 2006;24(18):2765-72.  121  38.  J o h a n s s o n K, Tibe K, Weibull A , Newton R C . Low intensity resistance exercise for breast cancer patients with arm lymphedema with or without compression sleeve. Lymphology. 2005;38(4):167-80.  39.  Lane K, J e s p e r s e n D, M c K e n z i e D C . The effect of a whole body exercise program and dragon boat training on arm volume and arm circumference in breast cancer survivors. European Journal of C a n c e r Care. 2005;14:353-8.  40.  A b e T, D e H o y o s DV, Pollock M, Garzarella L. Time course for strength and muscle thickness changes following upper a n d lower body resistance training in men and w o m e n . European Journal of Applied Physiology and Occupational Physiology. 2000;81:174-80.  41.  Krasnow A Z , Hellman R S . Lymphoscintigraphy revisited: 1999. Nuclear Medicine Annual. Philadelphia: Lippincott, Williams & Wilkins; 1999. p. 17-97.  42.  S z u b a A , Shin W S , Strauss H W , R o c k s o n S . T h e third circulation: Radionuclide . lymphoscintigraphy in the evaluation of lymphedema. Journal of Nuclear Medicine. 2003;44:43-57.  43.  Witte C L , Witte M H , Unger E C , Williams W H , Bernas M J , McNeill G C , et al. A d v a n c e s in imaging of lymph flow disorders. Radiographics. 2000;20(6):1697-719.  44.  Pain S J , Barber R W , Ballinger J R , Solanki C K , O'Mahony S O , Mortimer P S , et al. Sideto-side symmetry of radioprotein transfer from tissue s p a c e to systemic vasculature following subcutaneous injection in normal subjects and subjects with breast cancer. European Journal of Nuclear Medicine and Molecular Imaging. 2003;30(5):657-61.  45.  Williams W H , Witte C L , Witte M H , McNeill G C . Radionuclide lymphangioscintigraphy in the evaluation of peripheral lymphedema. Clinical Nuclear Medicine. 2000;25(6):451-64.  46.  S z u b a A, Strauss W , Sirsikar S , R o c k s o n S G . Quantitative radionuclide lymphoscintigraphy predicts outcome of manual lymphatic therapy in breast cancerrelated lymphedema of the upper extremity. Nuclear Medicine Communications. 2002;23:1171-5.  47.  Lane K, Worsley D, M c K e n z i e D. Lymphoscintigraphy to evaluate the effects of upper body dynamic exercise and handgrip exercise on radiopharmaceutical clearance from the hands of healthy females. Lymphatic R e s e a r c h & Biology. 2005;3(1):16-24.  48.  Lane K, Dolan L, Worsley D, M c K e n z i e D. Lymphoscintigraphy to evaluate the effects of high intensity versus low intensity arm cranking exercise on clearance rates in healthy females. Lymphatic R e s e a r c h and Biology. 2006;4(3):159-65.  49.  Aukland K, R e e d R K . Interstitial-lymphatic mechanisms in the control of extracellular fluid volume. Physiological Reviews. 1993;73(1):1-78.  50.  Bourgeois P, Leduc O, Leduc A . Imaging techniques in the management and prevention of posttherapeutic upper limb edemas. C a n c e r . 1998;83:2805-13.  122  51.  Mortimer P S . Evaluation of lymphatic function: abnormal lymph drainage in venous d i s e a s e . International Angiology. 1995;14:32-5.  52.  Y u d d A P , Kempf J S , G o y d o s J S , Stahl T J , Feinstein R S . U s e of sentinel node lymphoscintigraphy in malignant melanoma. Radiographics. 1999;19:343-53.  53.  Goffman T E , Laronga C , Wilson L, Elkins D. L y m p h e d e m a of the arm and breast in irradiated breast cancer patients: risks in an era of dramatically changing axillary surgery. Breast Journal. 2004;10(5):405-11.  54.  Pain S J , Purushotham A D . Lymphoedema following surgery for breast cancer. British Journal of Surgery. 2000;87(9):1128-41.  55.  van der V e e n P, De Voogdt N, Lievens P, Duquet W , Lamote J , S a c r e R. L y m p h e d e m a development following breast cancer surgery with full axillary resection. Lymphology. 2004;37(4):206-8.  56.  Williams A F , Franks P J , Moffatt C J . L y m p h o e d e m a : estimating the size of the problem. Palliative Medicine. 2005;19(4):300-13.  57.  Y o o n Y , M u r a y a m a T, Gravereaux E, Tkebuchava T, Silver M, Curry C , et al. V E G F - C therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. Journal of Clinical Investigation. 2003;111 (5):717-25.  58.  Gustafsson T, A m e l n H, Fischer H, Sundberg C , Timmons J , J a n s s o n E. V E G F - A splice variants and related receptor expression in human skeletal muscle following submaximal exercise. Journal of Applied Physiology. 2005;98(6):2137-46.  59.  Threefoot S A . The clinical siginifcance of lymphaticovenous communications. Annals of Internal Medicine. 1970;72(6):957-8.  60.  Threefoot S , K o s s o v e r M F , Aiken D W . Radioisotopic detection of lymphaticovenous communications in living animals. Journal of Laboratory and Clinical Medicine. 1965;65:688-97.  61.  C a m p i s i C , Boccardo F. Microsurgical techniques for lymphedema treatment: derivative lymphatic-venous microsurgery. World Journal of Surgery. 2004;28(6):609-13.  62.  Kubik S . The role of the lateral upper arm bundle and the lymphatic watersheds in the formation of collateral pathways in lymphedema. A c t a Biologica. 1980;31(1-3):191-200.  63.  A r m e r J M , Stewart B R . A comparison of four diagnostic criteria for lymphedema in a post-breast cancer population. Lymphatic R e s e a r c h and Biology. 2005;3(4):208-17.  123  C H A P T E R SIX  General S u m m a r y and C o n c l u s i o n s  Approximately 2 8 % of women treated for breast cancer are at risk for developing breast cancer related lymphedema ( B C R L ) yet it remains a poorly understood complication of this d i s e a s e . Treatment variables commonly associated with increased risk (mastectomy, extent of axillary surgery, axillary radiotherapy, radiotherapy to the breast, nodal d i s e a s e status), do not, on their own, accurately distinguish the at risk population (1). Furthermore, little is known about how to manage B C R L . Although compression sleeves (2, 3), pneumatic pumping (4-7), manual lymphatic drainage (8-11), and low-level laser therapy (12,13) are often recommended to contain swelling, research investigating their efficacy is often limited by the use of anthropometric measurements, such as arm volume and arm circumference, to reflect a change in lymphedema status. While anthropometric measurements are simple and non-invasive, they do not provide information on c h a n g e s in the physiology of the lymphatic system. It is possible that studies showing no change in arm volume with a therapeutic intervention have, in fact, m a d e positive adaptations to the lymphatic system not reflected in an arm volume measurement. Considering that most interventions are either acute or relatively short in duration (i.e., 4 - 1 2 weeks), adaptations to the lymphatic system may precede changes in arm swelling unless the intervention is continued over a long duration. Consequently, there is a need for a better clinical tool to evaluate the effectiveness of various therapeutic interventions prescribed for B C R L .  Lymphoscintigraphy has added another dimension to the evaluation of lymphatic function. This technique w a s developed to a s s e s s lymphatic status in patients with a variety of conditions that c a u s e lymphatic obstruction (14, 15).  Lymphoscintigraphy is being used increasingly in the  investigation of the pathology of B C R L (16-27) and in the examination of various therapeutic interventions prescribed to manage B C R L (9, 28-31). While these studies provide s o m e new insight into the pathophysiology of B C R L and potentially useful therapeutic interventions, they are limited in the application of the lymphoscintigraphy protocol. Specifically, lymphoscintigraphy is usually performed at rest and when exercise is used to stimulate lymph flow, subjects perform intermittent forearm exercise between imaging s c a n s , such a s clenching the fists or squeezing a rubber ball (20, 2 1 , 24-26, 32, 33). While exercise can facilitate lymph clearance of the radiopharmaceutical from the injection depot and help to reduce variability in data, the intensity and duration of the exercise protocol must be precisely quantified. Otherwise the effort, or work, will differ among subjects or between conditions and compromise the  124  research design. Currently, a clinical test involving a standardized exercise protocol combined with lymphoscintigraphy that will provide information on lymphatic function of the upper extremity in w o m e n with B C R L does not exist. Therefore, the purpose of this thesis w a s to design a lymphatic stress test that could be used to measure lymphatic function in w o m e n treated for breast cancer with and without B C R L . Initial studies were performed on healthy, college-aged females in order to determine a suitable exercise protocol and to appreciate a normal response of the lymphatic system to exercise.  The purpose of the first study (Chapter 2) w a s to evaluate the effects of arm crank ergometry and handgrip contractions on radiopharmaceutical clearance from the hands of six healthy females. O n separate days, subjects performed arm cranking (6 repeated bouts of arm cranking for 5 minutes at 0.6 W k g " followed by 5 minutes rest) or handgrip exercise (12 repeated bouts 1  of 75 contractions in 2.5 minutes at 5 0 % M V C followed by 2.5 minutes of rest). The handgrip protocol w a s done with the right hand only while the left hand served a s a control. Prior to the start of exercise,  99m  T c - a n t i m o n y colloid w a s injected into the first and fourth finger-web of e a c h  hand and one minute spot views were taken immediately after the injection and every 10 minutes thereafter over 60 minutes. C l e a r a n c e from the injection sites w a s linear and expressed as a slope (% administered activitymin' ). Significantly faster clearance w a s 1  observed with arm cranking (rt = -0.27 ± 0.03 % m i n " ; left = -0.29 ± 0.06 %min" ) compared to 1  1  both handgrip (-0.18 ± 0.03 % m i n ' ) and the control condition (-0.14 ± 0.05 % m i n " ; p < 0.000). 1  1  The results of this study indicated that arm cranking was more effective in promoting lymphatic clearance from the hand and may be a useful protocol to challenge the lymphatic system in breast cancer survivors.  Although the first study demonstrated that arm cranking was superior to intermittent handgrip exercise in promoting lymphatic clearance from the hand, it w a s not clear if changing exercise intensity would have an appreciable effect on lymphatic function. Thus, the purpose of the s e c o n d study (Chapter 3) w a s to determine the effect of low versus high intensity upper body exercise on lymphatic function in healthy females. O n separate days, eight females performed either high intensity arm cranking (12 repeated sets of arm cranking for 2.5 minutes at 0.6 W k g " 1  followed by 2.5 minutes of rest) or low intensity arm cranking (12 repeated sets of arm  cranking for 2.5 minutes at 0.3 W k g ' followed by 2.5 minutes of rest). T h e s a m e 1  lymphoscintigraphy protocol described in the first study was used for this project except one additional outcome variable, radiopharmaceutical uptake in the axillary regions (AX) at 65 min  125  post-injection, w a s also measured. High intensity arm cranking exercise resulted in significantly greater C R (-0.24%'min" ±0.06) than did low intensity exercise (-0.19%min' ±0.05; p=0.003). 1  1  A similar trend w a s s e e n in A X (high intensity protocol: 6 . 3 % ±1.6 versus low intensity protocol: 4.8% ± 1 . 1 , p=0.004). T h e results of the second study indicated that an arm cranking protocol of higher intensity is more effective in promoting both lymphatic clearance from the hand and radiopharmaceutical uptake at the axillary lymph nodes. Furthermore, A X appeared to be a useful outcome variable in the a s s e s s m e n t of lymphatic function. The high intensity protocol was selected to be used as the lymphatic stress test.  Before applying the lymphatic stress test to breast cancer survivors with and without B C R L , another study using healthy females w a s needed for two reasons - to determine reliability of the lymphatic stress test and to establish if symmetry in lymphatic function between upper extremities occurs while performing the standardized exercise protocol. Thus, the purpose of the third study (Chapter 4) w a s to determine the reliability of the lymphatic stress test and to evaluate if lymphatic function is similar between the arms. The lymphatic stress test protocol was as described in the preceding paragraph. Symmetry was s e e n in both C R (y=0.95x-0.02; r=0.83; p<0.001; n=21)and A X (y=0.90x+0.56; r=0.81; p=0.001; n=12). Additionally, the lymphatic stress test was shown to be reliable (r=0.94, n = 7). T h e results of this study indicated that the lymphatic stress test is reliable and lymphatic function a s measured by C R and A X is similar between arms during exercise. Thus, when investigating the effect of exercise on lymphatic function in women with breast cancer related lymphedema the affected arm can be expressed relative to the normal arm.  A s a result of the initial pilot work, an intermittent, moderate intensity arm cranking protocol w a s selected to investigate lymphatic function in women treated for breast cancer with B C R L ( B C R L , n=10), breast cancer survivors with no B C R L ( B C , n=22), and age-matched controls ( C O N T , n=17). This exploratory study (Chapter 5) w a s the first to investigate the response of the lymphatic system to exercise in women treated for breast cancer with and without B C R L using a standardized exercise test. Three main questions were identified: 1) Is contralateral lymphatic function in women treated for breast cancer with and without B C R L equivalent to controls, 2) Is lymphatic function in the ipsilateral arm relative to the contralateral arm (assuming the contralateral arm is normal) different between groups in response to exercise, and 3) C a n the lymphatic system respond to an exercise stimulus if lymphatic function has been compromised by breast cancer treatment? Originally, the primary outcome measure w a s C R a s used by  126  Stanton et al. (23) and the secondary outcome measure was A X a s used by S z u b a et al. (33). Early in data collection, radiopharmaceutical uptake in the forearm region relative to the initial dose ( F O R E ) and time of first radiopharmaceutical appearance at the axilla ( A P P ) were added as secondary outcome measures.  Overall, this study revealed the following: 1) contralateral lymphatic function is similar between groups, 2) B C R L have similar clearance to B C and C O N T of  9 9 m  T c antimony colloid from the  hand depot during exercise; however, the amount stored in ipsilateral axillary lymph nodes relative to the contralateral side is impaired and the radiopharmaceuticals get trapped in the forearm, 3) on average, B C demonstrated a normal response to exercise (faster C R , greater A X , no change in F O R E , and faster A P P ) yet in B C R L only C R and A P P improved from rest to exercise (AX did not change and F O R E increased), 4) breast cancer survivors have similar lymphatic function a s C O N T ; however, there is a highly variable response which may suggest that s o m e B C subjects may be at risk for developing lymphedema, and 5) the coefficient of variation w a s lower with exercise compared to rest.  There were several limitations to these studies. W e chose to use a relative exercise load (based on body weight) rather than using an absolute intensity. A s a result, several subjects (primarily those with B C R L ) could not complete the prescribed intensity. Relative exercise loads based on body m a s s are generally used in exercise physiology because those with a greater m a s s usually also have more lean muscle tissue. However, when the greater body m a s s is in the form of adipose tissue, then an exercise load based on body weight may not be appropriate. It would have been desirable to use a relative load based on a percentage of maximal aerobic power or maximal heart rate, but this would have necessitated the subjects performing an upper body maximal exercise test on a separate day. For future studies, if 0.6 W a t t s k g " cannot be 1  tolerated, then 0.3 W a t t s k g " can be used. Our previous work in healthy, college-aged females 1  has demonstrated that 0.3 Watts kg" results in C R that are still greater than rest (34). Hand 1  volume should be measured to ensure this potential confounding variable is controlled in data analyses. Markers should be used to identify the wrist, elbow, and axilla to allow for exact regions of interest around the forearm. This would also allow the upper arm segment to be evaluated. Although we consider A X and A P P as appropriate outcome measures to a s s e s s the efficacy of the lymphatic drainage system, there are limitations to these measures. For example, lymph node retention of tracer in axillary lymph nodes is only a 'snapshot' of the amount of tracer present in the axillary lymph nodes at any one time. Another limitation is that  127  breast cancer treatment often requires lymph node excision and/or radiation therapy, which reduces the number of functional nodes on the treated (ipsilateral) side. Consequently, dual isotope lymphoscintigraphy should be considered to measure the efficacy of the lymphatic drainage system. However, dual isotope lymphoscintigraphy requires additional injections for blood sampling; moreover, it still a s s u m e s (as with any lymphoscintigraphy protocol) that the majority of particulate administered reaches mixed venous blood via the lymphatic system.  There are several directions for future research that stem from the findings of this thesis. First, exercise has the potential to be a useful clinical tool in identifying breast cancer survivors at risk for developing lymphedema similar to the way exercise is used by the cardiologist or respirologist. Further research is needed to develop a validated scoring system for identifying women treated for breast cancer at risk for developing lymphedema. W e modified a scoring system empirically developed by S z u b a et al. (33) and identified several B C and C O N T subjects with scores similar to the B C R L group. W o m e n diagnosed with breast cancer should be evaluated longitudinally using our exercise protocol combined with lymphoscintigraphy. For example, measuring lymphatic function in breast cancer patients before treatment (i.e., axillary lymph node dissection and/or radiation therapy), after treatment, and thereafter at six month intervals over several.years would determine the ability of our scoring system to predict development of lymphedema. S e c o n d , the efficacy of various treatment options recommended for B C R L should be re-evaluated using our lymphatic stress test. A s we have demonstrated, our lymphatic stress test reduced variability in data; thus, there is improved power to detect changes in lymphatic function due to an intervention. Third, regular upper body exercise should be investigated to determine if it can lead to adaptations in the lymphatic system.  128  6.1  REFERENCES  1.  R o c k s o n S G . Precipitating factors in lymphedema: myths and realities. Cancer. 1998;83:2814-16.  2.  Bertelli G , Venturini M, Forno G , Macchiavello F, Dini D. Conservative treatment of postmastectomy lymphedema: a controlled, randomized trial.[see comment]. A n n a l s of Oncology. 1991;2(8):575-8.  3.  Collins C D , Mortimer P S , D'Ettorre H, A'Hern R P , Moskovic E C . Computed tomography in the a s s e s s m e n t of response to limb compression in unilateral lymphoedema. Clinical Radiology. 1995;50(8):541-4.  4.  Dini D, Del Mastro L, G o z z a A , Lionetto R, Garrone O, Forno G , et al. T h e role of pneumatic compression in the treatment of postmastectomy lymphedema. A randomized phase III study. Annals of Oncology. 1998;9(2):187-90.  5.  Kim-Sing C , B a s c o V E . Postmastectomy lymphedema treated with the Wright linear pump. C a n a d i a n Journal of Surgery. 1987;30(5):368-70.  6.  Klein M J , Alexander M A , Wright J M , R e d m o n d C K , L e G a s s e A A . Treatment of adult lower extremity lymphedema with the Wright linear pump: statistical analysis of a clinical trial. Archives of Physical Medicine & Rehabilitation. 1988;69(3 Pt 1):202-6.  7.  P a p p a s C J , O'Donnell T F , Jr. Long-term results of compression treatment for lymphedema. Journal of Vascular Surgery. 1992;16(4):555-62.  8.  A n d e r s e n L, Hojris I, Erlandsen M, A n d e r s e n J . Treatment of breast-cancer-related lymphedema with or without manual lymphatic d r a i n a g e - a randomized study. Acta Oncologica. 2000;39(3):399-405.  9.  S z u b a A , Strauss W , Sirsikar S P , R o c k s o n S G . Quantitative radionuclide lymphoscintigraphy predicts outcome of manual lymphatic therapy in breast cancerrelated lymphedema of the upper extremity. Nuclear Medicine Communications. 2002;23(12):1171-5.  10.  Wilburn O, Wilburn P, R o c k s o n S G . A pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema. B M C C a n c e r . 2006;6:84.  11.  Williams A F , V a d g a m a A , Franks P J , Mortimer P S . A randomized controlled crossover study of manual lymphatic drainage therapy in women with breast cancer-related lymphoedema. European Journal of C a n c e r C a r e . 2002;11 (4):254-61.  12.  Carati C J , Anderson S N , G a n n o n B J , Piller N B . Treatment of postmastectomy lymphedema with low-level laser therapy: a double blind, placebo-controlled trial. C a n c e r . 2003;98(6):1114-22.  13.  Piller N B , Thelander A . Treatment of chronic postmastectomy lymphedema with low level laser therapy: a 2.5 year follow-up. Lymphology. 1998;31(2):74-86. 129  14.  Krasnow A Z , Hellman R S . Lymphoscintigraphy revisited: 1999. Nuclear Medicine Annual. Philadelphia: Lippincott, Williams & Wilkins; 1999. p. 17-97.  15.  Witte C L , Witte M H , Unger E C , Williams W H , Bernas M J , McNeill G C , et al. A d v a n c e s in imaging of lymph flow disorders. Radiographics. 2000;20(6): 1697-719.  16.  Stanton A W B , Modi S , Mellor R H , Peters A M , S v e n s s o n W E , Levick J R , et al. A quantitative lymphoscintigraphic evaluation of lymphatic function in the swollen hands of women with lymphoedema following breast cancer treatment. Clinical S c i e n c e . 2006;110(5):553-61.  17.  Pain S J , Vowler S , Purushotham A D . Axillary vein abnormalities contribute to development of lymphoedema after surgery for breast cancer. British Journal of Surgery. 2005;92(3):311-5.  18.  Pain S J , Barber R W , Solanki C K , Ballinger J R , Britton T B , Mortimer P S , et al. Short-term effects of axillary lymph node clearance surgery on lymphatic physiology of the arm in breast cancer. Journal of Applied Physiology. 2005;99(6):2345-51.  19.  Modi S , Stanton A W B , Mellor R H , Peters A M , Levick J R , Mortimer P S . Regional distribution of epifascial swelling and epifascial lymph drainage rate constants in breast cancer-related lymphedema. Lymphatic R e s e a r c h & Biology. 2005;3(1 ):3-15.  20.  Pain S J , Purushotham A D , Barber R W , Ballinger J R , Solanki C K , Mortimer P S , et al. Variation in lymphatic function may predispose to development of breast cancer-related lymphoedema. European Journal of Surgical Oncology. 2004;30:508-14.  21.  Pain S J , Barber R W , Ballinger J R , Solanki C K , Mortimer P S , Purushotham A D , et al. Tissue-to-blood transport of radiolabeled immunoglobulin injected into the web s p a c e s of the hands of normal subjects and patients with breast cancer-related lymphoedema. Journal of V a s c u l a r R e s e a r c h . 2004;41(2):183-92.  22.  Pain S J , Barber R W , Ballinger J R , Solanki C K , Mortimer P S , Purushotham A D , et al. Local vascular a c c e s s of radioprotein injected subcutaneously in healthy subjects and patients with breast cancer-related lymphedema. Journal of Nuclear Medicine. 2004;45(5):789-96.  23.  Stanton A W , Mellor R H , C o o k G J , S v e n s s o n W E , Peters A M , Levick J R , et al. Impairment of lymph drainage in subfascial compartment of forearm in breast cancerrelated lymphedema. Lymphatic Research and Biology. 2003;1(2):121-32.  24.  Pain S J , Barber R W , Ballinger J R , Solanki C K , O'Mahony S O , Mortimer P S , et al. S i d e to-side symmetry of radioprotein transfer from tissue s p a c e to systemic vasculature following subcutaneous injection in normal subjects and subjects with breast cancer. European Journal of Nuclear Medicine and Molecular Imaging. 2003;30(5):657-61.  25.  Pain S J , Nicholas R S , Barber R W , Ballinger J R , Purushotham A D , Mortimer P S , et al. Quantification of lymphatic function for investigation of lymphedema: depot clearance and rate of appearance of soluble macromolecules in blood. Journal of Nuclear Medicine. 2002;43(3):318-24.  130  26.  Stanton A W , S v e n s s o n W E , Mellor R H , Peters A M , Levick J R , Mortimer P S . Differences in lymph drainage between swollen and non-swollen regions in arms with breast-cancerrelated lymphoedema.[comment]. Clinical Science. 2001;101(2):131-40.  27.  S v e n s s o n W , G l a s s D M , Bradley D, Peters A M . Measurement of lymphatic function with technetium-99m-labelled polyclonal immunoglobulin. European Journal of Nuclear Medicine. 1999;26(5):504-10.  28.  Gothard L, Stanton A , M a c L a r e n J , Lawrence D, Hall E, Mortimer P, et al. N o n randomised phase II trial of hyperbaric oxygen therapy in patients with chronic arm lymphoedema and tissue fibrosis after radiotherapy for early breast cancer. Radiotherapy & Oncology. 2004;70(3):217-24.  29.  de G o d o y J M , Batigalia F, Godoy M d e F. Preliminary evaluation of a new, more simplified physiotherapy technique for lymphatic drainage. Lymphology. 2002;35(2):91-3.  30.  Miranda F, Jr., P e r e z M C , Castiglioni M L , Juliano Y , Amorim J E , Nakano L C , et al. Effect of sequential intermittent pneumatic compression on both leg lymphedema volume and on lymph transport as semi-quantitatively evaluated by lymphoscintigraphy. Lymphology. 2001 ;34(3): 135-41.  31.  Hwang J H , Kwon J Y , L e e K W , Choi J Y , Kim BT, L e e B B , et al. C h a n g e s in lymphatic function after complex physical therapy for lymphedema. Lymphology. 1999;32(1):15-21.  32.  Williams W H , Witte C L , Witte M H , McNeill G C . Radionuclide lymphangioscintigraphy in the evaluation of peripheral lymphedema. Clinical Nuclear Medicine. 2000;25(6):451-64.  33.  S z u b a A , Strauss W , Sirsikar S , R o c k s o n S G . Quantitative radionuclide lymphoscintigraphy predicts outcome of manual lymphatic therapy in breast cancerrelated lymphedema of the upper extremity. Nuclear Medicine Communications. 2002;23:1171-5.  34.  Lane K, Worsley D, M c K e n z i e D. Lymphoscintigraphy to evaluate the effects of upper body dynamic exercise and handgrip exercise on radiopharmaceutical clearance from the hands of healthy females. Lymphatic R e s e a r c h and Biology. 2005;3(1):16-24.  131  C H A P T E R EIGHT  Appendices  A P P E N D I X A . INDIVIDUAL D A T A F R O M C H A P T E R T W O  T a b l e A-1  Individual descriptive data  Subject  Weight (kg) 41.7 56.7 56.7 63.3 61.7 56.7 60.0 56.7  1 2 3 4 5 6 7 8  T a b l e A-2 Subject  Dominant A r m right right right left right right right right  Individual clearance rate data. A r m Cranking Right A r m (%min~ ) -0.24 -0.26 -0.44 -0.31 -0.30 -0.25 -0.25 -0.27 1  1 2 3 4 5 6 7 8  MVC (kg) 30 30 30 30 36 33 30 33  Arm Cranking Left A r m (%-min- ) -0.26 -0.26 -0.35 -0.38 -0.34 -0.19 -0.31 -0.28 1  Hand Grip Right A r m (%-min' ) -0.11 -0.19 -0.16 -0.17 -0.21 -0.15 -0.09 -0.09 1  132  Control Left A r m (%min- ) -0.06 -0.15 -0.15 -0.14 -0.19 -0.13 -0.13 -0.17 1  A P P E N D I X B. INDIVIDUAL D A T A F R O M C H A P T E R T H R E E  T a b l e B-1  Age  Weight  Height  1 2  (yr) 28 31  (kg) 45.0 55.0  (cm) 162 165  Body M a s s Index (kgm ) 17.1 20.2  3  24  64.0  183  19.1  4  30  63.0  rt  29  50.5  165 164  23.1  5  18.8  rt  6 7  25 25 26  62.0 76.5  167 183 164  22.2 22.8 22.9  rt rt rt  8  T a b l e B-2  1 2 3 4 5 6 7 8  Individual descriptive data.  61.5  Dominant Arm  2  rt  rt rt  Individual data for clearance rate (CR), axillary uptake (AX), and heart rate during the high and low intensity arm cranking conditions. CR-high -0.207 -0.199 -0.195 -0.180 -0.183 -0.302 -0.291 -0.325  CR-low -0.172 -0.134 -0.163 -0.184 -0.141 -0.207 -0.250 -0.279  AX-high 7.13 4.84 4.45 4.93 5.73 9.10 7.41 7.07  133  AX-low 5.50 3.74 4.28 3.53 3.58 5.58 5.95 6.32  HR-high 127 101 111 117 103 120 124  HR-low 102 95 83 94 99 77 92 108  A P P E N D I X C . INDIVIDUAL D A T A F R O M C H A P T E R F O U R  T a b l e C-1 Subject 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21  Individual descriptive data. Age (yr) 27.0 30.0 24.0 29.0 29.0 24.0 25.0 33.0 34.0 24.0 23.0 28.0 25.0 24.0 24.0 24.0 24.0 22.0 22.0 24.0 24.0  Weight (kg) 41.7 56.7 64.0 56.7 50.5 63.5 91.5 77.0 78.0 73.3 66.7 78.3 75.5 63.5 70.0 59.0 70.0 57.0 59.0 76.5 51.0  Height (cm) 160.0 165.0 183.0 165.0 164.0 169.0 188.0 188.0 178.0 181.0 182.0 183.0 181.9 169.0 175.0 162.0 170.2 168.5 161.5 178.0 162.0  134  BMI (kgm ) 16.3 20.8 19.1 20.8 18.8 22.2 25.9 21.8 24.6 22.4 20.1 23.4 22.8 22.2 22.9 22.5 24.2 20.1 22.6 24.1 19.4 2  Dominant Arm right right right right right right left right right right right right right right right right right right right right right  T a b l e C-2  Subject  Individual clearance rate ( C R ) and axillary uptake (AX) data for the right and left upper extremities. CR-right (%-mm ) -0.192 -0.176 -0.238 -0.161 -0.184 -0.297 -0.184 -0.222 -0.199 -0.312 -0.269 -0.151 -0.139 -0.107 -0.030 -0.103 -0.182 -0.265 -0.118 -0.246 -0.123 1  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21  CR-left (%min" ) -0.222 -0.221 -0.152 -0.198 -0.182 -0.306 -0.125 -0.253 -0.134 -0.370 -0.266 -0.151 -0.145 -0.122 -0.056 -0.071 -0.296 -0.267 -0.167 -0.237 -0.130 1  135  AX-right  AX-left  (%) 5.56 4.42 5.15 5.10 5.99 9.32 1.86 2.50 2.16 4.99 6.71 1.56  (%) 8.70 5.27 3.74 4.77 5.47 8.88 0.96 3.24 1.69 7.08 4.50 2.49  A P P E N D I X D. INDIVIDUAL D A T A F R O M C H A P T E R F I V E  T a b l e D-1 Subject  Individual clearance rate data for breast cancer related lymphedema subjects. Rest Ipsilat.  Rest Contralat.  Exercise Ipsilat.  Exercise Contralat.  (%-min- ) -0.039  (%min" ) -0.092  -0.048 -0.134 -0.085 -0.123 -0.141 -0.097 -0.082  -0.068 -0.121 -0.121 -0.142 -0.260 -0.086 -0.053  (%min" ) -0.093 -0.267 -0.340 -0.090 -0.135 -0.211 -0.219 -0.265 -0.208 -0.142  (%min" ) -0.167 -0.306 -0.176 -0.073 -0.173 -0.268 -0.216 -0.264 -0.141 -0.117  1  1 2 3 4 5 6 7 8 9 10 T a b l e D-2  Subject  1  1  70.6 110.4 70.4 86.7 54.2 11.9 154.8  Exercise (Ipsilat. V s . Contralat.) (%) 55.8 87.5 192.7 123.0 78.0 78.8 101.4 100.3 147.3 122.0  Individual clearance rate data for breast cancer, subjects. Rest Ipsilat.  Rest Contralat.  Exercise Ipsilat.  Exercise Contralat.  (%-min" ) -0.185 -0.044 -0.195 -0.019 -0.179 -0.062 -0.106 -0.097 -0.031 -0.040 -0.083  (%-min" ) -0.106 -0.167 -0.200 -0.009 -0.240 -0.066 -0.121 -0.064 -0.082 -0.141 -0.143  (%mm ) -0.243 -0.138 -0.220  (%-min" ) -0.303 -0.157 -0.277  -0.133 -0.100 -0.137 -0.065 -0.013 -0.015 -0.111 -0.215 -0.238 -0.183  -0.071 -0.098 -0.194 -0.190 -0.118 -0.071 -0.161 -0.160 -0.200 -0.063  -0.117 -0.183 -0.158 -0.138 -0.067 -0.205 -0.137 -0.212 -0.284 -0.203 -0.179 -0.164 -0.128 -0.176 -0.277 -0.376 -0.374 -0.254  -0.131 -0.189 -0.301 -0.184 -0.105 -0.209 -0.167 -0.192 -0.173 -0.199 -0.241 -0.132 -0.149 -0.157 -0.265 -0.313 -0.282 -0.215  1  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22  1  Rest (Ipsilat. V s . Contralat.) (%) 42.0  1  1  136  1  Rest (Ipsilat. V s . Contralat.)  (%)  174.7 26.2 97.7 205.9 74.4 94.1 87.6 150.7 37.4 28.1 58.3 187.7 102.5 70.5 34.3 10.9 20.9 68.6 134.4 118.8 291.5  Exercise (Ipsilat. V s . Contralat.)  (%)  80.4 87.8 79.5 89.5 97.0 52.4 75.0 63.8 98.1 81.8 110.7 164.6 102.1 74.4 123.7 85.6 111.7 104.5 120.0 132.6 118.5  T a b l e D-3 bject  Individual clearance rate data for control subjects. Rest Ipsilat. (%-min- ) -0.067 -0.095 -0.062 -0.054 -0.102 -0.054 -0.104 -0.065 -0.109 -0.078 -0.097 -0.019 -0.112 -0.151 -0.130 -0.053 -0.125 1  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17  T a b l e D-4 Subject  1 2 3 4 5 6 7 8 9 10  Rest Contralat.  Exercise Ipsilat.  Exercise Contralat.  Rest (Ipsilat. V s . Contralat.)  Exercise (Ipsilat. V s . Contralat.)  (%-min- ) -0.059 -0.198 -0.058 -0.098 -0.033 -0.011 -0.110 -0.084 -0.064 -0.142 -0.086 -0.046 -0.135 -0.135 -0.175 -0.080 -0.109  (%-min- ) -0.103 -0.194 -0.077 -0.193 -0.098 -0.117 -0.122 -0.227 -0.154 -0.211 -0.166 -0.153 -0.149 -0.229 -0.259 -0.099 -0.132  (%min ) -0.128 -0.339 -0.108 -0.233 -0.111 -0.138 -0.142 -0.254 -0.138 -0.167 -0.135 -0.166 -0.338 -0.226 -0.244 -0.104 -0.146  (%) 113.8 48.2 107.4 55.5 308.9 499.6 94.4 77.9 169.9 54.8 113.5 41.5 83.2 112.1 74.2 66.1 113.8  (%) 80.7 57.2 71.2 82.7 88.5 84.4 86.0 89.1 111.3 125.9 122.2 92.4 44.1 101.6 106.2 95.4 90.3  1  1  1  Individual axillary uptake data for breast cancer related lymphedema subjects. Rest Ipsilat.  Rest Contralat.  Exercise Ipsilat.  Exercise Contralat.  Rest (Ipsilat. V s . Contralat.)  Exercise (Ipsilat. V s . Contralat.)  (%) 0.637  (%) 2.378  (%) 0.647 1.194 0.745  (%) 5.096 7.729 13.966  (%) 26.8  (%) 12.7 15.5  0.306 1.007 0.918 1.070 0.687 3.786 1.296  1.155 15.593 8.612 7.930 10.607 5.287 3.764  0.966 0.665 0.589 6.032 1.113  7.120 11.508 10.500 6.481 3.904  137  26.5 6.45 10.65 13.5 6.5 71.6 34.4  13.6 5.8 5.6 93.1 28.5  Table D-5 Subject  1 Z  3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 Table D-6 Subject  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17  Individual axillary uptake data for breast cancer subjects. Rest Rest Exercise Exercise Rest Ipsilat. Contralat. Ipsilat. Contralat. (Ipsilat. V s . Contralat.) (%) (%) (%) (%) (%) 11.476 7.101 6.685 7.008 161.6 4.072 2.334 12.878 2.667 2.891 4.636 1.086 1.048 4.328  5.259 3.242 18.284 2.956 4.096 4.286 2.728 4.827 15.693  4.173 5.010 2.482 2.243 1.355 2.193 3.677 6.520 9.539 2.965  7.092 3.944 4.508 3.323 5.544 6.113 8.093 6.942 7.871 2.390  4.071  6.576  10.450 9.107 4.143 4.570 0.833 1.710 2.210 6.575 7.452 9.485 3.421 4.223 2.512 8.243 4.950 9.194 . 14.844 3.247  10.886 12.662 8.698 8.562 5.218 9.444 12.313 7.073 14.169 14.146 4.958 2.002 5.409 10.080 10.922 8.714 11.449 6.342  77.4 72.0 70.4 90.2 70.6 108.2 39.8 21.7 27.6 58.8 127.0 55.1 67.5 24.4 35.9 45.4 93.9 121.2 124.1  Individual axillary uptake data for control subjects. Rest Rest Exercise Exercise Rest Contralat. Ipsilat. Contralat. (Ipsilat. V s . Ipsilat. Contralat.) (%) (%) (%) (%) (%) 7.436 8.040 114.3 11.332 9.914 2.568 6.645 49.8 1.980 3.975 7.491 6.497 117.1 6.110 5.218 2.895 4.735 5.756 64.6 1.869 252.3 5.945 2.356 12.763 7.273 11.794 6.657 172.8 2.643 4.566 12.654 80.3 8.156 15.348 6.549 4.735 5.756 64.6 1.869 2.895 5.133 105.3 4.060 3.854 5.946 6.234 87.1 5.236 5.339 4.559 113.4 12.929 9.094 8.151 7.189 99.6 2.808 9.121 10.710 2.797 66.2 6.562 9.912 6.363 16.895 8.071 10.266 5.795 10.378 78.6 12.697 11.808 11.496 68.5 8.091 3.504 2.201 3.926 73.5 2.576 8.232 7.137 4.519 176.0 14.488  138  Exercise (Ipsilat. V s . Contralat.) (%) 95.4 61.9 96.0 71.9 47.6 53.4 16.0 18.1 17.9 93.0 52.6 67.0 69.0 211.0 46.4 81.8 45.3 105.5 129.6 51.2  Exercise (Ipsilat. V s . Contralat.) (%) 92.5 38.6 115.3 82.3 175.5 177.2 82.4 82.3 115.8 85.6 142.2 85.2 37.7 55.8 90.5 56.1 157.9  T a b l e D-7 Subject  1 2 3 4 5 6 7 8 9 10 T a b l e D-8 Subject  1  o Z  3 zi 't 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22  Individual forearm uptake data for breast cancer related lymphedema subjects. Rest Rest Exercise Exercise Rest Exercise Ipsilat. Contralat. Ipsilat. Contralat. (Ipsilat. V s . (Ipsilat. V s . Contralat.) Contralat.) (%) (%) (%) (%) (%) (%) 1.689 0.968 2.771 1.043 174.5 265.7 1.571 0.933 168.4 11.296 1.191 948.3 0.862 0.776 111.1 3.187 0.807 5.912 1.028 395.1 574.9 2.194 0.63 4.746 1.23 349.7 385.0 1.938 1.269 3.739 1.297 152.8 288.3 3.352 1.345 6.761 0.944 249.2 716.2 3.174 0.702 5.532 0.717 452.3 771.1 1.094 1.164 1.099 0.971 93.9 113.1 Individual forearm uptake data for breast cancer subjects. Rest Rest Exercise Exercise Rest Ipsilat. Contralat. Ipsilat. Contralat. (Ipsilat. V s . Contralat.) (%) (%) (%) (%) (%) 0.721 0.991 1.040 1.349 72.8  Exercise (Ipsilat. V s . Contralat.) (%) 77.1  1.204  0.966  0.772  1.080  124.6  71.5  1.146 0.944 1.014 0.822  1.193 0.887 1.045 0.869 1.047 2.679  1.424 0.940 1.119 0.769 0.691 1.452 1.286 0.964 1.260 1.367  1.396 0.962 1.166 0.782 0.890 1.269 1.292 1.286 1.250 1.497  0.641 0.908 0.930 1.043 0.601 1.138 1.468 1.015 1.238 1.625 1.155 . 0.742 1.053 1.309 1.441 1.308 1.254 1.289  96.1 106.4 97.0 94.6  0.915 2.120  0.599 0.951 1.081 1.016 0.962 1.363 1.221 0.878 1.161 1.681 0.897 0.884 1.047 1.455 1.199 1.133 1.232 1.177  93.5 104.7 116.2 97.4 160.0 119.7 83.2 86.5 93.8 103.5 77.6 15.0 99.5 111.1 83.2 86.6 98.2 91.3  139  87.4 79.1 102.0 97.8 96.0 25.0 77.7 114.4 99.6 75.0 100.8 91.3  T a b l e D-9 Subject  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 T a b l e D-10  Subject  Individual forearm uptake data for control subjects. Rest Ipsilat.  Rest Contralat.  Exercise Ipsilat.  Exercise Contralat.  (%) 0.705 0.917 0.948 1.200 0.651 0.562 0.639 1.178 0.837 1.067 0.899 1.123 1.190 0.823 1.424 0.921  (%) 0.772 0.747 0.847 1.900 0.586 0.845 0.926 1.108 1.306 0.964 1.043 1.022 1.046 0.912 1.588 1.273  (%) 0.787 0.856 1.005 1.229 1.126 1.323 0.685 1.229 0.882 0.785 1.231 1.016 1.295 0.915 1.072 1.182 1.205  (%) 0.928 1.008 0.879 1.283 0.903 1.930 0.811 1.283 1.046 0.894 1.288 1.043 1.385 0.928 1.224 1.057 1.117  (%) 91.4 122.8 111.9 63.2 110.9 66.5 69.0 . 106.3 64.1 110.7 86.2 109.9 113.8 90.2 89.7 72.3  Exercise (Ipsilat. V s . Contralat.) (%) 84.7 84.9 114.4 95.8 124.6 68.5 84.4 95.8 84.4 87.8 95.5 97.4 93.5 98.6 87.6 111.8 107.9  Individual time of first appearance data for breast cancer related lymphedema subjects. Rest Ipsilat.  Rest Contralat.  Exercise Ipsilat.  Exercise Contralat.  1  (min) No app  (min) 15  (min) No app  (min) 15 '  3 4 5 6 7 8 9 10  No app No app No app No app 35 No app 35 55  25 25 25 15 15 15 15 25  No app  15  No app 25 45 25 35  15 15 5 15 15  9  Rest (Ipsilat. V s . Contralat.)  140  T a b l e D-11 jbject  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 T a b l e D-12 Subject  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17  Individual time of first appearance data for breast cancer subjects. Rest Rest Exercise Exercise Ipsilat. Contralat. Ipsilat. Contralat. (min) (min) (min) (min) 15 5 5 5 35 15 15 15 15 15 25 25 25 15 35 35 15 15 25 25 15 15 35 25 55 35 No app 25 25 15 25 15 25 5 20 20 5 5 25 35 15 25 5 5 25 25 15 15 45 25 15 25 25 35 15 25 15 15 15 25 5 15 15 15 15 15 15 5 25 25 Individual time of first appearance data for control subjects. Rest Rest Exercise Exercise Ipsilat. Contralat. Ipsilat. Contralat. (min) (min) (min) (min) 25 15 15 5 15 5 • 15 5 20 15 15 20 25 5 5 25 35 35 25 25 15 15 25 5 5 25 15 35 35 15 25 15 35 15  15 35 25 15 25 15 35 15  5 15 15 15 15 15 25 15  5 15 15 5 15 15 15 15  141  Table D-13.  C o m p a r i s o n of scoring system for evaluating breast cancer related lymphedema developed by S z u b a et al. and modified by Lane et al.  Scoring S y s t e m Proposed by S z u b a (103) Visualization of lymph nodes on the ipsilateral side • Symmetrical bilateral lymph node visualization •  Asymmetrical axillary lymph node clearly visible after exercise  •  Other lymph node visible after exercise • A n y lymph node on the affected side, visible only on the late images • No lymph node visible on the affected side Dermal backflow •  Modified Scoring System by Lane Axillary uptake (%, relative to contralateral arm) 78-120% (based on 9 5 % C l of C O N T )  Score 0  56-77%  1  34-55%  2  12-33% 3 <11%  5 Score  F O R E (%, relative to contralateral arm)  No dermal backflow 0  90-105% (based on 9 5 % C l of C O N T ) 106-160%  •  Small, localized, dermal backflow  1  •  Circumferential dermal backflow involving one segment of the limb  2  •  Circumferential dermal backflow involving more than one limb segment  3  Total  161-238% >239%  8  r  142  Total  T a b l e D-14.  Subj. BCRL 1 2 3 4 5 6 7 8 9 10 BC 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  Application of the modified scoring system for evaluating breast cancer related lymphedema applied to subjects with breast cancer related lymphedema ( B C R L ) , breast cancer (BC), and controls ( C O N T ) at rest and during exercise.  At risk? (3 or higher)  AX  13  REST TOTAL /8  15  FORE /3  3  2  5  At risk?  3 3 5  3 2 3  6 5 8  At risk? At risk? At risk?  3 5 5 3 5 1 2  1 3 3 1 3 3 0  4 8 8 4 8 4 2  At At At At At At  3 5 5 0 3  3 3 3 3 1  6 8 8 3 4  At At At At At  0  0  0  0  0  0  0  1  1  1  0  1  1 0 1 0  0 1 0 0  1 1 1 0  3 3  0 0  3 3  1 0 1 1 3 2 2 0 0 0  0 0 0  1 0 1  0 1 0 0 0 0  3 3 2 0 0 0  0 1 2 2 3 3 3 0 2 1 0 2 2 0 2 0 0 2  0 0 1 0 2 1 0 0 0 0 0 0 0 1 0 0 0 0  0 1 3 2 5 4 3 0 2 1 0 2 2 1 2 0 0 2  AX  FORE  15  risk? risk? risk? risk? risk? risk?  At risk? At risk?  At risk? At risk?  143  Exercise TOTAL /8  At risk? (3 or highe  risk? risk? risk? risk? risk?  At risk? At risk? At risk? At risk?  CONT 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49  0 2 0 1 2 3 0 1 0 0 0 0 1 0 1 1 0  0 1 1 1 1 1 1 1 1 1 1 1 0 0 1 0  0 3 1 2 3 4 1 2 1 1 0 1 2 0 1 2 0  At risk?  At risk? At risk?  144  0 2 0 0 3 3 0 0 0 0 1 0 2 1 0 1 2  0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 1 0  0 2 1 0 4 3 0 0 0 0 1 0 2 1 0 2 2  At risk? At risk?  At risk?  Panel A  • BCRL • BC A CONT  15  £ 41  10  1  -0.30  -0.25  -0.20  -0.15  -0.10  A  5  I •  -0.05  CR (% min' ) 1  • BCRL IBC . CONT  Panel B  20  -0.40  -0.35  -0.30  -0.25  -0.20  -0.15  CR (% min' ) 1  Figure D-1  Scattergram of contralateral clearance rate (CR) plotted against contralateral axillary uptake (AX) at rest (Panel A) and during exercise (Panel B) in all subjects (n=44). B C R L - diamond, B C - square, C O N T - triangle. 145  Panel A  • BCRL I BC  20  25 ALND  (#)  Panel B  • BCRL • BC  10  15  20  25  30  35  40  45  A L N D (#)  Scattergram of axillary lymph nodes dissected ( A L N D ) plotted against clearance rate ( C R , Panel A) and axillary uptake (AX, P a n e l B) during exercise in women treated for breast cancer ( B C - diamond, B C R L square). 146  Panel A  * radiation therapy * no radiation therapy  10  15  20  25  30  35  40  45  ALND (#)  Panel B  * radiation therapy H no radiation therapy  20  25  ALND (#)  Scattergram of clearance rate ( C R , P a n e l A) and axillary uptake (AX, P a n e l B) during exercise in women treated for breast c a n c e r ( B C and B C R L ) plotted against number of axillary lymph nodes dissected ( A L N D ) and stratified by whether radiation therapy w a s performed (radiation therapy - diamond, no radiation therapy - square).  147  

Cite

Citation Scheme:

        

Citations by CSL (citeproc-js)

Usage Statistics

Country Views Downloads
United States 12 0
China 7 27
Germany 7 7
Russia 3 0
Brazil 2 0
Japan 2 0
City Views Downloads
Unknown 15 7
Shenzhen 7 27
Ashburn 5 0
Stanford 2 0
Tokyo 2 0
Tucson 1 0
Rancho Santa Margarita 1 0

{[{ mDataHeader[type] }]} {[{ month[type] }]} {[{ tData[type] }]}
Download Stats

Share

Embed

Customize your widget with the following options, then copy and paste the code below into the HTML of your page to embed this item in your website.
                        
                            <div id="ubcOpenCollectionsWidgetDisplay">
                            <script id="ubcOpenCollectionsWidget"
                            src="{[{embed.src}]}"
                            data-item="{[{embed.item}]}"
                            data-collection="{[{embed.collection}]}"
                            data-metadata="{[{embed.showMetadata}]}"
                            data-width="{[{embed.width}]}"
                            async >
                            </script>
                            </div>
                        
                    
IIIF logo Our image viewer uses the IIIF 2.0 standard. To load this item in other compatible viewers, use this url:
http://iiif.library.ubc.ca/presentation/dsp.831.1-0077005/manifest

Comment

Related Items